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THE CRITICAL ROLE OF MECHANICAL
FORCES IN BLOOD VESSEL DEVELOP-
MENT, PHYSIOLOGY AND PATHOLOGY
VASCULAR ENDOTHELIUM: AN INTEGRA-
TOR OF HUMORAL AND BIOMECHANICAL
STIMULI IN THE CARDIOVASCULAR SYSTEM
Hemodynamics and vascular endothelial biology
The involvement of vascular endothelium in disease process-
es, such as atherosclerosis, has been recognized for over a
century, but a working knowledge of its relevant pathophys-
iology has been developed only recently, largely as a result of
the application of modern cellular and molecular biological
techniques. We now appreciate that this single-cell, thick lin-
ing of the circulatory system is, in fact, a vital organ whose
health is essential to normal vascular physiology and that its
functional phenotype can be dynamically regulated by vari-
ous physiologic and pathophysiologic stimuli, including bio-
chemical mediators, such as inflammatory cytokines, growth
factors, circulating hormones, and bacterial products.
Nonadaptive changes in this functional phenotype, so called
“endothelial dysfunction,” can be a critical factor in the
pathogenesis of vascular diseases.
In addition to biochemical stimuli, the endothelial lin-
ing of the cardiovascular system also is subjected to various
types of biomechanical stimuli resulting from pulsatile
blood flow. These stimuli include fluid shear stresses, cyclic
strains, and hydrostatic pressures. As the cellular layer
directly in contact with blood, the endothelium constantly
bears the frictional forces (wall shear stress) derived from the
flow of this viscous fluid. A number of in vivo observations
suggest that these hemodynamic forces can play a central
role in vascular homeostasis and pathophysiology. Blood
flow is an important modulator of vascular tone, acutely,
and also can influence more chronic processes of vascular
remodeling in both health and disease. Experimentally,
many of these effects appear to result at least in part from
the ability of the endothelium to sense and transduce hemo-
dynamic stimuli into changes in structure and function.
Examples include the increased macromolecular permeabil-
ity, lipoprotein accumulation, endothelial cell damage and
repair, leukocyte adhesion molecule expression, and
mononuclear leukocyte recruitment near branch points and
bifurcations (ie, in areas of complex, nonuniform disturbed
laminar flows). In addition, experimental alterations of vas-
cular architecture (eg, surgical shunts or deformations)
result in both acute and chronic vessel wall changes that
appear at least in part to be endothelium dependent and, in
the presence of hypercholesterolemia, can result in lesions
resembling atherosclerosis. Taken together, these observa-
tions are consistent with either direct or indirect effects of
one or more hemodynamic stimuli on endothelial func-
tion/dysfunction.
Evidence of the direct action of specific hemodynamic
forces on endothelial structure and function has come from
in vitro studies in which cultured endothelial monolayers
have been subjected to defined fluid mechanical forces.
Using experimental apparatuses that can reproducibly gen-
erate defined flows in vitro, a variety of cell biological
effects have been observed in endothelial monolayers in
response to applied shear stresses. Structural changes
include reorganization of cytoskeletal elements and gross
modification of cell shape; other functional changes include
a wide variety of alterations in the metabolic and synthetic
activities of endothelial cells. Certain of the more rapid
shear-induced changes appear to involve regulation of the
level of rate-limiting enzymes or substrate availability, and
other more delayed responses, in which de novo protein
synthesis is occurring, actually appeared to result from
upregulation of gene expression.
Patterns of endothelial gene expression induced
by biomechanical and humoral stimulation
The observation that defined fluid mechanical forces can
specifically influence endothelial gene expression has led to
the rapid elucidation of a growing, diverse set of endothelial
genes, whose expression can be modulated by fluid shear
stresses in vitro. In the majority of cases, these studies have
involved the detailed investigation of relevant “candidate
genes” (ie, genes that have been discovered or studied pre-
viously in other contexts) and have used primarily a simple
form of fluid mechanical stimulation (eg, a step application
of laminar shear stress). These studies have led to the appre-
ciation that many of these genes are being regulated at the
transcriptional level, a process involving definable, and in
SPECIAL COMMUNICATION
The following extended abstracts were presented at the Research Initiatives in
Vascular Disease Conference, Movers and Shakers in the Vascular Tree—
Hemodynamic and Biomechanical Factors in Blood Vessel Pathology, sponsored by The
Lifeline Foundation and the Cardiovascular & Interventional Radiology Research
and Educational Foundation; jointly sponsored by the International Society for
Cardiovascular Surgery, North American Chapter, The Society for Vascular Surgery,
and The Society of Cardiovascular and Interventional Radiology; in cooperation
with the National Institutes of Health–National Heart, Lung & Blood Institute on
Mar 11–12, 1999, in Bethesda, Md.
In order to ensure the widest dissemination possible, these
abstracts also will appear in the July issue of the Journal of
Vascular and Interventional Radiology (published by
Lippincott-Raven).
JOURNAL OF VASCULAR SURGERY
Volume 29, Number 6 Special Communication 1105
some cases unique, cis-acting regulatory elements in the pro-
moters of these genes and corresponding trans-acting pro-
tein (transcription factors) that interact with these genetic
regulatory elements.
Initially, our laboratory group focused on the analysis of
the promoter elements responsible for the transient upreg-
ulation of the PDGF-B gene in response to applied steady
laminar shear stresses. These studies led to the identification
of a novel six-base pair motif, which was termed the “shear
stress response element (SSRE),” which was demonstrated
to be both necessary and sufficient for the upregulation of
the PDGF-B promoter in response to a shear stimulus in
vitro. This novel element, which is capable of interacting
with the transcription factor NF-kB, is able to confer shear
stress responsiveness to a normally nonshear responsive pro-
moter construct in vitro. Subsequently, work in several lab-
oratories has identified additional SSREs, which are present
in the promoters of various pathophysiologically relevant
endothelial expressed genes, including MCP-1, PDGF-A,
TGF-b 1, and VCAM-1 genes, which interact with a variety
of trans-acting factors.
In addition to these candidate gene and detailed pro-
moter analysis studies, more recently, we have begun to
apply complementary strategies to study the problem of
endothelial gene expression in response to biomechanical
stimulation. These studies have involved the use of high-
throughput gene analysis techniques, such as differential
RT-PCR display and subtraction hybridization, which, by
their very nature, do not require a priori identification of
“candidate genes” and thus can yield potentially unantici-
pated insights into the patterns (eg, the magnitude and
complexity) of the endothelial response. Taken together,
the data from such studies have defined unique patterns of
endothelial gene expression that appear to be regulated
either by biochemical (humoral) or biomechanical stimula-
tion. In certain cases, in addition, biomechanical and bio-
chemical stimuli appear to act in a complementary or syn-
ergistic fashion in the upregulation of endothelial genes.
Endothelial genes differentially responsive to
steady laminar shear stress
The observation that the early lesions of atherosclero-
sis are predominantly localized to regions of the arterial
vasculature associated with complex, nonuniform flows
(eg, bifurcations and curvatures) and areas characterized
by relatively uniform flows (steady laminar shear stresses)
tend to be spared strongly suggests that fluid mechanical
stimuli are playing an important role in the atherogenic
process. In collaboration with Dr Dean Falb’s group at
Millennium Pharmaceuticals, Inc (Cambridge, Mass), we
used a high-throughput differential display of mRNA
transcripts to compare the patterns of genes that are up-
regulated or down-regulated in human endothelial cells in
response to a physiological level of steady laminar shear
stress, compared with a comparable level of turbulent
(nonlaminar) shear stress and also a soluble inflammatory
cytokine stimulus. These studies revealed distinctive pat-
terns of gene expression not previously observed in
endothelial cells, including a subset of genes that
appeared to be upregulated, in a sustained fashion, by
steady laminar shear stress but not by turbulent shear
stress. Certain of these differentially regulated transcripts
reflect the upregulation of novel genes, such as ecNOS
(the endothelial isoform of nitric oxide synthase), 
COX-2 (the inducible isoform of cyclooxygenase), and
MnSOD (manganese-dependent superoxide dismutase).
Interestingly, both MnSOD and COX-2 have not previ-
ously been appreciated as flow-regulated genes. These
endothelial genes include enzymes that can exert potent
antithrombotic, antiadhesive, antiproliferative, antiinflam-
matory, and antioxidant effects both within the endothe-
lial lining and in interacting cells, such as platelets, leuko-
cytes, and smooth muscle. The biological consequences of
these steady-laminar-shear-stress upregulated endothelial
genes would be predicted to be “vaso-protective” or
“anti-atherogenic.” In addition, steady laminar shear
stress has been reported to inhibit the cytokine-induced
expression of the mononuclear leukocyte adhesion mole-
cule VCAM-1, which has been implicated in the recruit-
ment of circulating monocytes at sites of atherosclerotic
lesion formation.
These findings have suggested a hypothesis, which we
have termed the “athero-protective gene hypothesis,”
which can be stated as follows: the coordinated induction
of a subset of endothelial genes whose effects would be
predicted to be anti-atherogenic, or vaso-protective, by
uniform shear stress associated with areas of the vasculature
that are protected from early lesions of atherosclerosis may
contribute to the focal nature of this disease process.
Although this hypothesis does not exclude a role for the
disturbed flows (eg, disturbed laminar, oscillatory, or
reversing flows) associated with locally complex geometries
as “direct pro-atherogenic stimuli,” it represents an addi-
tional conceptual framework in which to approach this
complex biological phenomenon. 
Integration of biomechanical and biochemical
stimuli in the modulation of endothelial phenotype
Recently, our differential display strategy has led to the
discovery of two novel genes, Smad6 and Smad7, which
include members of the MAD-related family of molecules,
important in the signaling pathways that are activated by
TGF- b stimulation. Thus, Smad6 and Smad7 appear to
constitute a novel class of MAD-related proteins that are
induced by fluid mechanical forces and can modulate gene
expression in response to both humoral and biomechanical
stimulation. These findings suggest that distinct biome-
chanical or biochemical input stimuli can be integrated in
the endothelial cell.
The endothelial lining of the cardiovascular system
comprises a dynamically mutable interface, whose pheno-
type appears to be responsive, on the one hand, to sys-
temic and local humoral factors, and, on the other hand,
to biomechanical forces generated by the flow of blood,
the precise properties of which can vary, depending on the
local vascular geometry. Currently, the challenge for
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future studies will be to gain a working understanding of
how these very different input stimuli are integrated and
transduced into biological responses in the endothelial cell
and further how their interplay contributes to the function
of this vital component of the cardiovascular system in
health and in disease.
Original research studies in the Gimbrone Laboratory
were supported by grants from the National Institutes of
Health (P50-HL56985, R37-HL51150) and a Sponsored
Research Agreement from Millennium Pharmaceuticals,
Inc, Cambridge, Mass, to the Brigham and Women’s
Hospital.
Michael A. Gimbrone, Jr, MD
Keith R. Anderson
James N. Topper
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FLUID DYNAMICS IN VASCULAR PATHOLOGY:
ADAPTATIONS OF THE ARTERIAL WALL TO
CHRONIC CHANGES IN BLOOD FLOW
Local hemodynamic forces control the development,
structure, and function of blood vessels;1 therefore, it is
not surprising that these forces have been implicated in the
pathogenesis of vascular disorders. Two of these disorders,
atherosclerosis and bypass graft occlusion, give rise to focal
proliferative lesions at reproducible locations near natural
or constructed branch sites in large and medium-sized
arteries, where hemodynamic stresses are much different
from those prevailing in unbranched vessel segments. A
role for local hemodynamics, especially shear stress, in the
initiation of lesions is supported by experiments in which
manipulations of shear modify lesion development in ani-
mal models.2,3 Furthermore, pathologies that chronically
modify blood flow in arteries elicit shear-related remodel-
ing that probably influence substantially the progression of
these disorders. This presentation will review the local
hemodynamics that are imposed on arterial sites that are
susceptible to lesion development, then we will consider
tissue responses to these forces and how they might con-
tribute to proliferative and remodeling responses.
Hemodynamics in the arterial tree
Two factors conspire to greatly complicate local
hemodynamics near arterial bends and branch sites: the
complex geometry of these sites and the momentum of
flowing blood. Momentum of blood, which is associated
with the relatively high flow velocities in arteries, results in
flow streamlines that do not simply follow vessel geome-
try; instead, complex secondary flows (eg, vortices) result.
These secondary flow patterns near branch sites fluctuate
with the cardiac cycle; consequently, endothelium near
arterial branch sites is exposed to shear stresses that pulsate
in both magnitude and direction, and they are exposed to
large temporal and spatial gradients in shear stress. These
secondary flows are not turbulence, which occurs only
with very high momentum flow and results in random
fluctuations in blood velocity. Transient turbulence may
occur during systole in the human aorta4 and at very high
physiologic flow rates in some arteries (eg, large arteries
supplying maximally exercising muscle). Also, it may be
produced by severe pathologic stenoses in large vessels.
However, it is not characteristic of most of the human
arterial tree under resting conditions. The transition from
flow that follows vessel geometry (Stokes flow) to sec-
ondary flows, and then to turbulence, is determined by
the Reynolds number. The Reynolds number is the ratio
of momentum-related forces, which promote secondary
flows and turbulence, to viscous forces, which damp out
these flow disturbances. (Secondary flows first appear
when the Reynolds number exceeds approximately 1,
whereas turbulence requires that it exceed 1000 to 2000.)
Reynolds number is lower in smaller vessels, due to rela-
tively higher viscous forces.
Dependence of Reynolds number on vessel size
impacts significantly on the inferences that can be drawn
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from common animal models. For example, the most real-
istic rabbit and mouse models of atherogenesis show a
lesion distribution that is primarily localized to high shear
regions, whereas humans first get lesions at sites of sec-
ondary flows where low, fluctuating shear stresses prevail.
This finding may reflect fundamental species differences in
vessel wall biology that impact on atherogenesis; however,
the influences of body size on hemodynamics suggest
other explanations. For example, the Reynolds number at
comparable sites increases dramatically with body size.
According to available data, the Reynolds numbers in
descending thoracic aortas are approximately 50 in mice,
600 in rabbits, and 1500 in humans. It follows that sec-
ondary flows near arterial branch sites are much more
prominent and extend over relatively greater distances in
larger species, so any atherogenic consequences of low,
fluctuating shear stress may be rare in small animals.
Although secondary flows are suppressed in smaller ani-
mals, shear stresses are much higher because the relatively
high metabolic rate of these animals demands relatively
higher blood flow rates. For example, if published data on
cardiac outputs5 are combined with aortic diameters (our
unpublished data), then computed shear stress is 10-fold
higher in the mouse aorta (>100 dynes/cm2) than in the
human aorta (@ 10 dynes/cm2).
These considerations indicate that arterial systems of
smaller species are characterized by higher shear stresses
and by more stable flow conditions. If both high shear
stress and secondary flows can result in atherogenic stim-
uli, then the former may dominate in smaller species and
the latter in larger species.
The endothelium: transducer and target of shear
stress
Almost all available evidence supports the hypothesis
that the endothelium is the site of shear stress transduction
in the arterial wall. There is now evidence that multiple
endothelial shear sensors elicit responses via interlinked
signal transduction pathways. Recent work has focused on
shear sensing at focal adhesion plaques and at G protein-
coupled receptors. However, shear-sensitive ion channels
also have been identified. The capacity of shear stress to
drive multiple signal transduction cascades is not surpris-
ing, given the spectrum of physiological responses and the
large panel of genes that shear regulates via a growing
array of transcriptional regulators.
Endothelial cells not only transduce shear stress, but
remodeling of the arterial wall in response to shear begins
at the level of the endothelium. Thus, cell shape, orienta-
tion, and cytoskeletal organization are sensitive to shear
stress. Although this morphologic sensitivity to shear is
well known, its regulation is poorly understood and some
important implications are generally ignored. For exam-
ple, shear-induced formation of large stress fibers, which
insert into focal adhesion plaques at the basal surface of
the cells, may enhance substrate adhesion; however, it also
may dramatically affect the sensitivity of shear transduc-
tion at these focal adhesion sites.
Shear stress–induced changes in cell shape also have
potentially important implications for physiologic func-
tions of endothelium. We have found that cell shape
change necessitates the partial disassembly then reassem-
bly of the adherens junction, a cadherin-based protein
complex that mediates cell-cell adhesion. Reassembly is
not completed until 24 to 48 hours after shear stress is
imposed; furthermore, endothelial cells exhibit a discon-
tinuous adherens junction under steady state shear stress.
Disruption of the adherens junction compromises the
endothelial permeability barrier, which may explain high
endothelial permeability at vascular sites that are exposed
to complex, time-dependent flow conditions.
Shear stress–induced medial remodeling
Flow-induced remodeling of the arterial media results
in changes in arterial diameter that return wall shear stress
toward normal in a negative feedback manner. It involves
acute vasomotor responses followed by chronic wall
restructuring, and both phases are driven by endothelial
cell sensitivity to shear stresses. Acute vasomotor respons-
es are predominantly mediated by nitric oxide release, a
response that probably is amplified over time by increased
expression of the endothelial cell nitric oxide synthase
(ecNOS) gene.
Structural changes with long-term blood flow alter-
ations involve both elaboration of wall tissue and its reor-
ganization. Experimental decreases in flow rates in devel-
oping arteries slow accumulation of endothelial and
smooth muscle cells, the two cell types found in the inti-
ma/media of healthy arteries, and this effect is due to reg-
ulation of both apoptosis and cell proliferation.6
Arterial elastin also is influenced by blood flow alter-
ations. Elastin is a very important matrix constituent in
large arteries because it bears much of the wall tension
generated by blood pressure. Therefore, it is a major
determinant of resting vessel diameter. Both spontaneous
and experimental reductions in blood flow rates inhibit
elastin accumulation in immature arteries. Also, reorgani-
zation of elastin, and net accumulation, are important in
arterial remodeling. Elastin in large arteries is laid down in
concentric, fenestrated lamellae. New elastin is deposited
randomly onto the surfaces of lamellae, except from some
targeting to fenestrae.7,8 Therefore, pre-formed elastin
must be reorganized during remodeling, probably
through coordinated synthesis and degradation. An
endogenous vascular elastase was identified in developing
arteries, and its expression during normal development
suggests a role in normal remodeling, although both
MMP-2 and MMP-9 appear to be involved also.
We have also found that fenestrae that perforate elas-
tic lamellae increase both in size and in number during
postnatal growth, such that the space occupied by the
fenestrae increased over 20-fold between 3 weeks of age
and adulthood.9 This enlargement of fenestrae occurred
while the lamellae accumulated large amounts of 
new elastin and despite preferential deposition at fenes-
trae. Thus, production and enlargement of fenestrae 
contributes substantially to growth of the lamellae.
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Importantly, manipulations of blood flow dramatically
altered growth of fenestrae. They enlarged much more
rapidly when flow rates were increased, and they became
smaller when flow rates were suppressed. Changes in
other matrix constituents have not been widely studied,
but total collagen contents are relatively insensitive to
decreases in blood flow.
B. Lowell Langille, PhD




1. Langille BL. Blood flow-induced remodeling of the artery
wall. In: Bevan JA, Kaley G, Rubanyi G, editors. Flow-depen-
dent regulation of vascular function. New York: Oxford;
1995. p. 277-99.
2. Krais LW, Kirkman TR, Kohler TR, Zieler B, Clowes AW.
Shear stress regulates smooth muscle proliferation and neoin-
timal thickening in porous polytetrafluoroethylene grafts.
Arterioscler Thromb 1991;11:1844-51.
3. Roach MR, Fletcher J. Effect of unliateral nephrectomy on
the localization of aortic sudanophilic lesions in cholesterol-
fed rabbits. Atherosclerosis 1976;24:327-33.
4. Nichols WW, O’Rourke MF. McDonald’s blood flow in
arteries. Philadelphia: Lea and Febiger; 1990.
5. Wang P, Ba ZF, Burkhardt J, Chaudry IH. Trauma-hemor-
rhage and resuscitation in the mouse: effects on cardiac out-
put and organ blood flow. Am J Physiol 1993;264:H1166-73.
6. Cho A, Mitchell L, Koopmans D, Langille BL. Effects of
changes in blood flow rate on cell death and cell proliferation
in carotid arteries of immature rabbits. Circ Res 1997;
81:328-37.
7. Davis EC. Immunolocalization of microfibril and microfibril-
associated proteins in the subendothelial matrix of the devel-
oping mouse aorta. J Cell Sci 1994;107:727-36.
8. Davis EC. Elastic lamina growth in the developing mouse
aorta. J Histochem Cytochem. In press 1995.
9. Wong LCY, Langille BL. Developmental remodeling of the
internal elastic lamina of rabbit arteries. Effect of blood flow.
Circ Res 1996;78:799-805.
REGULATION OF INTIMAL GROWTH AND
REGRESSION BY BLOOD FLOW
Changes in blood flow are usually associated with cor-
responding changes in vascular diameter and structure;
high flow causes vasodilation, and reduced flow causes
vasocontraction.1 In rigid, diseased arteries or in synthetic
arterial grafts, vasomotor activity is not possible, and
changes in blood flow and velocity might have other
effects. We have begun to test the hypothesis that blood
flow can affect the structure of the neointima of polytetra-
fluoroethylene (PTFE) grafts in baboons by stimulating
smooth muscle cell (SMC) growth or inducing SMC
apoptosis.
PTFE grafts (4 mm i.d.) placed in the retroperi-
toneum as replacements for baboon iliac arteries develop a
neointima lined on the lumenal surface by endothelium
and composed of SMCs and extracellular matrix. These
vascular cells appear to come from the adjacent transected
artery or microvessels arising from the surrounding gran-
ulation tissue.2 It is also possible that some of the cells
come from the blood or evolve from undifferentiated
fibroblasts.3-5 The neointima formed on the inner surface
of the PTFE grafts reaches a maximum within 3 months
and does not change thereafter.
If the grafts are placed under high flow conditions, the
neointima that develops is thinner, even though the mor-
phological appearance is identical to the neointima formed
under normal flow conditions.6,7 The neointima, once
formed, can be induced to grow simply by restoring blood
flow to normal (“flow switch”). On the other hand, if the
neointima develops under normal flow conditions, it can
be induced to shrink by the addition of a small femoral
arteriovenous fistula and a three-fold increase in blood
flow (“reverse flow switch”). The biological basis for
growth and atrophy of the neointima in PTFE grafts is just
now being worked out.
In the “flow switch” experiments, the grafts are insert-
ed into the aortoiliac circulation and distal AV fistulas are
established in both legs. After 2 months, one of two fistu-
las is closed. The neointimal area increases three-fold to
five-fold during the next month on account of SMC pro-
liferation and the deposition of matrix. It is of note that
endothelial denudation and platelet deposition are not
part of this kind of intimal response, yet in ballooned rat
carotid arteries they are absolutely required for SMC
migration and intimal thickening.8 Nevertheless, some of
the platelet borne factors (eg, platelet-derived growth fac-
tor) active in the denuded artery might still play a role in
the endothelialized graft. Platelet-derived growth factor
(PDGF), first detected in platelets, is synthesized by all
vascular wall cells. The corresponding PDGF receptors
(PDGFR-a and PDGFR-b ) are expressed by the SMCs.9
We have shown that “flow-switch” induces the expression
of PDGF-A chain while PDGF-B chain cannot be detect-
ed in the neointima, although the dimeric PDGF-B–con-
taining proteins are found in the macrophages associated
with the graft matrix. PDGF-B might also be expressed by
the endothelium, even though we have been unable to
detect it.10 The importance of PDGF and activation of the
PDGF receptors has recently been demonstrated in block-
ing experiments. Neointimal thickening in response to
“flow switch” is suppressed by treatment with highly spe-
cific monoclonal antibodies to PDGFR-b (Davies, Owens,
Clowes, unpublished observations).
Neointimal atrophy caused by “reverse flow switch,” a
shift from normal to high blood flow, is the result of
decreased SMC proliferation, SMC death, and loss of
matrix; the response to “reverse flow switch” is already
apparent within 4 to 7 days11 (Davies, Berceli, Fischer,
Kenagy, Clowes, unpublished observations). What factors
are responsible for killing the cells and inducing a prote-
olytic response are not known. It is clear that PDGF-A
chain expression is suppressed and endothelial nitric oxide
synthase expression induced by high blood flow
(Mattsson, Kraiss, Clowes, unpublished observations). It
is also know that PDGF, like many growth factors, is also
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a survival factor. Nitric oxide, the enzymatic product of
eNOS, usually functions as a vasodilator, but it can also
inhibit SMC growth and cause cell death. It is possible
that the combination of a decrease in PDGF and a local
increase in NO triggers the apoptotic response. This
hypothesis has not yet been tested.
These experiments indicate to us that intimal thicken-
ing in humans is probably not a unidirectional injury
response and that under some conditions it can be made
to regress. The implications of this conclusion need to be
explored as a strategy for reversing restenosis in vascular
reconstructions.
Alexander W. Clowes, MD
Scott Berceli
Mark G. Davies
The University of Washington School of Medicine
Seattle, Wash
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PRINCIPLES OF BLOOD VESSEL DEVEL-
OPMENT—ANGIOGENESIS, VASCULOGE-
NESIS AND ARTERIOGENESIS
CONTRIBUTION OF UNIQUE SMC SUBPOP-
ULATIONS TO VASCULAR DISEASE
Abnormal accumulation of cells within the intimal
space is a fundamental pathologic feature of vascular dis-
ease.1 The changes in vessel wall function caused by this
process are significant, and their impact on human health is
tremendous. Therefore, much attention has been focused
on the mechanisms contributing to abnormal cell accumu-
lation in the intima as well as on strategies aimed at inhibit-
ing abnormal cell replication. Experiments in animal mod-
els have suggested that several growth factors may play
important pathogenic roled in neointimal lesion formation.
However, clinical trials based on targeted blockade of a sin-
gle growth factor have been largely unsuccessful, suggest-
ing either a multiplicity of growth factors involved in
neointima formation or the existence of unique pro-prolif-
erative mechanisms intrinsic to the cells forming the neoin-
tima. Work in our laboratory has focused on the latter
hypothesis and is briefly summarized below.
It has been hypothesized that SMC replicating after
vascular injury reiterate a developmental pattern of gene
expression related to growth control.2,3 Previous studies
in our laboratory have demonstrated that one mechanism
contributing to SMC growth during embryonic vascular
development is the capacity for extremely rapid growth
independent of known mitogens (autonomous, self-driven
growth).4 Consistent with the above hypothesis, we have
found that at least some SMC obtained from the neointi-
ma of the balloon catheter–injured rat carotid artery
exhibit a growth phenotype, which is very similar to that
expressed by vascular SMC during embryonic develop-
ment.5 In particular, we have shown that early neointima
formation, which is characterized by rapid increases in
SMC number, is associated with the transient reexpression
of an autonomous, mitogen-independent growth pheno-
type by SMC. Autonomous replication of embryonic and
neointimal SMC appears to be very tightly regulated tem-
porally and largely independent of serum or mitogens,
suggesting that replication of SMC during embryonic
development and after vascular injury may be genetically
predetermined and self-regulated. To facilitate our charac-
terization of the autonomous growth phenotype, using a
subtractive hybridization approach, we cloned 14 inde-
pendent embryonic genes (operationally referred to as
“emb” genes) that were expressed by autonomously repli-
cating cells but were not found in replicating, serum-stim-
ulated adult SMC. Preliminary sequencing and in situ
hybridization screening of all 14 clones showed that five of
the 14 clones (emb7, emb8, emb20, emb37, and emb41)
are apparently novel genes and are highly expressed in
SMC during periods of autonomous replication (ie, in
embryonic and injured arteries) but are undetectable in
adult, uninjured arteries. Preliminary antisense studies
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using single-stranded sense and antisense oligonucleotides
designed against the 5´ region containing the start codon
of one of these clones, emb8, have shown that antisense,
but not sense, oligonucleotide treatment attenuated
autonomous growth of embryonic SMC. Therefore, given
their in vivo expression patterns, it seems likely that “emb”
genes will be found to play important biological roles in
early vascular development when rapid SMC replication is
occurring. Further, reexpression of certain emb genes after
vascular injury may contribute to the excessive replication
of SMC in the forming neointima.
Our observation that cells accumulating in the neoin-
tima, at specific time points after mechanical injury, exhib-
it a self-driven growth phenotype raises the question as to
whether differentiated contractile SMCs comprising the
arterial media have the potential to acquire this phenotype
or there is a subset of cells that pre-exists in the normal
arterial media and is capable of expressing this unique pro-
liferative phenotype. Previous data from our laboratory
have demonstrated the existence of phenotypically hetero-
geneic SMC subpopulations within the bovine arterial
media, which contribute selectively to the vascular changes
observed in hypoxia-induced neonatal pulmonary hyper-
tension.6,7 We therefore sought to determine whether
there is a subset of cells in the normal vessel wall that pos-
sess the capacity for autonomous, self-driven growth and
that therefore could contribute selectively to the neointi-
ma formation.
We were able to selectively isolate from the suben-
dothelial region of normal mature bovine arterial media
subpopulations of cells (termed L1-cells), which are phe-
notypically distinct from SMC in the adjacent middle
media (L2-SMC).8 The subendothelial L1-cells exhibited
enhanced growth potential compared with middle media
L2-SMC and, most interestingly, demonstrated a unique
ability for autonomous or self-driven growth under serum-
deprived (0.1% serum) conditions. Middle media L2-SMC
always remained quiescent in 0.1% serum. Importantly, we
found that hypoxia (3% oxygen) stimulated the growth of
L1-cells under serum-deprived conditions while growth of
L2-SMC was always inhibited by hypoxia.
We went on to investigate the intracelluar signaling
mechanisms that contribute to the self-driven serum-inde-
pendent growth of unique subpopulations of subendothe-
lial L1-cells and compared them with those operating in
L2-SMC.9 Because proliferation in most cell types has
been shown to correlate with activation of the p44mapk
and p42mapk members of the mitogen activated protein
kinase (MAPK) family, also known as ERK-1 and ERK-2,
we evaluated ERK-1/ERK-2 (ERK1/2) activity in both
cell types after prolonged periods of serum deprivation (72
hours in 0.1% serum). Basal ERK1/2 activity in suben-
dothelial L1-cells was three-fold higher than that in mid-
dle media L2-SMC. We then employed PD90859, a high-
ly selective inhibitor of MEK-1, which has been previous-
ly shown to effectively inhibit activation of ERK1/2.
Treatment of L1-cells with PD90859 markedly (by 80%)
inhibited autonomous, self-driven growth of these cells,
suggesting that the constitutively activated ERK1/2 in
subendothelial L1-cells were playing an essential role in
the autonomous, self-driven growth of these cells. We
then assessed the role of the upstream activator of ERKs,
small GTP-binding protein Ras (p21ras), in mediating
ERK-dependent autonomous growth of subendothelial
L1cells. The farnesyl transferase inhibitor, BZA-5B, which
has been previously demonstrated to effectively block acti-
vation of Ras, partially (43%) inhibited growth of L1-cells
under serum-deprived conditions, suggesting that self-dri-
ven growth of L1-cells is mediated through both Ras-
dependent and Ras-independent signaling pathways. Ras
has been previously shown to be a point of convergence
for many cell surface mitogenic signals, including those
mediated through Pertussis toxin (PTx)–sensitive Gi-pro-
tein coupled receptors (GiPCR) and receptor tyrosine
kinases (RTK). Utilizing both agonist and antagonist
strategies, we found that one critical factor that may con-
tribute to the elevated levels of ERK1/2 activity and aug-
mented growth potential of subendothelial L1-cells
(under both serum-derived and serum-stimulated condi-
tions) is the heightened sensitivity of these cells to mito-
genic signaling via GiPCR pathways. GiPCR pathway in
L1-cells is readily activated by Gi agonists, such as throm-
bin and lysophosphotidic acid. In contrast, middle media
L2-SMC, which grow slowly under serum-stimulated con-
ditions and do not grow in the absence of serum, appear
to mediate mitogenic signals predominantly via RTK-
mediated pathways.
It has recently been shown that differential growth
responses of vascular SMC may be the result of differences
in the availability of downstream targets for ERKs, includ-
ing the cytosolic form of phospholipase A2 (cPLA2), a key
enzyme in the eicosanoid production pathway. We there-
fore sought to determine whether the elevated levels of
ERK activity in L1-cells would be associated with
increased expression of cPLA2 and other members of
eicosanoid pathway. cPLA2 protein expression and activity
were markedly elevated in subendothelial L1-cells as com-
pared with middle media L2-SMC. Arachidonic acid, lib-
erated by cPLA2, is metabolized by constitutive or
inducible cyclooxygenases (COX-1 and COX-2, respec-
tively) to prostaglandins. We observed high levels of
expression of the inducible form of cyclooxygenase, COX-
2, in L1-cells but not in L2-SMC under serum-deprived
conditions. L1-cells demonstrated remarkably high basal
levels of PGE2 and PGI2 release into culture medium
compared with L2-SMC. To assess the potential contribu-
tion of the secreted prostanoids to the autonomous
growth of L1-cells, we tested two nonselective cyclooxy-
genase inhibitors that suppress prostaglandin production
(indomethacin and sulindac sulfide). Both inhibitors had
no effect on autonomous growth of L1-cells. These data
are consistent with previous reports demonstrating a lack
of growth inhibition of neointimal cells (in contrast to
growth inhibition of medial SMC) by endogenous or
exogenous prostaglandins.10
In summary, experimental data from our laboratory
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demonstrate that SMC isolated from the neointima at
early time points after injury (7 to 14 days) exhibit serum-
independent, self-driven growth. Importantly, we were
also able to demonstrate that similar cells with serum-
independent, self-driven proliferative potential ordinarily
exist in the subendothelial region of the normal mature
arterial wall. Taken together, our data raise the possibility
that formation of the neointima may result from selective
expansion of a unique subset of cells with a heightened or
self-driven growth potential resulting from constitutive
activation of pro-proliferative intracellular signaling path-
ways. The development of future therapeutic strategies
should be based on continuing advancements in our
understanding of the cell types/phenotypes comprising
the neointima and contributing to pathogenesis of vascu-
lar disease.
Kurt R. Stenmark, MD
M. G. Frid
M. C. M. Weiser-Evans
A. A. Aldashev
R. A. Nemenoff
University of Colorado Health Sciences Center
Denver, Colo
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DEVELOPMENTAL ORIGINS OF VASCULAR
SMOOTH MUSCLE DIVERSITY
Vascular development begins with the differentiation
of endothelial cells from angioblasts and the subsequent
formation of a primary network of capillary-like vessels
throughout the embryo.1 As development proceeds, the
primary network undergoes structural remodeling to pro-
duce a series of large and small vessels.2 At the onset of
contractile activity within the tubular heart, endothelial
cells begin to recruit a supporting layer of mesenchymal
cells that will form a tunica media. Smooth muscle cell
(SMC) differentiation occurs within mesenchymal cell
clusters as they form and condense around the endotheli-
um. SMC differentiation is followed by the production of
a highly organized extracellular matrix that defines the
vessel wall. Although these general features of vascular
development have been known for many years, the genet-
ic and molecular mechanisms that control vascular devel-
opment have remained a mystery. Recently, new genetic
approaches to the study of vertebrate development have
begun to identify the molecules that control critical steps
in the formation and remodeling of the vascular system.
Origins of endothelial cells
The first visible structure to emerge in vascular devel-
opment is the blood island, a cluster of hematopoietic cells
surrounded by endothelial cells that appear as isolated foci
dispersed across the extraembryonic mesoderm.1 The
close proximity of blood cells and endothelial cells in
blood islands first led to the proposal of a common prog-
enitor cell called the hemangioblast early in this century.
Over the years, multiple lines of evidence provided by his-
tologic, immunochemical, and molecular genetic studies
have provided strong support for the existence of heman-
gioblasts. A primitive vascular plexus is then formed by dif-
ferentiation of endothelial cells in situ followed by the
anastomosis of adjacent endothelial cells to form intercon-
necting blood islands.3 The process of vessel formation by
connection of endothelial aggregates that differentiate in
situ is called vasculogenesis.1 Vasculogenesis first takes
place in the extraembryonic mesenchyme to form blood
islands and then shortly thereafter in splanchnopleural
mesoderm within the embryo proper to form the dorsal
aorta and other large vessels.4 Vasculogenesis requires
inductive interactions between the splanchnopleural
mesoderm and the underlying endoderm because removal
of the endoderm results in failure of angioblast differenti-
ation. Members of the fibroblast growth factor (FGF)
family are implicated as endoderm-derived inducers that
direct embryonic mesoderm to form angioblasts while
VEGF and angiopoietin-1 are critical factors for endothe-
lial differentiation and maturation, respectively.
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Origins of smooth muscle cells
Once the basic pattern of capillary-like vessels has
been established in the embryo, the next step in wall for-
mation is the assembly of a tunica media. Endothelial cells,
responding to the onset of blood flow resulting from con-
tractile activity in the developing heart, recruit SMCs from
the surrounding mesenchyme. Lineage analysis studies 
in the avian and mammalian embryo have shown that vas-
cular SMCs arise from multiple independent lineages
throughout the embryo. For example, chick-quail chi-
meric embryos have established that the aortic tunica
media is composed of SMCs from two different types of
progenitor cells.5 One type originates in the cranial neur-
al crest and is therefore neural ectoderm in origin (Ect
SMCs). The other type originates from lateral mesoderm-
derived mesenchyme that surrounds the developing out-
flow elastic arteries (Mes SMCs). Because the proximal
aorta develops within the pharyngeal arch complex and
the mesenchymal cells within the pharyngeal arches are
almost entirely of neural crest origin, it follows that the
SMCs that form the walls of the proximal aorta are Ect
SMCs. This holds true also for the common carotid arter-
ies, pulmonary and brachiocephalic arteries, and ductus
arteriosus whose SMCs are largely Ect SMCs. The distal
aorta is composed entirely of Mes SMCs. The borders
between Ect and Mes SMCs tend to be sharp with little or
no intermixing.6
Origins of coronary SMC
More recent studies employing retroviral lineage
markers and gene targeting have provided evidence for a
third independent origin for vascular SMCs in the verte-
brate embryo. Coronary artery smooth muscle cells
(SMCs) originate from progenitors in the proepicardial
organ (PEO), a transient structure formed by mesothelial
cells at the ventral surface of the pericardial coelom over-
lying the sinus venosus.7,8 In the avian embryo, the PEO
first appears at Hamburger-Hamilton stage (HH) 14 as a
small cluster of finger-like projections that extend across
the coelomic cavity toward the external surface of the
looped heart tube. Around HH18, the PEO makes con-
tact with the heart in the region of the atrioventricular
(AV) sulcus. From HH20 to 24, epicardial cells extend
over the surface of the myocardium to cover the heart.
Failure of the epicardial covering to form in mice deficient
in VCAM-1 or its counter-receptor a 4-integrin results in
a thin myocardial wall and a failure of coronary vessels to
develop. Coronary endothelial cells are thought to arise
from preexisting vessels in the sinus venosus plexus via
migration across the tissue bridge formed when the PEO
contacts the heart. During stages 19 to 23, the subepicar-
dial matrix in the region of the AV canal and interventric-
ular septum thickens and becomes populated by mes-
enchymal cells. The principle source of subepicardial mes-
enchymal cells has recently been shown to be epicardial
cells that have undergone epithelial to mesenchymal trans-
formation (EMT).9 These subepicardial mesenchymal cells
subsequently give rise to cardiac fibroblasts and coronary
SMCs and contribute to subendocardial cushion tissue
cells involved in valvulogenesis. Around HH32, the nas-
cent coronary plexus makes connections with the systemic
circulation at the level of the aortic root and coronary
blood flow is established. At the same time, endothelial
cells in the proximal coronary segments begin to recruit
SMCs to estabish a tunica media. Although these cellular
events have been described in considerable detail, the
extracellular factors and signaling pathways that direct
mesenchymal cells to express a SMC phenotype remain
largely unknown.
Differentiation of vascular smooth muscle cells
To begin to better understand the molecular pathways
that control differentiation of vascular SMCs, we chose to
study coronary SMC differentiation from committed prog-
enitor cells in the PEO. For this analysis, PEOs were
removed from HH17 quail embryos, placed into explant
culture, and examined over 5 days in vitro. During the first
24 hours, a monolayer of epicardial cells formed around the
explant that displayed extensive cell-cell contacts and promi-
nent subcortical actin bundles. By 3 days, cells at the periph-
ery of the outgrowth had become detached from their
neighbors and exhibited formation of vinculin-containing
focal adhesions and a marked rearrangement of the actin
cytoskeleton characteristic of mesenchymal transformation.
By 5 days, the vast majority of epicardial cells had become
mesenchymal, appeared to be motile, displayed few, if any,
direct cell-cell contacts, and exhibited cytoplasmic actin fil-
aments organized into prominent stress fibers. To deter-
mine whether PEO-derived cells that had become mes-
enchymal also expressed a SMC phenotype, we examined a
panel of cell-type specific markers by immunoflourescence.
Cells in the monolayer that appeared around the explant at
1 day were uniformly positive for cytokeratin, an epicardial
cell marker. These cells were also uniformly positive for
SMa A, which appeared to be co-localized within the same
prominent peripheral actin bundles as those labeled by
FITC-phalloidin. By contrast, no specific immunostaining
was found for either calponin, SMg A, or SM22a . By 5 days,
nearly all PEO-derived cells had become mesenchymal in
appearance, developed vinculin-containing focal adhesions,
and displayed a reorganization of subcortical actin bundles
into prominent stress fibers. PEO-derived cells remained
SMa A-positive and cytokeratin-positive, the former being
redistributed from subcortical bundles into prominent
stress fibers. Epicardial-derived mesenchymal cells now
exhibited strong immunostaining for the SMC markers pro-
teins calponin, SMg A, and SM22a in a stress fiber pattern
similar to SM a A. Therefore, expression of SMC marker
proteins in PEO-derived cells could be factored into three
stages: (1) a proepicardial stage in which none of the SMC
markers were expressed, (2) an epicardial stage in which
SMa A was strongly expressed in essentially all cells while
calponin, SMg A, and SM22a remained undetectable, and
(3) a mesenchymal stage in which all four SMC markers
were coexpressed in the same cells.
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ROLE OF SERUM RESPONSE FACTOR (SRF)
IN SMC DIFFERENTIATION
To gain insight into factors that mediate SMC differen-
tiation in proepicardial cells, we next examined the expres-
sion of a set of regulatory genes that have been implicated
in the control of SMC-specific gene expression. SRF tran-
scripts were undetectable in freshly isolated HH17 PEOs,
whereas low but detectable levels of Mef2b, GATA5, and
Crp2/SMLim transcripts were found. The expression of all
four genes increased strongly by day 1 and continued to
increase, albeit at a slower rate, between day 1 and day 5.
We next examined the distribution of SRF protein by
immunofluorescence. Strong nuclear immunostaining for
SRF was found in essentially all PEO-derived cells, either
epicardial or mesenchymal, from day 1 to day 5. Double-
label immunofluorescence revealed that virtually all SMa A-
positive cells exhibited strong nuclear immunostaining for
SRF. Likewise, all calponin-positive or SMg A-positive cells
displayed nuclei that were positive for SRF expression. To
determine whether SRF activity is required for coronary
SMC differentiation from proepicardial cells, two different
dominant negative constructs (dnSRF) were employed to
inhibit SRF function. Neither form of dnSRF had any effect
on mesenchymal transformation. By contrast, both forms of
dnSRF inhibited the appearance of calponin-positive cells by
60% to 80%. Likewise, dnSRF blocked SMg A-positive cells
or SM22a -positive cells to the same extent as that observed
for calponin. Co-transfection of wtSRF together with either
form of dnSRF rescued SMC differentiation, confirming
the specificity of dnSRF for inhibition of SRF function in
PEO-derived cells in vitro. These results strongly suggest
that differentiation of SMCs from proepicardial cells
requires functional SRF.
Mark W. Majesky, PhD
Thomas E. Landerholm
Jun Lu
Baylor College of Medicine
Houston, Tex
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PHYSICAL FORCES AND THE FORMATION
OF COLLATERALIZATION IN CHRONIC
OCCLUSIVE ARTERIAL DISEASE
Changes in physical forces, like shear stress, acting on
the vessel wall have long been known to modulate the
architecture and the diameter of vessels via true prolifera-
tive processes. The most dramatic changes occur in small
preexisting arteriolar anastomoses upon occlusion of the
main blood supplying artery. Such preexisting arteriolar
anastomoses have been shown to exist in many organs, like
skeletal muscle, but also in the human heart, where they
have a diameter of about 50 to 150 m m, as Fulton and
Baroldi have demonstrated in the 1960s. Upon occlusion
of the main blood-supplying artery, shear force in these
preexisting arteriolar anastomoses rises by a factor of more
than 200.
Collateral growth is a very rapid adaptive response. We
previously were able to show that, in the rabbit hindlimb,
proliferation of endothelial and smooth muscle cells starts
as early as 24 hours after femoral artery occlusion and is
maximal during the first 3 days after occlusion.1 The main
rise in collateral conductance and vessel diameters also
occurs within the first week after femoral artery occlusion
leading to the formation of a functional collateral circula-
tion. Similar kinetics of growth are observed in the hearts
of dogs after ameroid constrictor placement and in
patients after myocardial infarction, suggesting that the
basic mechanism of collateral growth is the same in differ-
ent organs and different species.
Shear force, rather than ischemia, is the main regula-
tor of collateral growth. We were not able to detect any
perfusion deficits, changes in ATP, ADP, or AMP, a rise in
lactate, or a fall in creatine phosphate in regions in which
collateral arteries were growing.1 This is in line with obser-
vations in human and dog hearts in which collateral arter-
ies largely grow outside the ischemic area at risk.
Considering the rapidity of growth and the fact that col-
lateral arteries grow largely outside the ischemic territory,
it is rather unlikely that ischemia-driven sprouting of cap-
illaries (true angiogenesis) contributes significantly to the
formation of a collateral circulation. It is much more like-
ly that the vast changes of hemodynamical forces that
occur in small preexisting anastomoses upon occlusion of
the main arterial supply are the primary stimulus for the
growth of collateral arteries. The observation that, under
certain circumstances, the proliferation starts at the border
of the ischemic territory is not an argument against the
involvement of shear forces because the diameter of pre-
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existing arteriolar anastomoses is smallest in this border
region and thus shear force is highest. In contrast to col-
lateral arteries supplying the ischemic territory with blood,
veins draining blood from the ischemic region are subject
to higher levels of growth factors released by the ischemic
tissue. The observation that, in some instances, veins are
also seen to proliferate is therefore not an argument for
the involvement of ischemia in the growth of collateral
arteries. It is common to all models of collateral growth
that flow reserve never reaches the level before occlusion.
This is another argument in favor of local shear force as a
regulator of collateral growth. Shear force is correlated to
vessel diameter, to blood viscosity, and to turbulence that
depends on vessel architecture. Collateral vessels usually
assume a corkscrew formation, which is further enforced
by the formation of a neointima in certain areas of the ves-
sel. This remodeling, together with the proliferation of the
vessel, leads to the lowering of shear force to a certain level
at which the collateral artery stops to grow any further,
irrespective of the blood supply to the ischemic territory.
Monocytes play an important role in translating
changes of physical forces into proliferation. We observed
a very specific and localized adhesion and migration of
monocytes in vessels becoming collateral arteries already
12 hours after occlusion.3 These monocytes/macrophages
were the main source of basic fibroblast growth factor dur-
ing the maximal proliferation of collateral arteries.
Monocyte adhesion and migration was also observed in
the dog heart during maximal proliferation of collateral
arteries. In both cases, monocyte/macrophage accumula-
tion correlated well with the time of maximal prolifera-
tion. Local infusion of the monocyte chemoattractant pro-
tein MCP-1 increased the rise in collateral conductance
almost three-fold in the rabbit hindlimb, suggesting that
indeed monocytes may play an important functional role
in translating changes in physical forces acting on the ves-
sel wall into proliferation of the vessel itself.2
Collateral growth is associated with local upregulation
of specific cell adhesion molecules. Monocytes adhere and
migrate via cell adhesion molecules expressed on the sur-
face of the endothelium and via chemokines like MCP-1.
The only cell adhesion molecule, however, seen to be
upregulated during the first wave of monocyte migration
was ICAM-1. This cell adhesion molecule, which is also
constitutively expressed on many endothelial cells, is not
sufficient to explain the specific localized adhesion of
monocytes in collateral vessels. In a search for cell adhe-
sion molecules specifically expressed on endothelial cells of
growing collateral arteries, we therefore immunized mice
with membrane preparations of isolated collateral arteries
and were able to raise several antibodies recognizing anti-
gens, which solely were expressed on collateral vessels.
These antigens are also expressed on endothelial cells after
cytokine stimulation with a kinetic differing from known
cell adhesion molecules, suggesting that these antibodies
recognize to date unknown cell adhesion molecules. We
are currently further characterizing these antigens.
In summary, growth of collateral arteries (arteriogen-
esis) is a very rapid adaptive response due to dramatic
changes in physical forces in preexisting arteriolar anasto-
moses, leading to the upregulation of specific to date
unknown cell adhesion molecules, followed by the adhe-
sion and migration of growth factor producing mono-
cytes/macrophages and the induction of endothelial and
smooth muscle cell proliferation.
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SIGNAL TRANSDUCTION OF PHYSICAL
FORCES
DIFFERENTIAL RESPONSES OF ENDOTHE-
LIAL CELLS TO UNIFORM AND DISTURBED
LAMINAR SHEAR STRESS
Atherosclerosis occurs most frequently at vascular
geometries, such as bifurcations, ostial openings, and curva-
tures—sites that have in common a unique blood flow pat-
tern termed disturbed laminar shear stress. This shear stress
regime is characterized by having a region of flow recircula-
tion and a reattachment point (the position at which forward
flow is reestablished). At sufficient distances upstream and
downstream from the disturbed flow region, uniform lami-
nar shear stress usually exists, and these sites are relatively
protected from atherosclerotic development. Within the dis-
turbed flow region, there are extremely high gradients of
shear stress at the vessel wall, but the magnitude of the wall
shear stress is quite low, even falling to zero at the reattach-
ment point. In contrast, in the uniform flow regions, the
shear stress gradient is effectively zero, and the shear stress
magnitude assumes a relatively high constant value.1
Endothelial cells lining the vessel wall at disturbed
flow sites in vivo assume polygonal, non-oriented shapes,
in contrast to cells exposed to primarily uniform flow,
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which become elongated and aligned in the direction of
flow. This finding has motivated considerable interest in
the potential role of endothelial gene regulation by hemo-
dynamic shear stress, given the recognized role of the
endothelium in the atherosclerotic process. We have pre-
viously developed an in vitro disturbed flow model,
designed to mimic the spatial shear stress gradients that
occur at atherogenic loci in vivo. Using this model, we
have induced endothelial cell shape changes similar to
those found in vivo. In addition, in vitro experiments with
this model system have demonstrated enhanced prolifera-
tion and migration of cells near the reattachment point.2,3
Recent data from DePaola et al4 have shown that expres-
sion of the gap junction protein, connexin 43, is increased
in cells exposed to disturbed flow, as compared with those
subjected to uniform laminar shear stress. However, quan-
titation of gene induction in disturbed flow models has
been limited, largely due to the cell density alterations
induced by long-term exposure to disturbed flow.
In order to gain insights regarding the regulatory path-
ways through which disturbed flow may modulate
endothelial gene expression, we chose to examine the
expression patterns of four transcription factor proteins
that are known to mediate gene regulation by uniform
laminar shear stress via their interactions with several previ-
ously identified shear stress response elements (SSREs).
The first known SSRE is a six base pair element, GAGACC,
which was identified in the promoter of the platelet-derived
growth factor-B (PDGF-B) gene and shown to mediate the
uniform flow-induced upregulation of this gene by binding
the transcription factor nuclear factor- k B (NF- k B).5,6
Subsequent work demonstrated that induction of the
platelet-derived growth factor-A (PDGF-A) gene required
functional interactions between the early growth response-
1 (Egr-1) response element and its transcription factor.7
Other studies demonstrated that upregulation of the
monocyte chemotactic protein-1 (MCP-1) gene by uni-
form flow was mediated by binding of a non-consensus
TPA (tetra-decanoyl phorbol acetate) response element
(TRE) to the transcription factor activator protein-1 (AP-
1, composed of protein dimers of c-Jun and c-Fos).8 While
the regulation of NF-k B, Egr-1, c-Jun, and c-Fos by uni-
form laminar shear stress has been well characterized, their
potential role in gene regulation by disturbed laminar shear
stress has not been previously examined.
Quantitation of transcription factor activation within
the disturbed flow model was complicated not only by the
induced spatial differences in cell proliferation and migra-
tion but also by the small geometry of the model system
(the recirculation zone is less than 1 mm in width). This
precluded the application of many standard analysis tech-
niques, such as Northern blot analysis, transient transfec-
tion of reporter gene constructs, etc. Thus, it was neces-
sary to devise a novel examination method. We chose to
measure the amount of nuclear localized transcription fac-
tor protein by computerized image analysis.9 This tech-
nique permitted quantitation of transcription factor acti-
vation, independent of cell density, and also provided bio-
logically relevant information, because the primary site of
action of these transcription factors is in the nucleus.
Analysis was performed on endothelial monolayers that
had been exposed to disturbed flow or uniform flow for 30
minutes or maintained under static conditions for an equal
time period. After fixation, the monolayers were stained
first with a specific antibody coupled to a fluorescent mark-
er (Texas Red), which showed the amount and cellular dis-
tribution of the transcription factor being studied, as well
as with a second fluorescent dye (DAPI) that delineated
the nuclear compartment. Digitized microscopic images
were acquired for each dye, and a nuclear mask was then
created from the DAPI image and superimposed on the
Texas Red image. Thus, the resulting image revealed tran-
scription factor that was contained primarily within the
nucleus. Quantitation by this method revealed significant
increases in the nuclear localization of NF-k B, Egr-1, c-
Jun, and c-Fos in cells exposed to disturbed laminar shear
stress as compared with those subjected to uniform flow or
maintained under static conditions. These findings are par-
ticularly striking given the fact that all four transcription
factor proteins are regulated through different general acti-
vation mechanisms: pre-formed NF-k B is sequestered in
the cytoplasmic space by members of the I k B family of
inhibitory proteins and translocates to the nucleus upon
cellular activation; Egr-1 undergoes rapid de novo synthe-
sis following activation; and c-Jun and c-Fos are also rapid-
ly synthesized, then form protein dimers that may require
subsequent phosphorylation in order to activate transcrip-
tion. In addition, these data have important implications
regarding the subsequent regulation of multiple endothe-
lial genes, because all four transcription factor proteins are
known to bind previously identified SSREs. Quantitative
image analysis on a cell-by-cell basis also indicated that
endothelial cells exposed to disturbed flow displayed a
striking heterogeneity in their responsiveness to the flow
stimulus, as compared with cells subjected to uniform flow.
Future experimental and theoretical studies are necessary
to determine whether such heterogeneity could reflect
microscopic variations in the local shear stress profile.
Taken together, these data provide new insights regarding
the nature of pathophysiologically relevant shear stress
stimuli and suggest that disturbed laminar shear stress pat-
terns—in particular, spatial shear stress gradients—may be
important regulators of endothelial gene regulation at
atherogenic loci in vivo.
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ENDOTHELIAL HETEROGENEITY IN SIG-
NAL TRANSDUCTION OF SHEAR STRESS
RESPONSE
The decentralization model of endothelial mechan-
otransduction1 proposes that hemodynamic forces are
transmitted to multiple sites throughout the cell where
conversion of mechanical forces to electrophysiological,
biochemical, and genetic responses occur at multiple loca-
tions. This model readily accommodates a variety of
mechanotransduction mechanisms, including stress sen-
sors at the luminal endothelial surface, force transmission
throughout the cell via the cytoskeleton, and sensors of
tension change at basal adhesion sites. There is substantial
evidence to support each of these mechanisms.1 The pri-
mary cellular interface between fluid forces and the cell,
however, remains the luminal cell surface, the geometry of
which influences the magnitude and distribution of
mechanical forces acting throughout the cell.2 Variations
in endothelial surface topography from region to region
and cell to cell therefore become relevant in determining
flow responses in the endothelial monolayer.
Immediate responses to flow involve the participation
of small molecules and ions (eg, IP3, Ca++ electropotential
changes). Within the confluent endothelial monolayer, cell
to cell communication of such molecules is efficiently con-
ducted via highly coupled gap junctions3 comprised of
assemblies of connexin proteins. We have recently investi-
gated the relationships between hemodynamics, the
expression of the principal endothelial connexin in vitro
connexin 43 (Cx43), and gap junctional communication
between cells in the monolayer.4 The endothelium was
exposed to fluid shear stresses in a unique flow chamber
where precise fluid forces were spatially related to regions
of the monolayer, including areas of disturbed laminar
flow. Flow separation and recirculation were created for
periods of 5, 16, and 30 hours, with laminar shear stresses
ranging between 0 and 13.5 dyne/cm2. Within 5 hours,
endothelial Cx43 mRNA expression was increased in all
cells when compared with no flow controls with highest
levels (up to 6 to 8 fold) expressed in regions of flow recir-
culation corresponding to high shear stress gradients. At
16 hours, Cx43 mRNA expression remained elevated in
regions of flow disturbance, whereas in areas of fully devel-
oped undisturbed laminar flow, Cx43 expression returned
to control levels. In all flow regions, the typical macular
distribution of Cx43 immunoflourescence at cell borders
was disrupted by 5 hours; Cx43 was relocated to the cyto-
plasm. After 30 hours of flow, disruption of gap junctions
persisted in cells subjected to flow separation and recircula-
tion, whereas the Cx43 immunofluorescence pattern in
regions of undisturbed flow was substantially restored to
normal. These gene and protein expression differences
were reflected in sustained inhibition of intercellular com-
munication as measured by dye transfer throughout the
zone of disturbed flow (84% and 68% inhibition at 5 hours
and 30 hours, respectively). In contrast, cell to cell com-
munication was fully reestablished by 30 hours in cells
exposed to undisturbed laminar shear stress. Upregulation
of Cx43 transcripts, sustained disorganization of Cx43 pro-
tein, and impaired communication throughout the mono-
layer suggest that shear stress gradients in regions of dis-
turbed flow regulate the expression and function of Cx43.
Regional differences in endothelial communication
may also occur in vivo where Cx40 and Cx37 are
expressed by endothelial cells in addition to Cx43.5 Cx43
connexins have been noted by immunofluorescence near
vascular branch points in rat aorta, but were absent at
other sites, suggesting an association between hemody-
namics and Cx43 protein in vivo. It appears therefore that
there are significant hemodynamic-related differences in
the expression and function of these important communi-
cation molecules both in vitro and in vivo.
In contrast to qualitative studies of gene expression by
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in situ hybridization or immunofluorescence, a quantita-
tive measurement of regional differences can be obtained
by scraping cells from the region of interest for northern
analysis of message expression or western analysis of pro-
tein expression. A useful alternative for analyzing smaller
numbers of cells typically present in defined hemodynam-
ic regions is differential display,6 which uses RT-PCR to
amplify all expressing genes in the cell population.
Differential expression is detected when PCR products
derived from cells in different hemodynamic regions are
displayed side by side. Despite limitations in the quantita-
tion of expression, differential display has permitted the
identification of hemodynamically-responsive endothelial
genes.7,8 However, regional gene expression either by
northern analysis following scraping or by differential dis-
play from a limited number of cells represents an average
from all of the cells isolated from a particular location. As
noted previously, endothelial surface topographies, and
consequently magnitude and gradients of shear stresses,
vary considerably from cell to cell.2 We have proposed
therefore that differences in hemodynamic signaling in
gene expression may arise from microscopic topographic
differences at the interface of the fluid and the cell surface.9
There are many examples of the heterogeneity of gene and
protein expression both in vivo and in vitro that imply a
few strongly expressed genes in only a few endothelial cells
in a given region may play a dominant role in vascular reg-
ulation and pathogenesis. We have recently applied an
amplified antisense mRNA technique to endothelial cells to
obtain gene expression profiling of single cells within the
monolayer.10,11 Using this approach, a cell by cell analysis
of endothelial gene expression as a function of position in
complex flow fields is attainable.
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MECHANO-SIGNALING PATHWAYS IN VAS-
CULAR CELLS EXPOSED TO CYCLIC STRAIN
Over the years, a large body of data has been acquired
to suggest that the study of vascular cells challenged with
mechanical stimuli is more appropriate for studying their
biology. Cyclic strain, along with other mechanical forces,
such as shear stress and hydrostatic pressure, have been
posited to play an important role in the regulation of vas-
cular tone, remodeling, and the genesis of atherosclerosis
in vivo.1 Cyclic strain represents the stress acting along the
vessel wall due to circumferential deformation induced by
pulsatile blood flow. Studies from various investigators
using models of cyclic strain in vitro have shown that var-
ious genes are induced by the effect of mechanical defor-
mation and that the expression of these mediators may be
regulated at the transcription level by mechanical forces.
There is emerging evidence that endothelial cells may also
act as mechanotransducers, whereby the transmission of
external forces induces various cytoskeletal changes and
second messenger cascades. The mechanism by which cul-
tured vascular endothelial cells perceive cyclic strain, uti-
lizing in vitro devices to model this force, is the subject of
this review.
Upon exposure to repetitive stretch, endothelial cells
are capable of altering their cytoskeletal structure and
mechanical properties in a pattern different from that seen
in static cells. It has been postulated that endothelial cells
act as mechanotransducers by responding to the transmis-
sion of forces via the activation of focal adhesion mole-
cules, such as paxillin, talin, and focal adhesion kinase
(FAK) in these plaques.2 In the “tensegrity model,” cells
are thought to be in a preexisting state of force equilibri-
um and the cells exert tension on their extracellular
attachments.3 The alteration of the structure by mechani-
cal forces produces changes in their internal cellular ten-
sions and creates a direct transmission of force internally,
which may result in activation of sensors at the cell surface
and at anchorage points, such as the focal adhesion
plaques. Integrins act as mechanotransducers by linking
actin filaments to the extracellular matrix via the focal
adhesion molecules.
Recent studies performed in our laboratory support
the involvement of focal adhesion plaques in the transmis-
sion of cyclic strain to the cell. We have demonstrated
phosphorylation of cytoskeletal proteins that reside at the
cytoplasmic face of the focal adhesion plaques, namely
pp125FAK and paxillin.4,5 The strain-induced phosphory-
lation of these proteins occurs on tyrosine residues and can
be inhibited by specific tyrosine kinase inhibitors. The tyro-
sine phosphorylation of pp125FAK occurs earlier and is
more robust than that observed with paxillin. However,
after a 4-hour exposure to strain, both cytoskeletal proteins
were found to align as shown by confocal microscopy. This
observation was in sharp contrast to their random distribu-
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tion found in stationary controls. Tyrphostin A25, a tyro-
sine kinase inhibitor, blocked the strain-induced phospho-
rylation of pp125FAK and paxillin as well as their strain-
induced alignment. Moreover, the importance of focal
adhesion proteins on the mechanically induced gross mor-
phological changes of endothelial cells was implicated by
the ability of tyrphostin A25 to reverse both cellular align-
ment and migration caused by strain.
Because integrins are also localized on focal adhesion
sites and have been reported to induce tyrosine phospho-
rylation of pp125FAK under a variety of stimuli, we stud-
ied the involvement of different integrins in signaling
induced by cyclic strain.6 Cyclic strain of 4 hours led to a
redistribution of a and b integrins in human umbilical vein
endothelial cells. In addition, b 1 integrin reorganized in a
linear pattern parallel with the long axis of the elongated
cells, creating a fusion of focal adhesion plaques in cells
plated on fibronectin (a ligand for a 5b 1) or collagen (a lig-
and for a 2 b 1) coated plates. In contrast, the vitronectin
receptor, b 3 integrin, failed to redistribute in endothelial
cells subjected to cyclic strain. Cyclic strain also caused a
reorganization of a 5 and b 2 integrins in a linear pattern on
cells seeded on fibronectin and collagen-coated plates,
respectively. However, the expression of a 5, b 2, and b 1 was
not influenced by 24 hours of cyclic strain as assessed by
immunoprecipitation of these integrins. Strain-induced
phosphorylation of pp125FAK occurred concomitantly
with the reorganization of b 1 integrin. Thus, a 5 b 1 and
a 2b 1 integrins may play an important role in transducing
mechanical stimuli into intracellular signals.
The identity of other candidate sensors at the cell sur-
face, if they exist, are not known.2 It has been posited that
mechanosensitive ion channels and G-proteins may be
involved. Activation of mechanosensitive Ca++ ion channels,
leading to an influx of Ca++, has been postulated to lead to
second messenger cascades, such as activation of protein
kinase C pathways responsible for the production of some
of the vasoactive molecules produced by endothelial cells.7
Some endothelial cell responses to physical stimuli have
been shown to be dependent on G-protein activation, and
recent evidence suggests that cyclic strain can activate cer-
tain G-proteins. We have also reported the activation of
phospholipase C as evidenced by generation of inositol
1,4,5 triphosphate (IP3), and diacylglycerol (DAG) in
endothelial cells subjected to cyclic strain,8,9 which also sug-
gests, albeit indirectly, the presence of G-protein activation.
Other second messenger metabolic pathways are also
activated by mechanical forces. For example, cyclic strain
leads to activation of protein kinase A/adenylate cyclase,
thereby increasing intracellular cyclic AMP, which is also
accompanied by an increased binding of the nuclear factor
CRE.10 We have also reported that the phosphoinositide
pathway is activated in EC subjected to cyclic strain with
the production of IP3 and DAG and activation of PKC
within seconds of the initiation of cyclic strain.8,9 Recently,
we examined whether extracellular signal-regulated kinases
1/2 (ERK1/2) are activated and might play a role in
enhanced proliferation and morphological change induced
by strain.11 Bovine aortic endothelial cells were subjected
to an average of 6% or 10% strain at a rate of 60 cycles/min
for up to 4 hours. Cyclic strain caused strain-dependent
and time-dependent phosphorylation and activation of
ERK1/2. Peak phosphorylation and activation of ERK1/2
induced by 10% strain were at 10 minutes. A specific
ERK1/2 kinase inhibitor, PD98059, inhibited phosphory-
lation and activation of ERK1/2 but did not inhibit the
increased cell proliferation and cell alignment induced by
strain. Treatment of BAEC with 2,5-di-(tert-butyl)-1,
4-benzohydroquinone to deplete inositol triphosphate-
sensitive calcium storage and gadolinium chloride, a Ca2+
channel blocker, did not inhibit the activation of ERK1/2.
Strain induced–ERK1/2 activation was partly inhibited by
the PKC inhibitor, calphostin C, and completely inhibited
by tyrosine kinase inhibitor, genistein.
ERK1/2 are known to phosphorylate transcription
factors after translocation into nucleus, such as Elk-1,
p62TCF (ternary complex factor), c-fos, and c-myc. We
have previously reported an increase in fos and jun expres-
sion with cyclic strain.12 The fos-jun or jun-jun dimers
form transcriptional activators, which can bind AP-1 pro-
moter sites [5’-TGAGTCAG-3’] of various genes, and we
have documented an increase in AP-1 in EC exposed to
strain.13 Thus, the cyclic strain stimuli can be coupled to
EC response via activation of MAPK, and c-fos and c-jun,
with the formation of nuclear proteins which regulate EC
genes containing these three binding sites.
Finally, mechano-sensitive genes have been identified
that appear to be finely tuned in their ability to distinguish
mechanical perturbations based on unique strain-sensitive
or shear-sensitive cis elements in their promoter regions.
These nuclear binding sites respond to unique strain-acti-
vated or shear-activated transcriptional factors that can
either induce or repress gene induction. Using promoter-
reporter gene constructs, bovine aortic endothelial cells can
be transiently transfected and promoter activity assayed fol-
lowing exposure of the endothelial cells to cyclic strain.
Deletion constructs of these genes can then determine
where important regions exist, and further promoter analy-
sis with point mutations can determine specific responsive
elements. Using this technique, Resnick et al14,15 have dis-
covered a putative shear stress response element (SSRE) in
the promoter region of PDGF. This sequence (GAGACC)
and its complementary sequence have been noted in other
genes that are responsive to shear stress. In contrast, bovine
aortic EC subjected to 10% (but not 6%) average strain
results in a 2.6-fold increase in PDGF-B steady state mRNA
and immunoreactive protein.16 By transfecting bovine aor-
tic EC with a construct containing 450 bp of human
PDGF-B promoter sequence coupled to chloroamphenicol
acetyltransferase (CAT), we reported that subjecting these
cells to 10% average strain resulted in a two-fold increase in
CAT activity by 4 hours.16 Analysis of nested 5´ deletions of
the promoter transfected into EC demonstrated a 55% drop
off in activity between positions –313 and –153 and a fur-
ther drop between positions –153 and –101 with no induc-
tion of activity with the –101 bp minimal promoter.
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Because the SSRE is located at position –125, we tested the
hypothesis that the SSRE site was necessary or sufficient for
induction of PDGF-B activity with strain. Electromobility
shift assays revealed that nuclear proteins from EC exposed
to strain for short intervals (30 minutes) bound to the
PDGF-B SSRE. However, transfection of EC with hybrid
promoter constructs, containing the SV40 sequence pro-
moter downstream of the SSRE, or the –153 PDGF-B pro-
moter sequence, bearing a mutation in the SSRE, demon-
strated that the SSRE was neither sufficient nor necessary
for inducible reporter gene expression in EC exposed to
cyclic strain. These studies demonstrate that cyclic strain,
like shear stress, upregulates PDGF-B gene transcription in
bovine aortic EC. However, transcriptional activation is not
dependent on proteins that bind to the SSRE.
In summary, our data to date suggest that a 5b 1 and
a 2b 1 integrins play an important role in transducing cyclic
strain stimulation into intracellular signals. Because inte-
grins induce ERK1/2 activation and pp125FAK and pax-
illin phosphorylation, it is likely that ERK1/2 activation and
pp125FAK phosphorylation share a common signal trans-
duction pathway. It is obvious that much work still needs to
be done in characterizing the sensing and biochemical cou-
pling of cyclic strain on vascular cells and, in particular, the
linkage between cytosolic pathways and nuclear events.
Bauer E. Sumpio, MD, PhD
Yale University School of Medicine
New Haven, Conn
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FLOW-DEPENDENT PROTEIN KINASES: ROLE
IN NO FORMATION
Fluid shear stress regulates endothelial cell function,
but the signal transduction mechanisms involved in
mechanotransduction remain unclear. In our research, we
have focused on three temporal signal responses to shear
stress: (1) production of nitric oxide (NO) as an immedi-
ate response; (2) activation of extracellular-regulated
kinases (ERK1/2; p44/p42 mitogen-activated protein
[MAP] kinases) as a rapid response; and (3) tyrosine phos-
phorylation of focal adhesion kinase (FAK) as a sustained
response. In terms of vessel biology, NO production and
ERK1/2 and FAK activation seem to correlate with vas-
cular homeostasis, gene expression, and cytoskeletal
rearrangement, respectively. We propose a model for
mechanotransduction in endothelial cells involving calci-
um-dependent and calcium-independent protein kinase
pathways. The calcium-dependent pathway involves acti-
vation of phospholipase C, hydrolysis of phosphatidylinos-
itol 4,5-bisphosphate (PIP2), increases in intracellular cal-
cium, and stimulation of kinases, such as calcium-calmod-
ulin and C kinases (PKC). The calcium-independent
pathway involves activation of a small GTP-binding pro-
tein and stimulation of calcium-independent PKC and
MAP kinases. The calcium-dependent pathway mediates
the rapid, transient response to fluid shear stress, including
activation of nitric oxide synthase (NOS) and ion trans-
port. In contrast, the calcium-independent pathway medi-
ates a slower response, including the sustained activation
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of NOS and changes in cell morphology and gene expres-
sion. We propose that focal adhesion complexes link the
calcium-dependent and calcium-independent pathways by
regulating activity of phosphatidylinositol 4-phosphate
(PIP) 5-kinase (which regulates PIP2 levels) and p125
focal adhesion kinase (FAK, which phosphorylates paxillin
and interacts with cytoskeletal proteins). This model pre-
dicts that dynamic interactions between integrin molecules
present in focal adhesion complexes and membrane events
involved in mechanotransduction will be integrated by cal-
cium-dependent and calcim-independent kinases to gener-
ate intracellular signals involved in the endothelial cell
response to flow.
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ROLES OF INTEGRINS AND RECEPTOR
TYROSINE KINASE IN MECHANOCHEMICAL
TRANSDUCTION IN ENDOTHELIAL CELLS
The shear stress resulting from blood flow modulates the
functions of endothelial cells (ECs), including the regulation
of genes encoding for vasoactive substances, growth factors,
adhesion molecules, chemoattractants, coagulation factors,
and proto-oncogenes.1,2 The shear modulation of these
genes can mediate many physiological and pathological
processes. This paper summarizes the research in our labora-
tory on shear-induced gene expression and the upstream
mechano-transduction mechanism in ECs, with special ref-
erence to the roles of integrins and receptor tyrosine kinase
as mechano-sensors. Cultured human umbilical vein
endothelial cells (HUVECs) and bovine aortic endothelial
cells (BAECs) were subjected to laminar shear stress in a flow
channel.3 The shear stress level was 12 dynes/cm2, which is
in the physiological range encountered in arteries.
Shear-induction of immediate early gene expres-
sion in endothelial cells through the RAS-
MEKK-JNK pathway
Shear stress causes a transient induction (<6 hour) of
the expression of a number of immediate early (IE) genes
in HUVECs, including the MCP-1 gene4 and the TF
gene.5 Functional analysis of the promoter region of the
MCP-1 gene shows that a divergent TPA responsive ele-
ment (TRE) with a nucleotide sequence of TGACTCC is
the cis element responsible for shear induction and that
the transcription factor for this TRE site is AP-1.6 In the
TF gene, the Sp-1 sites in a GC-rich region of the pro-
moter constitute the cis element for shear inducibility.5
The signaling molecules leading to the shear induction
of AP-1/TRE-mediated gene activation were studied in
BAECs.7 Shear stress induces a transient and rapid activa-
tion of the small GTPase Ras within 1 minute. This is fol-
lowed by the transient activation of mitogen activated pro-
tein kinase (MAPK) pathways, including c-jun NH2 ter-
minal kinases (JNK) and extracellular signal-regulated
kinases (ERK). Cotransfection of a dominant negative
mutant of Ras (ie, RasN17) attenuates the shear activation
of JNK and TRE. Using negative mutants of signaling
molecules shows a greater importance of the JNK pathway
over the ERK pathway in the shear induction of the AP-
1/TRE-mediated promoter.
Additional experiments shows that the Ras-activating
guanine nucleotide exchange factor Son of sevenless (Sos)
and its upstream adaptor molecules Shc and Grb2 all play
significant roles in mediating the shear activation of the
Ras-MEKK-JNK pathway.
Role of a receptor tyrosine kinase in mechano-
transduction in endothelial cells
The receptor tyrosine kinases (RTKs) have extracellu-
lar domains that can bind polypeptide growth factors and
initiate signal transduction by phosphorylating the tyro-
sine residues in the intracellular domains.
We studied the role of Flk-1, a RTK specific for vascu-
lar endothelial growth factor (VEGF), in mechano-trans-
duction in BAECs.8 Shear stress activates Flk-1, as indi-
cated by its tyrosine phosphorylation and association with
Shc. The time course of this shear-induced activation
(beginning in <1 minute and lasting ~30 minutes) is sim-
ilar to the action of VEGF on Flk- 1. The shear-induced
Flk-1 activation, however, is not blocked by anti-VEGF
antibody. Confocal microscopy shows the clustering of
Flk-1 in response to shear stress with a similar time course
as its phosphorylation and Shc association. These results
suggest that shear stress can activate Flk-1, independent of
its specific ligand, to initiate the downstream signaling
effects through its Shc association.
Shear induction of non-receptor tyrosine kinases
in focal adhesions
Nonreceptor protein tyrosine kinases such as focal
adhesion kinase (FAK) and c-Src in the focal adhesions are
involved in the mechano-transduction in BAECs induced
by shear stress. Our studies show that shear stress causes
FAK to increase its tyrosine phosphorylation, kinase activ-
ity, and association with Grb2 in a rapid (< 1 minute) and
transient manner.9 Dominant negative mutants of FAK
and Sos attenuate the shear-induced JNK activation.
These results suggest that FAK may be linked to the Ras
signaling pathway through the Grb2/Sos complex.
Shear stress also activates c-Src in a rapid and transient
manner.10 The shear activation of JNK is significantly
attenuated by the kinase-defective mutants of v-Src and c-
Src. The combined uses of positive and negative mutants
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of c-Src and Ras indicate that c-Src is upstream to Ras in
the signal transduction pathway.
Role of integrins in the mechano-transduction in
endothelial cells
We studied the role of integrins in mechano-transduc-
tion in HUVECs.11 Shear activation of JNK can be
observed in HUVECs cultured on slides coated with
fibronectin, vitronectin, or laminin but not when the slides
were coated with collagen or L-lysine. These results indicate
that the induction of JNK signaling requires the specific
interaction between integrins and their extracellular matrix
(ECM) receptors to initiate the mechano-transduction.
The role of a v b 3 integrin in mechano-transduction
was investigated in HUVECs cultured on fibronectin-
coated slides by using the activation of JNK and the asso-
ciation of a vb 3 with adaptor molecules as read outs. In this
system, shear stress induces the association of a vb 3 with
Shc, in addition to the activation of JNK. The shear-
induced JNK activation is attenuated by the anti- a v b 3
antibody LM609, indicating the importance of the inter-
action of a v b 3 integrin with fibronectin in initiating the
downstream signaling processes. Similar results have been
obtained in the a 6b 1-laminin system.
In another series of experiments, vitronectin-coated
slides containing HUVECs were treated with a blocking
or a non-blocking monoclonal antibody (mAb) against
vitronectin. Shear stress causes the association of a vb 3 and
Shc in control untreated HUVECs or HUVECs treated
with the non-blocking mAb 443, but this association is
markedly attenuated with the use of the blocking mAb
661. These results suggest that newly formed connections
between integrin and its ECM protein, in this case a vb 3-
fibronectin, are required for the mechano-transduction.
Discussion and conclusions
The results of our experiments, together with those
reported by others, indicate that shear stress can activate
IE genes through a number of specific cis elements. For
the AP1-TRE mediated shear activation of the MCP-1
gene, the Ras-MEKK-JNK pathway plays an important
role in signaling. Upstream to this pathway, adaptor mol-
ecules such as Shc, Grb2, and Sos all participate in the sig-
naling.
A critical question in mechano-transduction is the
nature of the mechano-sensor. It seems reasonable to
assume that the sensor resides in the cell membrane, which
is the first component of the cell that is exposed to
mechanical forces. In the present study, we investigated
the possible role of several membrane components in serv-
ing as mechano-sensors. We show that the receptor tyro-
sine kinase Flk-1 is shear sensitive. Shear stress can induce
its clustering, tyrosine phosphorylation, and Shc associa-
tion, thus triggering the Ras-MEKK-JNK pathway. The
integrins on the abluminal side of the EC (eg, a vb 3 and
a 6b 1) are also shear sensitive. Shear stress causes integrin
association with c-Src and Shc and the activation of the
Ras-MEKK-JNK pathway in the presence of the appropri-
ate ECM protein. There is evidence suggesting that shear
stress activates the integrins by inducing the formation of
new connections with the ECM proteins.
Thus, both the RTKs (eg, Flk-1) and the integrins,
which are located primarily on the luminal and the ablu-
minal sides of the EC, respectively, can serve as mechano-
sensors in response to shear stress. The shear activation of
these mechano-sensors leads to their association with Shc,
which may be a common pathway for the further activa-
tion of downstream pathways. The shear-induced Shc
association, however, is transient for Flk-1 and much more
sustained for integrins.
Although we have focused on RTKs and integrins as
mechano-sensors for shear stress, there are many other
possible mechano-sensors (eg, G-protein coupled recep-
tors, ion channels, etc). It is likely that the mechano-trans-
duction in ECs results from the activation of a multitude
of sensors in a relatively nonspecific manner, probably
through membrane perturbations and the ensuing
changes in membrane protein conformation or interac-
tion. This is to be contrasted with the signaling processes
initiated by chemical ligands, which act primarily through
binding to their specific receptors. The similarities and dif-
ferences of the sensing and signaling mechanisms between
mechanical and chemical activation indicate that mechan-
ical forces can superimpose its effects on the actions of
chemical stimuli on gene and protein expressions.
This work was supported in part by grants HL19454,
HL43026, HL44147, and HL56707 from the National
Heart, Lung, and Blood Institute and a Development
Award from the Whitaker Foundation. The authors would
like to acknowledge the valuable collaboration of Drs Y. S.
Julie Li, Martin Schwartz, Mohammad Sotoudeh, and
Shunichi Usami and the excellent assistance of Michael
Kim and Suli Yuan.





University of California, San Diego
La Jolla, Calif
REFERENCES
1. Davies PF. Flow-mediated endothelial mechanotransduction.
Physiol Rev 1995;75:519-60.
2. Chien S, Li S, Shyy JYJ. Effects of mechanical forces on sig-
nal transduction and gene expression in endothelial cells.
Hypertension 1998;31(Part 2):162-9.
3. Frangos JA, Eskin SG, McIntire LV, Ives CL. Flow effects on
prostacyclin production by cultured human endothelial cells.
Science 1985;227:1477-9.
4. Shyy YJ, Hsieh HJ, Usami S, Chien S. Fluid shear stress
induces a biphasic response of human monocyte chemotactic
protein 1 gene expression in vascular endothelium. Proc Natl
Acad Sci U S A 1994;91:4678-82.
5. Lin MC, Almus JF, Chen HH, Parry GC, Mackman N, Shyy
JY, et al. Shear stress induction of the tissue factor gene. J
Clin Invest 1997;99:737-44.
6. Shyy YJ, Lin MC, Han J, Lu Y, Petrime M, Chien S. The cis-
acting phorbol ester “12-O-tetradecanoylphorbol 13-
JOURNAL OF VASCULAR SURGERY
1122 Special Communication June 1999
acetate”-responsive element is involved in shear stress-
induced monocyte chemotactic protein 1 gene expression.
Proc Natl Acad Sci U S A 1995;92:8069-73.
7. Li YS, Shyy JYJ, Li S, Lee JD, Su B, Karin M, et al. The
Ras/JNK pathway is involved in shear-induced gene expres-
sion. Mol Cell Biol 1996;16:5947-54.
8. Chen KD, Kim M, Li S, Chien S, Shyy JYJ. Mechano-
transduction in response to shear stress: roles of receptor
tyrosine kinases, integrins, and Shc. Submitted.
9. Li S, Kim M, Schlaepfer DD, Hunter T, Chien S, Shyy JYJ.
The fluid shear stress induction of JNK pathway is mediated
through FAK-Grb2-sos. J Biol Chem 1997;272:30455-622.
10. Jalali S, Sotoudeh M, Yuan S, Chien S, Shyy JYJ. Shear stress
activates p60src-Ras-MAPK signaling pathways in vascular
endothelial cells. Arterioscler Thromb Vasc Biol 1997;18:
227-34.
11. Jalali S. Roles of c-Src tyrosine kinase and integrins in shear-
induced signal transduction [PhD dissertation]. San Diego
(CA): University of California, San Diego, 1998.
NOVEL IN VITRO SYSTEMS TO MIMIC IN
VIVO PHYSICAL ENVIRONMENTS AND
CLINICALLY RELEVANT SYSTEMS FOR
IMAGING OF THE IN VIVO PHYSICAL
FORCES
IN VIVO ESTIMATION AND IN VITRO SIMU-
LATION OF BIOMECHANICAL FORCES
It is well known that blood vessels and their con-
stituent cells are biologically sensitive to mechanical forces.
For example, the drag force caused by flowing blood on
the luminal surface of a vessel (referred to as “shear stress”)
is thought to play a role in atherogenesis and development
of intimal hyperplasia. Likewise, the forces acting within
the vascular wall in response to its distension and deforma-
tion (referred to as “wall stresses”) are thought to play a
role in these and other pathologies, including aneurysm
formation and rupture. To fully understand the role of nor-
mal and abnormal physiologic forces on vascular disease
processes, it is necessary to first estimate their magnitude
and then simulate them accurately in vitro.
Estimation of physical forces
In addition to the hemodynamic variables (blood flow
and pressure), the surface geometry and size of the vascu-
lar wall are also important factors in defining both the
shear stresses and wall stresses to which it is exposed.
Therefore, accurate determination of the shape of a blood
vessel is imperative for the estimation of these biomechan-
ical forces. Knowledge of the stresses acting on the vascu-
lature may be valuable for a number of reasons. Two
examples taken from our laboratory’s ongoing work are
estimation of the forces acting on abdominal aortic
aneurysms and also on coronary artery vein grafts.
Abdominal aortic aneurysm
Rupture of abdominal aortic aneurysm is an event
marked by catastrophic mechanical failure of the aortic
wall tissue. Mechanical failure of a material occurs when
the stress (ie, force normalized to cross-sectional area) act-
ing on it exceeds the material’s strength or its intrinsic
ability to withstand stress. Our laboratory has shown that
the strength of the abdominal aortic aneurysm is
decreased to 50% that of the non-aneurysmal aorta.16 We
have also utilized computer models to demonstrate that
the shape and size of an aneurysm influences the stresses
acting in the wall considerably.19 Consistent with the law
of Laplace, we showed in this previous work that the larg-
er the aneurysm, the greater the stress acting on it.
Therefore, as an aneurysm enlarges, the wall becomes
progressively weaker and the stress acting on it increases.
Together, these two factors greatly increase the potential
for aneurysm rupture. We therefore believe that knowl-
edge of the wall stress distribution acting on an individual
abdominal aortic aneurysm may provide a diagnostic esti-
mate of its particular severity or propensity to rupture.
With this as motivation, our laboratory has developed a
noninvasive method to estimate the wall stress acting on
aneurysms using three-dimensional reconstructions of
computed tomographic scans, or “virtual aneurysms,” and
an established engineering tool known as finite element
analysis.11 Application of this model shows that the wall
stress in AAA is highly variable both within a particular
aneurysm and from patient to patient. Regions of highly
localized wall stress are apparent, and anatomic location of
maximum wall stress varies but is typically found on the
posterior surface.
Coronary artery vein grafts
The saphenous vein remains the primary graft 
of choice in coronary revascularization procedures.
Successful synthetic alternatives have yet to be developed,
and arterial grafts, such as the internal mammary artery, are
limited in number. However, despite its wide use, the coro-
nary artery vein graft (CAVG) suffers a significant degree
of failure. Up to 20% of coronary artery bypass surgeries
performed using the saphenous vein occlude at 1 year.3
It is widely believed that the sudden change in biome-
chanical milieu when transposing a vein to the coronary
arterial circulation facilitates the development of throm-
bosis, intimal hyperplasia, or graft atherosclerosis, three
well-known vein graft failure mechanisms. Veins placed in
the arterial circulation are exposed to increased shear stress
due to increased blood flow and an elevated wall stress due
to increased pressure. Our laboratory has shown that vein
segments acutely exposed to simulated arterial pressure
and flow increase their tissue factor production as com-
pared with control segments exposed to simulated venous
conditions.9 These findings suggest a role of biomechani-
cal forces in vein graft thrombosis. Similarly, Berceli et al2
showed that increased pressure and flow lead to an
increase in LDL incorporation by the vein wall and sug-
gested that these conditions facilitate the development of
vein graft atherosclerosis.
It has previously been shown that the coronary arteries
undergo cyclic flexure, elongation and twisting due to their
attachment to the beating heart.4,10 Such motion may
directly influence atherogenesis. Indeed, Stein et al13 report-
ed a statistically significant correlation between the degree of
in vivo flexion of a coronary artery segment and the severity
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of atherosclerotic stenosis. We hypothesize that CAVG, like
the coronary arteries, also undergo heart-induced cyclic
motion. It is quite possible that the biomechanical forces
associated with cyclic stretching, bending, flexing, etc, would
augment the response by the vein segment to an already
injurious biomechanical environment of increased pressure
and flow. Cyclic motion of the vein graft would cause fluc-
tuations in shear stress6,12 and wall stress or strain,5,13,15
which in turn would affect the constituent cell biology.14
Characterizing the degree of cyclic stretching and bending
that coronary artery vein grafts undergo, therefore, would
be important in order to study the possible role of such
motion and concomitant forces in CAVG pathogenesis.
To address this, we recently performed three-dimen-
sional reconstruction of six individual CAVG based on
biplane cineangiographic images.20 Animations of the cen-
terline of each graft were created to observe its motion
throughout the cardiac cycle. Mathematical analyses
allowed us to quantify in vivo motion, such as longitudi-
nal stretching and bending. Among other findings, we
reported that CAVG undergo cyclic longitudinal stretch-
ing—a 7% change in length on average—over the cardiac
cycle. We also demonstrated that, like coronary arteries,
CAVG undergo significant cyclic flexure or bending.
In vitro simulation of biomechanical forces
Quantified information on the actual stresses or strains
acting on the vasculature in vivo, such as those given in the
previous examples, are necessary in order to guide con-
trolled experimental studies designed to elucidate their
effect on vascular pathophysiology. To be relevant, in vitro
studies require a means to simulate physiologically realis-
tic forces, for example. A number of state-of-the-art bio-
mechanical tools exist that attempt to achieve this. Much
seminal work has been accomplished using basic appara-
tuses, such as a cyclic strain apparatus, wherein cells cul-
tured on flexible membranes undergo controlled cyclic
strain (wall stress), or parallel-plate or cone-and-plate
apparatuses, wherein cultured cells are subjected to known
shear stresses.14 Although these experimental apparatuses
have advanced our knowledge considerably with regards
to the role of biomechanical forces in vascular biology,
native vascular cells are subjected to multidirectional,
simultaneous forces and deformations in situ.
Recently, more rigorous experimental systems have
been introduced that allow simultaneous application of
both types of forces,1,8 including a whole vessel perfusion
apparatus in our laboratory.7,17 Our device provides ster-
ile metabolic support to vascular segments intended for
study. We are also able to define and control the biome-
chanical environment to which the segments are exposed.
Intraluminal pressure and flow are controlled and may be
steady or pulsatile in nature. If pulsatile, responsive cyclic
wall distension will occur. Simultaneous bending, twisting,
and stretching of the segment is also possible, each as sep-
arate stimuli or in combination.17,18
By simulating realistic biomechanical forces in vitro,
studies may be designed to assess the effects of specific
forces on cellular response and vascular pathophysiology
or the ability of vascular devices (synthetic grafts, tissue
engineered grafts, stunts, etc) to withstand the rigors of
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RESPONSES OF ENDOTHELIAL CELLS TO
SUSTAINED HYDROSTATIC PRESSURE
Background
Of the various mechanical forces to which endothelial
cells are exposed, sustained hydrostatic pressure has been
the least studied. This mechanical force (which differs
from, and is generally lower than, the hydrodynamic pres-
sure commonly referred to as “blood pressure”) is the sum
of the hydrostatic (equitriaxial) component of the blood
pressure as well as the osmotic and oncotic pressures of
both the plasma and the surrounding tissue. Endothelial
cells sense and respond to the mechanical forces (includ-
ing hydrostatic pressure) to which they are exposed,
through various molecular signal transduction mecha-
nisms, and these molecular mechanisms may play a role in
numerous pathological and physiological conditions in
vivo. For example, endothelial cell elongation and align-
ment in the direction of blood flow is associated with
regions of laminar blood flow1; endothelial cell dysfunc-
tion leading to atherosclerotic plaques are associated with
regions of disturbed, non-laminar blood flow2 as well as
with regions of vessel wall stress concentrations3; and
endothelial cell proliferation is associated with conditions
of elevated hydrostatic pressure (namely, wound healing
and edema, glaucoma, and tumors). Although the
responses of endothelial cells to shear and tensile stresses
have been extensively studied in vitro, the mechanisms by
which endothelial cells sense and respond to sustained
hydrostatic pressure have been investigated only recently.
Early investigations in our laboratories demonstrated
that exposure of bovine endothelial cells to sustained
hydrostatic pressure resulted in cell elongation (without a
predominant cell orientation), cytoskeletal reorganization
(specifically, loss of the peripheral actin band and formation
of thick stress fibers aligned with the long axes of the cells),
cell proliferation, and cell multilayering.4 In addition, these
studies provided evidence that bovine pulmonary artery
endothelial cells respond to sustained hydrostatic pressure,
at least in part, through an autocrine stimulation mecha-
nism involving basic fibroblast growth factor (bFGF).4
Specifically, conditioned supernatant media from endothe-
lial cells exposed to sustained hydrostatic pressure were col-
lected and either were left untreated or were heat treated
(75°C; 5 minutes), freeze-thawed, subjected to heparin-
Sepharose affinity chromatography, or depleted with block-
ing monoclonal antibodies to bFGF. All samples were sub-
sequently supplemented with 20% fetal bovine serum and
were used to treat naive endothelial cells. Endothelial cells
exposed to untreated conditioned media demonstrated
morphological changes, cell proliferation, and cell multi-
layering, similar to the changes observed in endothelial
cells exposed to pressure. In contrast, the mitogenic activ-
ity of the conditioned media was abolished by all the treat-
ments tested in that study.4
More recent investigations in our laboratories have
investigated the response of human endothelial cells to
sustained hydrostatic pressure. Due to the requirement of
human umbilical vein endothelial cells (HUVEC) in cul-
ture for exogenous bFGF, the role of bFGF autocrine
mechanisms in the human endothelial cell pressure
response could not be directly investigated. However, sev-
eral aspects of the response of HUVEC to low, physiolog-
ical ranges of sustained hydrostatic pressure (specifically, 4
cm H2O) were investigated.
Methods
HUVEC (passage 3 to 9) were seeded subconfluently
to rigid, fibronectin-coated substrates and were either
maintained under control (0.2 cm H2O) pressure condi-
tions or exposed to 4 cm H2O sustained hydrostatic pres-
sure for time periods of 15 minutes to 4 days. Except where
otherwise noted, cells were maintained in Medium 199
(containing 10% fetal bovine serum and 0.4% bovine brain
extract [BBE], a crude extract rich in bFGF) under stan-
dard cell culture conditions (specifically, 37°C; humidified;
95% air/5% CO2) for the duration of all experiments.
Following exposure to pressure, HUVEC were ana-
lyzed using various standard or published techniques,
including immunocytochemistry, Western blot, immuno-
precipitation, BrdU incorporation, cell cycle analysis by
FACS, adhesion assays, and bFGF ELISA.
Results
Compared with cells maintained under control pres-
sure conditions, exposure of HUVEC to sustained hydro-
static pressure for time periods of 1 to 4 days resulted in
increased cell proliferation, as measured by total protein
and total DNA content, BrdU incorporation, cell cycle
analysis, and counts of total cell number. In addition,
exposure of HUVEC to sustained hydrostatic pressure
resulted in morphological changes, including loss of the
peripheral actin band and formation of stress fibers aligned
with the long axes of the cells.
Exposure of HUVEC to sustained hydrostatic pressure
resulted in alterations of focal adhesion plaque morphology
and composition. Specifically, in HUVEC maintained under
control pressure conditions, vitronectin receptor (VnR)
integrins (namely, a v b 3 and a v b 5) immunoreactivity was
localized to large, rounded, or oval regions predominantly
confined to the cell border. In contrast, HUVEC that had
been exposed to pressure showed VnR immunoreactivity in
small, elongated regions occurring throughout the spread
edge of the cell. Similarly, regions immunoreactive for vin-
culin were large and localized to the cell border in HUVEC
maintained under control conditions and were elongated
and localized throughout the cell spread edge in HUVEC
that had been exposed to sustained hydrostatic pressure.
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Both VnR-immunoreactive and vinculin-immunoreactive
regions colocalized with focal adhesion plaques, as demon-
strated by interference-reflectance microscopy. In addition,
the quantities of integrin subunits a v and b 3 were selective-
ly upregulated following exposure of HUVEC to sustained
hydrostatic pressure for time periods of 4 hours to 4 days.
In contrast, the quantities of integrin subunits b 1 and b 5
were unaffected by exposure of HUVEC to pressure at any
time point examined in the study. The functional conse-
quences of these changes were selective for VnR; specifical-
ly, exposure of HUVEC to sustained hydrostatic pressure
for 1 day resulted in increased adhesivity of the cells to vit-
ronectin-coated surfaces, whereas adhesivity of these cells to
fibronectin, laminin, and gelatin was unaffected. Lastly,
treatment of HUVEC with the selective VnR antagonist
SB2232455 blocked the proliferative response of the cells to
sustained hydrostatic pressure.
The role of bFGF in the HUVEC pressure response
mechanism was evaluated indirectly using bFGF ELISA and
BrdU incorporation assays for cell proliferation. In contrast
to the bovine endothelial cells,4 conditioned media (that is,
supernatant of HUVEC that had been exposed to sustained
hydrostatic pressure) did not induce morphological changes
or increased cell proliferation in naive HUVEC maintained
under control pressure conditions. ELISA measurements of
bFGF concentration indicated that media both from
HUVEC maintained under control pressure conditions and
from HUVEC that had been exposed to sustained hydro-
static pressure contained 15 ng/mL bFGF. However, cell
proliferation assays showed that the media had to be sup-
plemented with at least 160 ng/mL bFGF to induce
increased cell proliferation in this in vitro model.
Discussion and conclusions
Recent studies by our laboratories have demonstrated
that vascular endothelial cells sense and respond to sus-
tained hydrostatic pressure in vitro, in specific and coordi-
nated ways that are similar to the behavior of endothelial
cells exposed to conditions of elevated pressure (eg, glau-
coma, tumors, and edema) in vivo. Specifically, exposure
of endothelial cells to pressure results in increased cell pro-
liferation and in morphological changes involving the cell
cytoskeleton and focal adhesion plaques. The results of
these studies suggest that the morphological changes,
specifically those involving VnR-immunoreactive focal
adhesion plaques, may play a role in inducing, regulating,
or permitting the increased cell proliferation that occurs
following exposure of endothelial cells to pressure.
In contrast to bovine endothelial cells, exposure of
HUVEC to sustained hydrostatic pressure does not result
in a detectable increase in secretion of bFGF into the
supernatant cell culture media. This result, however, does
not rule out a role for bFGF autocrine stimulation in the
HUVEC pressure response. Local changes in bFGF con-
centration in the boundary layer immediately adjacent to
the cells and sequestration of bFGF into the extracellular
matrix cannot, as yet, be ruled out and may serve to explain
the discrepancy between the bovine and human results.
In summary, the results of recent studies have charac-
terized some aspects of the responses of endothelial cells
to sustained pressure and have elucidated some of the
mechanisms that may underlie these responses. These
results may provide new insights into pressure-related
physiological events in the vasculature and into diseases
(such as glaucoma and tumors) that are associated both
with elevated hydrostatic pressure and with endothelial
cell proliferation.
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NONINVASIVE CLINICAL TECHNIQUES
FOR FLOW VELOCITY MAPPING AND WALL
MOTION QUANTIFICATION
Motion sensitive MR techniques
Until a few years ago Doppler ultrasound was consid-
ered the gold standard for in vivo blood flow measure-
ments. However, over the last decade several magnetic res-
onance (MR) imaging methods have evolved that permit
noninvasive, accurate, and reliable in vivo motion quantifi-
cation.1,2 MR velocity sensitive methods are, unlike
Doppler ultrasound, not limited by access windows. With
the majority of MR motion sensitive methods, motion sen-
sitivity is introduced with a bipolar magnetic field gradient
along an arbitrary spatial direction. For stationary tissues,
this gradient has no effect, whereas for tissues or fluids
moving along the applied gradient, a phase shift results that
depends linearly on the velocity of the moving object.
Variation of gradient amplitude and duration permits
adjustment of motion sensitivity within wide limits, suit-
able for the measurement of physiological velocities, rang-
ing from slow tissue motion to accelerated flow in a
stenosed artery. However, similar to aliasing with Doppler
ultrasound, inadequate setting of the motion sensitivity
may result in velocity dependent phase shifts that exceed
the range of ±180 degrees and, therefore, become ambigu-
ous. A reference measurement with different or zero
motion sensitivity, but otherwise identical imaging parame-
ters, must be obtained to eliminate phase shifts introduced
by motion along the imaging gradients and due to other
effects, such as chemical shift or inhomogeneities of the
main magnetic field. Because the velocity dependent phase
is measured for each pixel of an image, velocity maps at
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high spatial resolution can be reconstructed. The measured
velocities represent the average velocities within the pixels
of an image. Typical matrix sizes for the two-dimensional
images range between 128 · 128 and 256 · 256 pixels,
with in-plane pixel dimensions of 1 mm or less and a slice
thickness of a few millimeters. The complete spatial veloci-
ty vector can be assessed for each pixel by performing con-
secutive velocity measurements along different spatial
directions. By collecting three-dimensional datasets and
calculating the complex signal difference instead of the
phase difference, morphologic angiograms with excellent
suppression of the static tissue signal can be obtained. MR
phase velocity imaging is the most widely used method for
in vivo motion quantification with MR. It has been exten-
sively validated in phantom calibration experiments and
with other modalities, such as ultrasound Doppler3 and
laser Doppler anemometry.
There exist a number of other MR motion sensitive
methods that are useful under certain circumstances. Fourier
velocity imaging is a phase method, where the motion sensi-
tizing gradient is varied in incremental steps. Similar to ultra-
sound Doppler imaging, a velocity spectrum is obtained for
each scanned volume element. The application of this tech-
nique has been limited to one-dimensional projection scans,
because the long scan time for two-dimensional images is
not suitable for experiments in vivo. With another method,
referred to as optical flow, in-plane motion vectors can be
assessed by tracking image brightness variations in consecu-
tive images. Velocity can be calculated as the ratio between
displacement and image frame time interval. In tissues like
the myocardium or in fluids, this method is unreliable
because of the absence of high-contrast landmarks. Artificial
landmarks, also called tags, can be created by selective spin
saturation prior to the image acquisition.4 Spin saturation in
a pattern of parallel stripes or after repeated application in the
pattern of a grid can be achieved with special radio-frequen-
cy pulses of a few milliseconds duration. The landmarks
appear in the final image as hypointense regions superim-
posed on the normal MR images. In-plane motion occurring
after labeling is visible as a distortion and displacement of the
initial pattern of landmarks. The lifetime of the spin satura-
tion is determined by the tissue specific longitudinal relax-
ation time T1 and the excitation pulses of the imaging pro-
cedure. Myocardial tagging has become the preferred
method to study cardiac motion. For very slow motion, such
as in the brain or in the vascular wall, tagging is inadequate
because the displacement is very small compared with the
size of the landmarks and the distance between them.
Nevertheless, average vessel wall distension has been assessed
by using sequences that produce a strong contrast between
the vessel wall and the in-flowing blood.5
Limitations of MR motion sensitive techniques
Because the image information is usually collected
within a number of excitations, cardiac triggering of the
acquisition is required for the observation of cardiac relat-
ed physiologic motion. Fast gradient echo sequences per-
mit a temporal resolution of 50 milliseconds or better.6
Single-shot, instant imaging methods, which do not
require gating, exist. However, lower spatial resolution
and increased image artifacts limit their application. Under
situations where cardiac output varies (eg, during a stress
test) methods with very short scan times are indispensable.
Dedicated scanner equipment, which permits continuous
real-time acquisition for assessment of morphology and
motion in the heart, is currently under development.
In conventional scanner systems, the horizontal, long
and narrow opening in the super-conducting magnetic field
coil limits the investigation of subjects in supine or prone
position. This is a disadvantage because cardiac output at
rest varies with body position. With the advent of interven-
tional MR systems that provide improved access for surgical
manipulations, subjects can also be scanned in a sitting or
even standing position, in which cardiac output is up to 50%
lower than in supine position. Moreover, the effect of joint
movement on peripheral blood flow can be studied.
Although MR motion sensitive methods are suitable for
accurate measurement of velocities on a macroscopic level,
other methods are needed to quantify flow patterns on a
microscopic level (ie, tissue perfusion). In some cases, tissue
perfusion can be estimated by looking at average flow rate
and temporal flow pattern in large vessels supplying the tis-
sue of interest and by comparing these values with values
obtained in the healthy contralateral side. In the case of
advanced disease, however, when multiple collateral vessels
have formed, determination of the flow rate in each collat-
eral becomes elusive. A direct observation of tissue perfu-
sion is possible with the application of a contrast agent,
which will lead to a signal enhancement in the perfused
regions of the tissue. On the other hand, with MR diffusion
imaging, tissue perfusion produces a signal loss. A more
detailed description of MR techniques for tissue perfusion
quantification can be found in the pertinent MR literature.
Artifacts with MR motion sensitive techniques
Several motion-dependent artifacts limit the applica-
tion of motion sensitive MR techniques. In areas of high
velocity shear, the resulting intra-voxel phase dispersion
may result in partial or complete loss of signal and velocity
information. To some extent, such signal loss can be
reduced by lowering the motion sensitivity and by using
motion-insensitive (motion-compensated) gradient pulses
for spatial encoding. Another possibility is the reduction of
voxel size, preferably along the slice select direction
because the anisotropic voxels used in imaging experiments
are usually elongated along the slice select direction. The
delay between image slice selection and gradient pulses for
in-plane spatial encoding, also referred to as echo time, can
lead to considerable image distortions in areas of high
velocities. Consequently, visualization of velocities in a
stenotic jet is difficult, except for cross-sectional views.
Sequences are therefore designed to minimize this delay
down to a few milliseconds, sometimes with a compromise
in image quality. A short delay is also necessary to reduce
additional phase shifts, which stem from acceleration and
higher-order motion (jerk) and which can not be distin-
guished from velocity dependent phase shifts. Variation of
JOURNAL OF VASCULAR SURGERY
Volume 29, Number 6 Special Communication 1127
the cardiac interval and the cardiac contraction pattern (eg,
during respiratory cycles) may lead to image ghosting arti-
facts. Inevitably, the measured velocities represent average
velocities of an average cardiac cycle.
Post-processing of MR velocity data
Post-processing permits the display of velocity vectors
on top of the anatomic MR image.7 Repetitive physiologic
events can be studied in cine loops of such images.
Instantaneous blood flow rate can be determined by sum-
ming up the product of pixel velocity and pixel size over
the entire cross section of a vessel. An estimate of velocity
shear along the vessel wall can be obtained by calculating
the spatial derivatives of velocities measured at high resolu-
tion.8 Spatial dislocation can be derived from the time inte-
gral of the instantaneous velocities. This approach has been
used to analyze the particle paths in complex blood
streams9 and motion in tissues, such as cardiac muscle,
brain, and vessel wall.10
Conclusions
In summary, a large number of MR techniques have
evolved over the last decade that permit the in vivo quan-
tification of motion. Most of the manufacturers of MR
equipment provide at least the basic sequences for the
observation of pulsatile blood flow. Velocities and blood
flow in large vessels can be determined with an accuracy of
a few percent, which is sufficient in view of normal physi-
ologic fluctuations at rest. With minor modifications of
sequences and imaging protocols, as well as post-process-
ing of the velocity data, further, very detailed in vivo
motion data can be obtained.
Stephan E. Maier, MD, PhD
Brigham and Women’s Hospital
Boston, Mass
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DEVELOPMENTS IN IMAGING TECHNIQUES
PLAQUE LOCALIZATION AND VESSEL BIO-
MECHANICS
Traditional methods for studying human coronary
artery disease have significant limitations. Angiography
allows evaluation only of the geometry of the unobstruct-
ed part of the lumen; it cannot provide information on the
structural or cellular composition of the arterial wall,
which is essential to understand the processes leading to
plaque rupture. In addition, limitations associated with
the projection of three-dimensional (3D) structures onto
a planar image further hinder this approach. Although his-
tological analysis directly evaluates atherosclerotic plaque
composition, it cannot be used to identify plaques “at
risk” for rupture because the necessary tissue specimens
can only be obtained at autopsy. An emerging technique,
intravascular ultrasound (IVUS), can provide the neces-
sary structural information in situ but only in a two-
dimensional (2D) format that makes it impossible to study
the 3D relationship of arterial wall components.
The development and refinement of IVUS have pro-
vided a powerful in vivo method to assess plaque morphol-
ogy. Recent clinical studies have documented the sensitivi-
ty of IVUS in detecting atherosclerosis, and it is increas-
ingly employed to assist in selecting an appropriate
therapeutic intervention. Perhaps, more importantly, the
potential of IVUS to quantify the structure and geometry
of normal and atherosclerotic coronary arteries will allow
one to characterize specific lesions and to distinguish which
plaques will or will not lead to coronary plaque rupture.
Vessel geometry
The utility of IVUS in visualizing and quantifying coro-
nary morphology has been limited by its 2D tomographic
nature. Typical three-dimensional (3D) reconstruction
techniques of coronary arteries from intravascular ultra-
sound (IVUS) have assumed that the artery was straight and
disregarded the angular orientation of IVUS slices. We
achieved accurate 3D reconstruction of coronary arteries by
following the transducer in time with the aid of biplane
angiograms. Simultaneously acquired IVUS images were
then placed perpendicular to the transducer path, using
angiography to aid in solving for the correct rotational ori-
entation. A novel 3D active surface method automatically
identified the lumenal and medial-adventitial borders,
which, when superimposed on the transducer trajectory,
could be surface rendered for visualization and morphome-
try (Fig 1; http://www.ri.ccf.org/ri/bme/image/IVUS
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morph.html). These reconstructions were performed with
software developed in our laboratory using SGI Unix work-
stations. The graphical user interface allows the vessel to be
rotated through 360 degrees. We conclude that this
method provides an accurate reconstruction, without any of
the possibly inaccurate assumptions or mechanical aids
required by other methods.
Plaque composition
IVUS is becoming accepted as an imaging technique
that allows precise tomographic assessment of the coro-
nary anatomy in vivo. Recent clinical studies have docu-
mented the sensitivity of IVUS in detecting atherosclero-
sis and in quantifying the morphology of coronary lesions.
More importantly, IVUS can potentially quantify the
structure and composition of normal and atherosclerotic
coronary arteries in the clinical setting rather than relying
on histologic data, which can only be obtained at autopsy.
Fibrous or “hard” plaques are generally advanced
lesions that contain dense fibrous tissue, collagen and
elastin fibers, and proteoglycans. Similar to calcified
regions of plaque, dense fibrous plaque components gen-
erally reflect ultrasound energy well and thus appear bright
and homogeneous on IVUS images. One of the major
problems with many of the studies performed to date is
their dependence on plaque brightness as a discriminant of
fibrous tissue content. Because this parameter is highly
dependent on the gain setting of the IVUS console and its
transmit power, direct comparison of brightness in IVUS
images may not be possible. A reliable method was there-
fore desired for assessing plaque composition in intravas-
cular ultrasound images. Over the past few decades, sever-
al texture analysis approaches have been developed and
applied to a variety of image types, but no one approach
has found widespread use in medical applications. Recent
work in our laboratory was directed towards the assess-
ment of texture analysis methods to identify plaque com-
ponents and to determine which analytic method provides
the most accurate representation of plaque composition.
The statistical techniques evaluated were: first-order statis-
tics (grayscale), Haralick’s method, Laws’ texture energies,
neighborhood gray-tone difference matrices (NGTDM),
Fig 1.
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and the texture spectrum method. These methods were
chosen for their reported success at differentiating soft tis-
sue and textural patterns in two-dimensional grayscale
images. Despite the apparent applicability of each of the
examined texture analysis techniques to IVUS imaging,
only Haralick’s method yielded significant results in our
study (Fig 2). One of the limitations of our studies was the
reliance on digitizing videotape. This process has three
major limitations: (1) it is very time consuming and there-
fore not feasible for near real-time analysis; (2) it reduces
the resolution of the image to that of videotape (approxi-
mately 330 m m); and (3) parameters, such as gain and
intensity, can be adjusted by the operator, thereby adding
variability to the data set. More recent studies by our
group were directed towards gaining access to the raw
ultrasound signal, often referred to as the RF signal. This
approach is fast because data can be streamed from the RF
port directly to a PC, does not reduce the resolution of
the image, and cannot be altered by the console display
controls. We are currently investigating the utility of sig-
nal processing algorithms to automatically identify plaque
components through correlation with histologic data.
Mechanical testing
Plaque rupture will occur when the stress on the
plaque cap and adjacent tissue, due to blood pressure and
flow, exceeds the tensile strength of the tissue. The tradi-
tional method for studying failure mechanisms in nonbio-
logic systems is to determine the typical loading condi-
tions, determine the material properties of the specimen,
and suggest an appropriate model for failure. The model
would be compared with actual failed examples to deter-
mine how well the model predicted failure loading and
mode of failure (ie, yielding, fracture, etc). Similar tech-
niques have been applied to atherosclerotic plaques in the
investigation of plaque rupture. When applied to coronary
plaques, traditional mechanical testing methods have
failed to provide a consensus on the properties of lesions.
This may be due to the small size of the arteries and
plaques making testing difficult and the heterogeneous
nature of lesions.
In order to gain a better understanding of the mecha-
nisms responsible for plaque rupture, the material proper-
ties of the arterial wall need to be better understood.
Although the stress distribution through the plaques
determine whether failure occurs, the artery wall material
properties together with the loading determine the exact
boundary conditions the plaque is subject to and directly
affect the stress distribution through the plaque. The aim
of this study was to develop material testing techniques
using intravascular ultrasound (IVUS) imaging that could
be used to determine arterial wall material properties in
vitro. Of particular interest were the quasi-static
stress/strain behavior and the viscoelastic response of the
tissue to sudden changes in loading. Previous studies have
shown that arteries exhibit nonlinear behavior. Most of
the studies performed to date have investigated the prop-
erties of carotid arteries because sections can be dissected
that do not contain bifurcations and side branches. This
allows inflation tests to be performed relatively easily. Few
results are available for coronary arteries due to the small
size of the vessels and the number of side branches sup-
plying the myocardium and fat surrounding the vessels.
IVUS gives a cross-sectional view of the artery, allow-
ing direct measurement of changes in wall thickness and
geometry and allows for testing of arterial material prop-
erties without the need to dissect out the artery from the
surrounding tissue. Previous testing methods could not
test in the radial directions and would make assumptions
on the basis of incompressibility as to the behavior of the
artery in the radial direction. This technique would allow
for minimally invasive study of arterial mechanics in vivo.
Hemodynamics
Hemodynamics play an important role in the develop-
ment and progression of coronary artery disease.
Understanding the relationships between the cardiovascu-
lar morphology and functionality is key to determining the
factors leading to the progression of arterial stenosis.
Much emphasis to date has focused on studying the effects
of low shear rate (separated, recirculating flows) or high
shear rate (alter endothelial cell function or cellular depo-
Fig 2.
JOURNAL OF VASCULAR SURGERY
1130 Special Communication June 1999
sition) on the local wall intima. The carotid artery bifur-
cation or the femoral artery have been commonly selected
models for such work. More recently, research efforts are
investigating the role of mass transport in the progression
of atherosclerosis. The convective mass transport of
macromolecules, such as albumin or globulin ,or the dis-
tribution of dissolved blood gases, all of which are depen-
dent on the velocity flow field within the arteries, may also
play a role in vascular disease. The geometric models used
for such vascular computational fluid dynamics (CFD)
studies are commonly based on CT, MRI, and angio-
graphic measurement methods. These methods for defin-
ing the blood flow path are currently limited to “larger”
size vessels, such as the carotid arteries or the abdominal
aorta. Our proposed work will use IVUS reconstructed
images to model blood flow through the “smaller” coro-
nary arteries.
The influence of arterial wall distensibility on the local
flow field and its role in the progression of arterial diseases
are other areas of growing interest. Fluid/structural inter-
action models couple the forces imposed by a pulsatile
blood flow field with those exerted back by the surround-
ing vessel wall. Here again, much of the current effort
focuses on larger vessels, such as the carotid artery bifur-
cation. We are proposing to conduct fluid/structural sim-
ulations on the coronary arteries to study the role of ves-
sel compliance on the progression of vascular disease in
these smaller vessels.
J. Fredrick Cornhill, DPhil
The Cleveland Clinic Foundation
Cleveland, Ohio
EFFECTS OF PHYSICAL FORCES ON
VASOREACTIVITY AND LUMEN SIZE
SHEAR STRESS REGULATION OF ARTERIAL
ADAPTATION
Blood flow and wall shear stress are important hemo-
dynamic factors that regulate arterial wall adaptation and
remodeling. Arteries enlarge in response to increased flow
and shear stress with no intimal thickening.1 Low levels of
shear, on the other hand, promote the development of
intimal thickening.2 Recently, animal models of increased
blood flow after creation of arteriovenous fistulas (AVF)
have allowed both the in vivo investigation of morpholog-
ic changes and the identification of important molecular
markers, which may initiate arterial adaptation to these
hemodynamic variables. Also, a unique animal model of
sequential increases and decreases of blood flow has
demonstrated the development of intimal thickening dur-
ing periods of subnormal wall shear stress without
endothelial injury or denudation.3 Many of these impor-
tant findings, which are summarized in this text, have
increased our understanding of arterial adaptation to
increased and decreased flow.
Basic fibroblast growth factor (bFGF), along with
other arterial wall mediators, such as transforming growth
factor beta-1 (TGF), nitric oxide, and nuclear transcrip-
tion factors (c-fos), have recently been described as poten-
tial markers describing the complex pathways involved in
arterial wall adaptation to increased wall shear stress using
cell culture experiments.4 The actual role and interaction
of each individual mediator in arterial adaptation studies is
still not fully understood. To further our understanding of
these important molecular markers in arterial adaptation
to increased flow, we studied the time course of expression
in animal models of increased flow.
Immediately after creation of a common carotid–exter-
nal jugular vein AVF in rabbits there is a five-fold to 10-fold
sustained increase in blood flow in the afferent artery, with
a marked increase in wall shear stress.5 Structural changes
in the morphology of the artery wall are visible within 24
hours, and lumen enlargement is detectable within 3 days
after internal elastic lamina fragmentation. Progressive
lumen enlargement results in a decrease in wall shear stress
to near normal values after 8 weeks of high flow. RT-PCR
has demonstrated the early transcription of two important
regulatory growth factors of the arterial wall, bFGF (active
in cellular proliferation and migration) and TGF (modu-
lates extracellular matrix deposition and decreases active
remodeling), before measurable flow induced arterial
enlargement. Using specific primers for each growth factor
and semi-quantitative densitometric analysis, arterial wall
TGF gene expression is increased after 1 day of increased
shear and decreased after 7 days,6 and bFGF expression
increases gradually, peaking at 7 days.4 Western blotting,
using specific antibodies against the desired protein, iden-
tified the specific arterial wall protein at all time points.
Immunohistochemical analysis indicates initial localization
of bFGF protein in endothelial cells with subsequent local-
ization in the media and adventitia after 7 days.4 These data
support the in vitro results and for the first time identify
these two important and different growth factors as impor-
tant early molecules for arterial adaptation to increased
blood flow and wall shear stress in normal arteries. The
actual role and cellular localization of these two regulatory
factors are still unknown and are the effort of ongoing
experiments.
Acute changes in arterial diameter are mediated by
endothelial production of nitric oxide (NO). In response
to increased blood flow, NO is synthesized from L-argi-
nine by the enzyme NOS. Synthesis of NO can be inhib-
ited by the L-arginine analog L-NAME. The role of NO in
chronic flow-induced adaptive enlargement was studied in
rats with a left femoral AVF model and oral L-NAME dis-
tribution.7 Using this model, left femoral arterial enlarge-
ment was evident after 7 days. Arterial enlargement to
high flow decreased with either high (2 mg/mL) or low
dose L-NAME (0.5 mg/mL) after 7 days compared with
controls. This finding suggests that NO may also play a
role in flow-induced arterial remodeling.
In vitro studies on cultured endothelial cells exposed
to high shear stress have demonstrated upregulation of the
proto-oncogene, c-fos, a nuclear transcription factor
involved in the regulation of growth factors, and matrix
degrading enzymes. In order to study the in vivo expres-
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sion of c-fos in the aortic wall of mice exposed to high
shear, transgenic mice with c-fos linked to a lac-z reporter
gene were studied after creation of an aorto-caval fistula.8
With this animal model, blood flow and shear increased
four-fold immediately after fistula creation and aortic
diameter increased significantly after 21 days. Using b -
galactosidase activity, early c-fos expression was detected in
endothelial cells during the first 3 days, and smooth mus-
cle cell expression peaked after 6 hours and gradually
declined after 21 days. Thus, increased shear stress results
in the expression of arterial wall proto-oncogenes before
the onset of flow-induced arterial enlargement and the
predominance of c-fos gene expression in smooth muscle
cells before aortic enlargement suggest that the up regula-
tion of matrix degrading enzymes may be a major control
mechanism regulating this enlargement.
The effect of reducing wall shear stress was studied in
enlarged arteries that had adapted to high flow by ligating
the AVF. Using the rabbit AVF model, enlarged arteries
after exposure to high blood flow for 4 weeks had sub-
normal wall shear stress levels after blood flow returned to
normal.9 Arterial diameter remained 80% larger than con-
trols. Lower than normal wall shear stress conditions
resulted in the development of intimal thickening after 3
weeks (0.6 ± 0.2 mm2) and progressively increased for 26
weeks (0.8 ± 0.1 mm2) of normal flow.
In another set of experiments, rabbits underwent mul-
tiple cycles of flow variation.3 Each cycle was defined as 4
weeks of increased flow followed by 6 weeks of normal flow
by fistula ligation. Animals underwent two or three cycles
by creation of a new proximal carotid jugular AVF after the
first fistula was ligated. Ligation of the fistula 4 weeks after
increased flow subjected the left carotid artery to sudden
low wall shear stress levels (2 to 4 dynes/cm2) because the
artery had fully enlarged and remodeled in response to the
increased flow. This experimental model confirmed that
intimal thickening can be induced by changes in blood flow
as well as wall shear stress without endothelial injury or
denudation. Each cycle of blood flow changes induced one
strata of intimal thickening (cycle 1, 0.3 ± 0.1; cycle 2, 1.0
± 0.2; and cycle 3, 1.9 ± 0.6). It is likely that additional
cycles would induce additional intimal thickening. High
blood flow and elevated wall shear stress inhibited intimal
thickening, and decreased blood flow and low wall shear
stress promoted intimal thickening. There is a intimate
relationship between intimal thickening and low wall shear
stress. All these effects are considered to be mediated by
endothelial cells, which sense changes in blood flow and
wall shear stress and produce many possible growth pro-
moters and growth inhibitors. Because the intimal thicken-
ing is structurally similar to early atherosclerotic plaques
and may predispose the artery to atherosclerosis, further
understanding of this regulation of proliferative response
may yield insight into the mechanisms of atherosclerotic
lesions. Thus, it appears that prolonged periods of reduced
blood flow and shear stress stimulate intimal thickening.
Thus, arteries respond differently to chronic increases
and decreases in wall shear stress. Increased shear leads to
arterial enlargement with no intimal thickening. There are
many potential molecular markers that may act individual-
ly or simultaneously to help initiate important cellular
events, which result in arterial enlargement. Chronically
decreased shear after previous arterial enlargement, on the
other hand, leads to intimal thickening. These changes are
cumulative with each period of increased and decreased
flow and shear. Further elucidation of the molecular mark-
er responsible for flow-induced arterial adaptive changes
may help understand pathologic changes affecting arteries.
Tej M. Singh, MD
Raul J. Guzman, MD
Christopher K. Zarins, MD
Stanford University School of Medicine
Stanford, Calif
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INOS EXPRESSION IN HUMAN VEIN GRAFTS
The long-term results of coronary and lower extremity
revascularization procedures are limited by the high inci-
dence of restenosis. A major event in the restenosis of vein
grafts is the development of intimal hyperplasia, which is
characterized by the migration and proliferation of vascular
smooth muscle cells with the subsequent deposition of extra-
cellular matrix.1 Early and intermediate failure of vein grafts
is often due to intimal hyperplasia, and late failure is most
often the result of recurrent or progressive atherosclerosis.
Nitric oxide (NO) is a short-lived humoral substance
that is known to play a critical role in vascular physiology
and pathophysiology. The three isoforms of NOS include
JOURNAL OF VASCULAR SURGERY
1132 Special Communication June 1999
endothelial nitric oxide synthase (cNOS), neuronal nitric
oxide synthase (nNOS), and inducible nitric oxide syn-
thase (iNOS). Two of the NOS isoforms (cNOS and
nNOS) are constitutive, and iNOS is expressed after cells
have been stimulated (by certain cytokines, for instance).
iNOS is much more potent than the constitutive forms,
making it ideal for rapid response to acute injury as seen
in the explantation and grafting of saphenous vein.
NO has been shown to inhibit smooth muscle cell pro-
liferation, the deposition of extracellular matrix components,
and platelet aggregation and adhesion—all key events in the
development of intimal hyperplasia. Systemic defects in NO
production or release have been implicated in the pathogen-
esis of the arterial abnormalities that accompany hypercho-
lesterolemia, diabetes, and atherosclerosis.2 Similarly, abnor-
mal NO-mediated vasoconstriction is observed after
endothelial injury associated with the development of exper-
imental arterial intimal hyperplasia. Restoration of NO levels
with the precursor L-arginine, NO donor drugs, or gene
transfer of NO synthase genes results in a significant decrease
in intimal hyperplasia and atherosclerosis in a variety of
experimental models.3-6 Thus, NO production seems to be
an inherent protective mechanism whereby blood vessels
resist restenosis and thrombosis.
Little is known regarding the role of NO in vein
bypass grafts. In studies of retrieved human aortocoronary
vein grafts, there was expression of the constitutive iso-
form of NO synthase (cNOS), although a change in the
receptor-dependent, NO-mediated vasorelaxation was
noted.7 Others have demonstrated a focal reduction in
cNOS expression in human vein grafts at sites of athero-
sclerosis.8 There is experimental evidence that augmenta-
tion of NO production in rabbit vein grafts significantly
inhibits intimal hyperplasia and atherosclerosis.9 Thus, the
potential for pharmacologic intervention to inhibit these
processes in human vein grafts exists if the L-arginine NO
pathway can be manipulated to produce more NO.
Because the inducible isoform of NO synthase (iNOS) is
capable of producing large amounts of NO and is found in
vascular smooth muscle cells, its potential utility in pre-
serving bypass patency is obvious. We have examined
whether human saphenous vein and vein bypass grafts
express the gene for iNOS and whether this expression is
different in aortocoronary and infrainguinal grafts.
Human vein grafts and saphenous veins were obtained
at the time of either redo aortocoronary bypass, revision
of grafts, or amputations of the lower extremities. There
was at least one risk factor for atherosclerosis (diabetes,
hypertension, smoking) in all of the patients undergoing
these redo vascular procedures or amputations. Small rings
of the vessels were collected and snap frozen in liquid
nitrogen for molecular studies. Total cellular RNA was
extracted from the tissue samples, and only RNA of high
quality was used. Gene transcript levels were measured
using reverse transcription/polymerase chain reaction
(RT/PCR). Glyceraldehyde-3-phosphate-dehydogenase
(GAPDH) was used as the internal control. The PCR was
performed in triplicate for each sample using primers that
were end labeled with 32P ATP using T4 DNA kinase.
PCR products were separated on an ethidium bromide-
stained 1.5% agarose gel and visualized using an ultravio-
let light source. The products were excised from the gel
and counted in a scintillation counter where a ratio of
iNOS pmol/GAPDH pmol was generated. There was a
significant increase in the iNOS gene expression in the
aortocoronary vein grafts (0.049 ± 0.01) as compared
with the infrainguinal bypass grafts (0.019 ± 0.001) or
control saphenous vein (0.011 ± 0.02; P < .05).
Sequencing of a fragment of the amplified 428 base pair
gene product confirmed an 84% homology with the avail-
able gene bank human sequence (GeneBank accession
L09210).10
This expression has been difficult to study in vitro
presumably due to the fact that iNOS does not seem 
to be translated even with the induction of signal by sev-
eral cytokines known to induce the enzyme. This is sim-
ilar to studies in dedifferentiated cardiac myocytes.11
Smooth muscle cells were isolated from stenotic vein
grafts or normal saphenous vein at the time of bypass.
Induction by IL-1 beta, TNF-alpha, lipopolysaccharide,
and interferon gamma showed no difference in nitrite
production by Greiss reaction or iNOS protein by
Western blot. Therefore, further in vivo studies may be
necessary in order to identify the cells responsible for
iNOS production.
Thus, iNOS is expressed in human vein bypass grafts.
Moreover, this expression may be differential, with a sig-
nificant elevation in the grafts in the aortocoronary posi-
tion as opposed to infrainguinal grafts. Removal of the
saphenous vein from its normal quiescent environment
(low pressure, nonpulsatile flow, low oxygen tension) and
its subsequent arterial implantation (pulsatile, high pres-
sure) may influence the expression of iNOS. The increased
expression in aortocoronary grafts may reflect the unique
flow characteristics of the arterial bed of the heart. The
presence of the iNOS expression in human grafts allows
for potential pharmacologic strategies to augment NO
production via manipulation of this enzyme.
Raymond G. Makhoul, MD
Medical College of Virginia Hospitals
Richmond, Va
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INOS OVEREXPRESSION AND INHIBITION
OF VASCULAR SMOOTH MUSCLE CELL
PROLIFERATION
Nitric oxide (NO) has been shown to possess many
vasoprotective properties. It can prevent platelets from
adhering to the vascular wall, inhibit leukocyte chemo-
taxis, inhibit vascular smooth muscle cell (VSMC) prolif-
eration and migration, and promote endothelial cell
growth. All of these actions can limit intimal hyperplasia
after arterial injury. Consistent with this, several new
approaches to increase local NO levels after vascular injury
have been used to inhibit intimal hyperplasia.1 We have
shown that gene transfer using the inducible NO synthase
(iNOS) effectively limits intimal hyperplasia in rat and
porcine models after balloon injury.2
NO can be produced by one of three NO synthase
(NOS) enzymes. All three share similar co-factor require-
ments, including NADPH, FAD, FMN, heme, and
tetrahydrobiopterin. However, the two constitutively
expressed isoforms, eNOS and nNOS, are calcium-depen-
dent and require increases in intracellular calcium levels for
activation. iNOS is calcium independent and is synthe-
sized in the active state. Thus, iNOS should produce more
NO and for this reason has been our choice for gene ther-
apy to prevent intimal hyperplasia. Once NO is produced,
it can diffuse rapidly from cell to cell. However, it has a
short half life (eg, seconds), and therefore the site of
action is limited locally to the site of production.
We have shown that short-term overexpression of
iNOS in vessels using an adenoviral vector not only pre-
vents balloon-induced intimal hyperplasia2 but also
inhibits intimal hyperplasia associated with transplant
rejection.3 Rat carotid arteries infected with AdiNOS
demonstrated a 98% inhibition of the development of the
neointima, and pig iliac arteries demonstrated a 52% inhi-
bition compared with control and AdlacZ infected ves-
sels.2 The adenoviral vector was also used to transfect
iNOS into aortic allografts ex vivo. Four weeks after trans-
plantation, there was near complete inhibition of intimal
hyperplasia in grafts infected with AdiNOS.3
With these in vivo studies, it is notable that the
observed effects resulted from using low titers of the ade-
novirus. In the rat carotid artery model, 2 · 106
pfu/artery resulted in this near complete inhibition, and
in the porcine model, 5 · 108 pfu/artery was efficacious.
In the allograft model, only 2 · 107 pfu were used. This
has several implications for the future of vascular iNOS
gene transfer. First, the ability to use such low titers will
theoretically result in less of a host immune response to
these first-generation adenoviruses. This in turn may
result in a more prolonged expression of the transgene
because it is the host immune response that eventually
leads to clearance of the cells expressing the foreign gene.
Lastly, using lower titers lessens the demand for the virus.
Hence, production of the adenovirus in quantities suffi-
cient for clinical application will be more feasible.
One of the mechanisms by which NO can limit intimal
hyperplasia is through the direct inhibition of VSMC pro-
liferation. We found that overexpression of iNOS in vitro
inhibited VSMC proliferation by approximatley 80% as
compared with control and AdlacZ infected cells as mea-
sured by 3H-thymidine incorporation. These results con-
firmed findings from other investigators who used exoge-
nous delivery of NO donors to inhibit VSMC prolifera-
tion.4-6 We then determined that NO inhibited VSMC
proliferation by inducing a cell cycle arrest at the G0/G1
phase of the cell cycle. Cells infected with iNOS had
approximately 20% more of the cells in the G0/G1 phase
and less in the synthesis phase. Given that VSMC prolifer-
ation has been shown to stem from certain subpopulations
of cells,7 this 20% increase in the G0/G1 population may
be sufficient to account for the ~80% inhibition of VSMC
proliferation.
Our studies on the mechanism of NO-induced cell
cycle arrest have focused on key proteins that control the
cell cycle. The cell cycle is governed by the interactions of
cyclins, cyclin-dependent kinases (cdk), and their naturally
occuring inhibitors, cyclin-dependent kinase inhibitors
(cdki). When cyclins and cdks form a complex, they
become active through the actions of certain kinases and
phosphatases. This leads to the phosphorylization of the
Rb protein and the release of its bound transcription factor.
The transcription factor will then bind to genes involved in
VSMC proliferation. To inhibit the cell cycle, cdkis can
bind to cyclins, cdks, or the complex of the two, prevent-
ing progression of the cell cycle. p21, a cdki in the Kip/Cip
family, binds to and inhibits cyclin A, B, D, and E, as well
as cdc2, cdk2, 4, and 6.8 We examined the effect of NO on
the expression of this universal inhibitor of the cell cycle.
Western blot analysis of VSMCs infected with AdiNOS
revealed a marked upregulation of p21 protein expression,
and this was completely inhibited with the NOS inhibitor,
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L-NIO. NO-dependent upregulation of p21 was also
observed in rat carotid arteries in vivo after iNOS gene
transfer. NO upregulated two other members of the
Kip/Cip family, p27 and p57, in vitro. However, these
findings were not as dramatic as the upregulation of p21.
Thus, it appears that one mechanism by which NO is able
to induce cell cycle arrest and result in inhibition of VSMC
proliferation is through the upregulation of p21, a natural-
ly occurring inhibitor of the cell cycle.
One of the main signaling pathways utilized by NO is
the soluble guanylate cyclase (sGC)–cGMP pathway. To
determine whether this pathway was responsible for the
NO-dependent inhibition of VSMC proliferation or the
upregulation of p21 expression, we used a highly specific
inhibitor of sGC, ODQ. We found that iNOS gene trans-
fer resulted in high levels of cGMP release. ODQ effec-
tively blocked cGMP release in VSMC infected with
AdiNOS. However, it did not reverse the inhibitory effect
of NO on VSMC proliferation after iNOS gene transfer
nor did it prevent the upregulation of p21 protein levels.
p53 is known to transactivate p21, and NO can upregulate
p53 in cells.9,10 When VSMCs from p53 knockout mice
were transfected with iNOS, p21 was upregulated in a
NO-dependent manner to a similar level as seen in con-
trol, wild-type cells. Therefore, the upregulationof p21 by
NO in VSMCs is independent of both cGMP and p53.
Prominent signaling pathways involved in VSMC pro-
liferation are the MAP kinase pathways. NO-related species
have been shown to activate the guanine nucleotide-bind-
ing protein ras in human Jurkat T cells.11,12 Additionally,
ras has been shown to upregulate p21 expression through
the p42/44 MAP kinase signaling pathway in Swiss 3T3
cells.13 Therefore, we wanted to determine whether NO
was exerting its effect through this pathway. Using Western
blot analysis, we found that VSMCs infected with AdiNOS
exhibited activation of the p42/44 MAP kinase, measured
by the presence of the phosphorylated form of the enzyme,
as compared with control and AdlacZ infected cells. The
inhibitor to the p42/44 MAP kinase, PD98059, prevent-
ed this activation by NO. In addition, PD98059 signifi-
cantly reversed the inhibitory effects of NO on VSMC pro-
liferation and prevented the upregulation of p21 by NO.
Hence, the antiproliferative and p21 stimulatory effects of
NO are mediated at least in part by the p42/44 MAP
kinase pathway.
iNOS gene therapy to the vasculature holds great
potential for the future as a prophylactic therapy to pre-
vent the development of the neointima after vascular
injury. We have demonstrated its efficacy in both rat and
pig arterial injury models and have furthered our under-
standing of how NO regulates VSMC proliferation at the
cellular level. Much remains to be learned about the opti-
mal approach for local vascular gene delivery as well as the
best vector for this target. However, because research is
increasingly directed toward these goals, the future of vas-
cular gene therapy remains promising.
Melina R. Kibbe, MD
Edith Tzeng, MD
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EFFECTS OF PHYSICAL FORCES ON INTI-
MAL THICKENING AFTER VASCULAR
INTERVENTIONS
PLAQUE RUPTURE: A HYPOTHESIS
Why people die from atherosclerosis
The conventional wisdom is that people die because the
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surface of the atherosclerotic lesion breaks down, which leads
to rupture or thrombotic occlusion. Hopefully, we can
replace this simplistic idea with specific targetable hypotheses.
Plaque rupture
We do not know why atherosclerotic plaques eventu-
ally rupture. Proteases obviously play a role.1 However,
proteases are abundant even in early lesions. Presumably,
whatever damage they cause is controlled by antiproteases
and, perhaps equally important, by wound repair. Efforts
to interfere with rupture with protease inhibitors will like-
ly fail because too many enzymes are involved. More
promising are efforts to block protease expression either
by interfering at a common point in the signal transduc-
tion pathway, by blocking a critical cytokine receptor, or
by identifying and blocking a critical inflammatory stimu-
lus, such as an oxidized epitope or microorganism.
Alternatively, we might ask why the normal processes of
repair ultimately fail.
Erosion
Erosion is a term invented by Renu Virmani to
describe the changes in vessels that appear when we look at
the coronary arteries of people who undergo sudden coro-
nary artery occlusion at a relatively young age, especially
before 50 years. Contrary to the Virchow hypothesis and
to conventional wisdom, these vessels typically show an
intact fibromuscular cap. Nonetheless, the vessel surface is
eroded, and the vessel is closed by acute thrombocoagula-
tive process. The assumption, although untested, is that
this kind of death also results from inevitability—inevitabil-
ity of breakdown of the surface of the plaque.
Erosion versus rupture
There is little doubt that ruptured plaque kills.
However, not all rupture kills. We know this because many
advanced plaques show evidence of previously healed rup-
tures. Thus, we need to ask three questions: (1) Is “ero-
sion” necessary for death even when rupture occurs? (2)
What process(es) are needed to rupture a lesion? (3) Is
healing important when rupture occurs?
Genomics and progression
Before thinking about why the cap breaks down, we
need to realize that the cap is comprised of a special popu-
lation of smooth muscle cells. The key concept here is that
the intima, the innermost of the smooth muscle layers of
the vessel wall, arises separately from the media and is com-
prised of cells that are different than the medial cells. At
this point, over a hundred genes have been described as
being differentially expressed between intima and media.2
Unfortunately, most of this expression data have been
obtained in the rat, and the relevance to human intima is
not clear. As we will discuss below, there is, however, sur-
prisingly, much data that show that plaque smooth muscle
cells are not only clonal but also—like neoplastic cells—
show extensive evidence of genomic damage. Different
laboratories have reported mutations of C-myc, h-ras, and
TGF-bR2 as well as major chromosomal rearrangements.
These observations suggest that the ultimate breakdown
of the fibrous cap could reflect clonal expansion of genet-
ically damaged cells.
Cell death
Interest in cell death events arises from two reasons.
First, cell death might explain the long time course
required before plaques rupture. We know something
about this long time course because we have shown that
the atherosclerotic plaque is a clone. Second, as we will
discuss subsequently, cell death is likely to be dependent
on genetic programs that we suspect are elicited during
plaque progression as a result of DNA damage.
Clonality implies a number of divisions, but we know
cell division is rare in the plaque smooth muscle cell.3 So,
the clonal event is probably early. In contrast, several lab-
oratories have shown that at least in vitro plaque smooth
muscle cells have a limited ability to replicate. Thus, the
proliferative process often posited to be important in ath-
erosclerosis4 is probably an early event. In turn, the
atrophic nature of the advanced fibrous cap suggests that
ultimately the breakdown of the cap may depend on the
plaque smooth muscle simply lacking the number of
replicative generations required to repair ongoing injury.
Of course, failure to replicate is only important if there is
cell death. This idea has become exciting because of studies
by several laboratories, including ours, showing that sponta-
neous cell death, “apoptosis,” is evident in the advanced
plaque. This phenomenon is probably genetic because
Martin Bennett, working in this laboratory, showed that cul-
tured plaque cells have a high endogenous apoptotic rate.5
The reason for the evolution of such a high rate of
death is unclear. Data from Drs Schwartz and Bennett
have suggested that this may reflect a p53-dependent
death process, implying that the initiating event would be
DNA damage, thus explaining the long time course
required before death develops.6
Inhibitors of death
The death cascade, perhaps even more than the coag-
ulation or complement cascades, must have built-in con-
trols that prevent accidental overactivation. Such controls
have begun to be found as critical to viral replication and
in neoplasia.
We and others have looked for death resistance genes
in the plaque. Two have been described. Dr Gary Gibbons
and colleagues showed the intima has high levels of
BcIXL—an antiapoptotic relative of Bcl2 and MRIT, a
caspase inhibitor cloned in this laboratory.7,8
MRIT is especially intriguing because it is up regulat-
ed in the neointima after angioplasty as well as in normal
human intima and endothelium. However, MRIT is down
regulated in atherosclerotic lesions.
Consequences of rupture
Although rupture and erosion do not necessarily pro-
duce death, repeated episodes of injury may have other
consequences for plaque progression. We know, for exam-
ple, that by the time a plaque finally ruptures, multiple pre-
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vious episodes of erosion or rupture must have occurred.
We propose that the responses to these episodes of injury
could themselves lead to vascular narrowing, that is, coro-
nary obstructive disease.
The issue of narrowing is important because, surpris-
ingly, we do not know why atherosclerosis narrow vessels.
Contrary to conventional wisdom, several pathologic
studies have shown that the lesion mass does not itself lead
to loss of lumen. Instead, loss of lumen requires either loss
of a normal ability of the affected vessel wall to remodel or
a pathologic narrowing.
Narrowing does not occur until lesions become
advanced. Thus, narrowing may be the result of plaque
ruptures and thrombosis. If so, then the narrowing of the
lumen could occur as a normal, though unfortunate, out-
come of wound healing, much like consequences of con-
traction seen during healing of severe wounds, such as
burns, and in hollow organs, such as the esophagus.9
Geary et al10 looked at wound healing after vascular injury
of pre-existing atherosclerotic lesions in the iliac arteries of
nonprimate monkeys. These monkeys were fed an athero-
genic diet for several years and then underwent vascular
injury using a balloon catheter. The healing process, up to
28 days after injury, displayed a pattern similar to cuta-
neous wound healing, with the majority of contractile cells
being smooth muscle a -actin positive cells (smooth mus-
cle cells/myofibroblasts). They concluded that because
wound healing in the arteries was so similar to cutaneous
wound healing, contraction as a mechanism of lumen nar-
rowing during atherosclerotic progression was plausible.
Because fibrin is a prominent feature of all healing
wounds, we recently explored the role of fibrin in vascular
narrowing or pathologic remodeling after vascular injury.
Courtman et al11 combined a double balloon injury rabbit
model with a factor VIIa inhibitor, called DEGR-VII. By
inhibiting binding of factor VIIa to tissue factor, the gen-
eration of thrombin was prevented. These studies demon-
strated that control rabbits, which were not infused with
DEGR-VII during the second balloon injury of the
abdominal aorta, developed a smaller lumen 3 weeks after
the second injury as compared with treated rabbits.
Furthermore, maintenance of lumen was associated with
loss of fibrin deposition within the vessel wall of the treat-
ed animals. Importantly, the areas of the media and the
intima in the two groups did not differ, suggesting that the
difference in lumen size was not due to mass but to con-
traction or remodeling. This study also suggests that fibrin
may play a role in vessel narrowing after vascular injury.
The cell generating the contractile force and responsi-
ble for lumen narrowing is presumably the intimal smooth
muscle cells. Courtman et al11 showed that fibrin forma-
tion was restricted to the intima. Smooth muscle cells are
the only cell type in the intima at 2 months after the initial
injury and would have the ability to contract. Furthermore,
the myofibroblasts that are found in cutaneous wounds and
that are responsible for wound closure are similar to
smooth muscle cells. Gabbiani and colleagues12 first iden-
tified the existence of myofibroblasts in wounds. They
found that fibroblasts in granulation tissue were similar to
smooth muscle cells by electron microscopy and immuno-
fluorescent. They demonstrated that strips of granulation
tissue as well as blood clots from rats are able to contract
when exposed to a number of pharmacologic agents that
have been shown to promote smooth muscle cell contrac-
tion. Using anti-serum against human smooth muscle cells,
they identified the presence of myofibroblasts in granula-
tion tissue at day 9, day 11, and up to day 15 of wound
healing. In the atherosclerotic plaque, smooth muscle cells
activated by injury presumably fulfill a similar role.
However, in the vasculature the contraction that occurs
during wound healing could be pathologic in nature.
Therapeutic targets for this pathologic contraction
may include specific integrins. Using an in vitro fibrin gel
contraction assay, we identified critical molecules: integrin
a 5b 1, fibronectin that acts as a bridge to fibrin; a vb 3 that
amplifies the effect of a 5b 1; and protease inhibitors need-
ed to stabilize the fibronectin.
Summary
Plaque rupture is probably an ongoing process. Our
studies and other studies suggest that the process may
depend on apoptotic cell loss in the fibrous plaque.
Moreover, rupture itself may have multiple outcomes.
One of these may be loss of lumen resulting from patho-
logic wound contracture. Integrin antagonists may func-
tion by blocking tissue contracture.
Stephen M. Schwartz, MD, PhD
The University of Washington School of Medicine
Seattle, Wash
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HEMODYNAMIC FACTORS AND ANASTO-
MOTIC INTIMAL HYPERPLASIA
Progressive intimal hyperplasia (IH) remains a major
cause of long-term failure of bypass grafts. In addition to
biomaterial incompatibility, physical forces have been asso-
ciated with vascular graft IH. Prominent among these sug-
gestions have been compliance mismatch between the
graft and host artery, which results in differential mechan-
ical strain, and various hemodynamic wall shear stress
(WSS) parameters, such as mean WSS, oscillating WSS,
and WSS spatial or temporal gradients. This presentation
will focus on the hemodynamic characteristics of end-to-
side anastomoses, as determined through in vitro models
and computational methods, and will relate these to
observations from animal studies.
Previous research has shown that WSS is an important
factor regulating long-term arterial adaptation to increas-
es and decreases in blood flow, with decreases in flow lead-
ing to smaller vessel diameter and increases in flow leading
to vessel enlargement. Systemic arteries seem to stabilize
in their adaptation when the time-averaged WSS reaches a
fairly narrow range of 10 to 20 dynes/cm2.1,2 Further,
WSS has been associated with localization of atheroscle-
rotic intimal thickening in the human carotid bifurcation:
areas of low mean WSS are strongly related to plaque
localization, and these are also sites at which WSS oscil-
lates in direction during the flow cycle.3
There have been a number of studies that have exam-
ined possible relationships in IH and flow in vascular
grafts. An increase in intimal thickness along PTFE grafts
in response to reduced hemodynamic WSS has been
reported by Geary et al.4 Sottiurai et al5 reported that IH
in end-to-side PTFE iliofemoral grafts in dogs was located
at the heel and toe of the graft and the floor of the host
artery. Ojha6 suggested that low wall shear stress or high
wall shear stress gradients might be responsible for the
localization of anastomotic IH. We have previously shown
that regions of IH in implanted canine iliofemoral PTFE
and autologous vein grafts corresponded to locations of
slow particle velocities in a scaled-up, in vitro model.7,8
Increasing the flow rate more than two-fold in experi-
mental canine anastomoses by creation of a distal arterial-
venous fistula virtually eliminated anastomotic IH at the
suture line.9 This is consistent with increased near-wall
particle velocities in the in vitro flow model. Furthermore,
outflow limitation in a model of anastomotic intimal
hyperplasia in a New Zealand white adult male rabbit
enhanced progression of IH to an occlusive lesion.10 The
findings of these studies suggest that anastomotic IH is
likely to occur in regions of low and oscillatory flow, but
the lack of quantitative in vitro and in vivo data has not yet
allowed direct comparisons of wall shear stress with IH.
To investigate further possible relationships between
the local hemodynamic environment and IH, our collabo-
rators at The University of Chicago constructed iliofemoral
bypasses in seven adult mongrel dogs using 6-mm, thin-
walled PTFE. The proximal anastomosis was end-to-end
with the common iliac artery, and the distal anastomosis
was end-to-side in the femoral artery. The distal anastomo-
sis was standardized with a hood length to vessel diameter
ratio between 4:1 and 5:1 and a maximum hood width of
6 mm at the center. The upstream femoral segment was lig-
ated, but side branches allowed flow through the graft to
move proximally as well as distally, so that the ratio of dis-
tal to proximal outflow was approximately 80:20. Pulsatile
flow waveforms were measured in the graft and in the dis-
tal artery. After 12 weeks, the animals were sacrificed using
an intravenous overdose of pentobarbital, and the vessels
were perfusion fixed with 3% gluteraldehyde at 100 mm
Hg. Vessel cross sections were embedded in paraffin,
stained, and examined for the presence and location of IH
by light microscopy using digital methods.
Casts of the graft and host vessel were made for sever-
al acute cases, and from these, an upscaled, transparent in
vitro model was developed. Fluid dynamic experiments
were performed at Georgia Tech using pulsatile flow
waveforms characteristic of the dogs, and velocity profiles
were measured at a number of stations in the model
employing laser Doppler velocimetry. Because of the
excellent spatial resolution, velocity gradients near the
model surfaces yielded estimates of the local WSS as a
function of time and location. These data then were avail-
able for comparison with the IH results from the animal
studies. The pulsatile flow waveform in the graft had a
mean Reynolds number (Re) of 220 and a Womersley
parameter of 3.0. Maximum Reynolds number was 850,
and the waveform has a reverse component with a mini-
mum Re of –120, characteristic of femoral artery flow in
the dog. All experimentally measured values were scaled
back to the dimensions of the dog model.
Light microscopic examination of the histologic sec-
tions revealed three distinct regions of IH: graft hood,
suture line, and anastomotic floor. Both graft hood and
suture line IH were present in all anastomoses. Hood IH
was diffuse, extending axially and circumferentially to the
suture line. Floor IH was present in only two of the seven
anastomoses and was focal, extending less than 1 mm axi-
ally, with no circumferential contiguity to the suture line.
IH consisted of smooth muscle cells within a relatively
abundant extracellular matrix. IH was common all along
the suture line, including the heel and toe regions, and
gave the impression of “filling in” surface irregularities
created by the surgical procedure.
The anastomotic flow field was complex. Flow separa-
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tion appeared transiently along sections of the graft hood
and at the heel and toe where the hood joined the host
vessel. As flow entered the anastomosis from the graft, it
divided into a dominant distal flow and a subordinate
proximal flow. This led to impingement of flow on the
floor of the host vessel, forming a stagnation point that
moved to and fro during the cycle. Because flow turned its
direction on entering the anastomosis, significant sec-
ondary flow patterns occurred with strong circumferential
velocity components. Thus, the anastomotic region expe-
rienced a complex, three-dimensional flow field that was
significantly influenced by the geometry and flow division.
Correlations between WSS and anastomotic IH were
examined to assess WSS at the various regions where IH
developed, using 24 anastomotic measurement positions
located a various sites. Linear regressions were computed
between IH and the hemodynamic parameters: mean
shear, maximum shear, minimum shear, reciprocal of mean
shear, reciprocal of maximum shear, reciprocal of minimum
shear, and an index of oscillatory flow (OSI). The results
revealed a significant correlation only for the reciprocal of
mean shear (r = 0.52, P < .01) and the reciprocal of maxi-
mum shear stress (r = 0.42, P < .05), and even these had
rather low correlation coefficients. If the data were subdi-
vided into data taken (1) along the suture line, (2) on the
graft hood, and (3) along the floor of the host artery, the
situation was somewhat more definitive. No relationship
between suture line IH and WSS was found, suggesting
that hemodynamic WSS was not a direct participant in
development of IH at these locations. In addition, because
there was virtually no IH on the host artery floor of the
dogs studied and because WSS at the floor was variable in
magnitude and direction, there was no direct relationship
apparent between these variables. In contrast, on the graft
hood, there was a much stronger correlation between IH
and the reciprocals of both the mean and the max WSS.
In summary, the anastomotic flow filed is extremely
variable and complex, being a strong function of geome-
try and inflow/outflow conditions. Hence, variability in
WSS among subjects, either animal or human, is great. In
our dog model, we found an inverse relationship between
IH and WSS on the graft hood but no relationship at sur-
faces near the suture line or along the floor of the host
artery. We also found no relationship between IH and
WSS gradients. Thus, data from several sources strongly
suggest that high WSS tends to inhibit anastomotic IH
and low WSS tends to favor IH development, but there
are clearly other localized effects that contribute to IH,
which are not directly related to hemodynamics.
The material presented is derived from collaborative
studies with C.K. Zarins (Stanford University), Seymour
Glagov (The University of Chicago), Francis Loth
(University of Illinois–Chicago), Steven Jones (Louisiana
Tech University), and Ming Lei (CFD Research, Inc).
Don P. Giddens, PhD
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SHEAR STRESS REGULATION OF MONO-
CYTE/ENDOTHELIAL INTERACTIONS
Arterial endothelial cells reside in a flow environment
in which they are chronically exposed to hemodynamic
shear stress, which varies greatly depending on arterial
geometry. Specifically, endothelial cells lining the straight
segments of the arterial tree are exposed to a relatively
high, laminar flow-associated shear stress of 15 to 20
dynes/cm2, whereas endothelial cells residing in the outer
aspects of arteries just distal to arterial branch points or in
arterial wall areas opposite major branch sites are exposed
to low oscillating or reversing laminar shear stresses of 0.5
to 2 dynes/cm2.1 Over the last several years, many inves-
tigators have demonstrated that these arterial sites chron-
ically exposed to oscillating low shear stress are coincident
with arterial sites known to be prone to develop athero-
sclerotic lesions.2 Furthermore, low shear flow patterns
created at sites of revascularization procedures, such as
graft bypass or stent placement, have been associated with
increased intimal hyperplasia and risk of restenosis.3
Previous in vivo studies have demonstrated that the
endothelium in these focal, atherosclerotic, lesion-prone
arterial sites exhibit enhanced permeability to proteins,
including fibrinogen, albumin, and lipoproteins, enhanced
turnover of endothelial cells, and an increased focal
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recruitment of blood monocytes under hypercholes-
terolemic conditions.2 It is apparent that these traits of
endothelial cells residing in lesion prone sites share char-
acteristics of “activated” endothelium at sites of inflamma-
tion.4 This similarity raises the possibility that the altered
hemodynamic flow pattern of oscillating, low shear stress
may activate the vascular endothelium to promote the
development and expression of the lesion prone traits
described previously.
Although enhanced monocyte recruitment to athero-
sclerotic lesion–prone arterial areas is a hallmark of early
atherogenesis in vivo,2 the possible mechanisms through
which flow-related shear stress might modify endothelial-
monocyte interactions in these areas remains to be fully
defined. To probe the role of low shear stress in modulat-
ing key endothelial cellular and molecular mechanisms
potentially involved in mediating in vivo events, such as
increased endothelial permeability, cell turnover, and
recruitment of the blood monocytes potentially involved
as early events in atherogenesis, our laboratory, along with
many others, has developed in vitro flow systems incorpo-
rating cultured endothelial cells. This presentation focuses
on our studies using these flow systems to examine the
influence of prolonged low shear stress on endothelial cell
recruitment of monocytes, the expression of two mole-
cules, VCAM-1 and MCP-1, and their respective genes
involved in monocyte recruitment, and some of the intra-
cellular signals involved in mediating this low shear-
induced gene expression.
Using a parallel plate flow chamber system to expose
cultured endothelial cells (EC) to prolonged defined lam-
inar flow shear stress levels, studies in this laboratory were
designed to test the hypothesis that aortic endothelial cells
conditioned to prolonged low shear would exhibit
increased recruitment and adhesion of blood monocytes
through the increased gene and protein expression of
MCP-1 and VCAM-1. Initial studies involved exposing
EC to either low (LS, 0.5 dynes/cm2) or high (HS, 30
dynes/cm2) shear stress using a circulating culture medi-
um containing 10% serum for 24 hours before assaying
subsequent adhesion of radiolabeled monocytes in a 30
minute static adhesion assay.5 Prolonged exposure of EC
to low shear stress (24 hours) was associated with a signif-
icant increase in monocyte adherence (162.5 ± 10.69%; P
< .01; n = 9), relative to static cultured cells. Moreover,
monocyte adherence to EC exposed to prolonged high
shear stress was also significantly lower relative to cells
exposed to LS and was not significantly elevated relative to
that observed in cells exposed to no shear (NS). To define
the time course for the onset of this endothelial cell
response to low shear stress, endothelialized substrates
were preconditioned in parallel to high and low shear
stress levels for increasing times ranging from 30 minutes
to 6 hours before measuring monocyte adhesion. A signif-
icant difference between replicate LS and HS measure-
ments was observed only after a minimum of 6 hours of
exposure to the respective shear stress regimens. To deter-
mine whether shear stress–associated changes in monocyte
adherence might be paralleled by changes in MCP-1 or
VCAM-1 gene expression within LS-conditioned EC, cells
were exposed to either low or high shear stress for increas-
ing times before extraction of total mRNA for Northern
Blot analysis. The results of these studies indicated that
MCP-1 and VCAM-1 mRNA levels were increased
approximately two–fold within 3 hours after initiation of
low shear stress exposure, relative to cells exposed to either
high or no shear stress. Most importantly, MCP-1 and
VCAM-1 gene expression remained elevated as long as LS
flow conditions were maintained (51 hours). Although a
transient elevation in MCP-1 gene expression was
observed in EC exposed high shear flow after 2 hour HS
exposure, consistent with previously reported observa-
tions by Shyy et al,6 both VCAM-1 and MCP-1 genes are
completely downregulated in cells exposed to HS for peri-
ods exceeding 4 hours. This inhibitory effect of shear
stress levels greater than 5 dynes/cm2 has now been well
defined by several investigators. To better simulate in vivo
conditions, adherence experiments were performed using
circulating monocytes. Specifically, after preconditioning
either EC to different levels of shear stress for 48 hours,
monocytes (105/mL) were added to the circulating medi-
um for a 1 hour adherence assay under LS flow. Under
flow conditions, an almost five-fold increase in monocyte
adherence to HAEC preconditioned to LS compared with
either HS or NS pretreated cells.
To provide evidence that the observed increase in
MCP-1 gene expression correlated with expression of pro-
tein, additional experiments were performed to determine
whether conditioned media obtained from EC subjected
to flow regimens contained monocyte chemoattractant
activity. Only media obtained from EC preconditioned to
low shear for 24 hours or incubated with lipopolysaccha-
ride (10 ng/mL, 4 hours) exhibited monocyte chemoat-
tractant activity significantly above the basal level seen in
control media (P < .001). To examine whether VCAM-1
molecules expressed on the surface of LS conditioned cells
might be involved in the observed increased monocyte
adherence, a blocking antibody to human VLA-4, the
monocyte surface integrin that acts as a ligand to VCAM-
1, was employed. Pretreatment of monocytes with anti-
VLA-4 reduced monocyte adherence to LS precondi-
tioned BAEC by 82 ± 9% but had no significant effect on
monocyte adherence to either HS or NS conditioned cells.
More recent studies employing an anti-VCAM-1 mono-
clonal antibody on human aortic endothelial cells (HAEC)
have now confirmed increased VCAM-1 antigen on cells
exposed to low shear stress for 6 hours or longer.
On the basis of available information that the promot-
er regions of both MCP-1 and VCAM-1 genes contain
specific putative binding sites for the transcription regula-
tor NF-k B, flow studies were performed to determine the
relative influence of different prolonged shear levels on
intracellular NF-k B activation.7 Our results demonstrated
that a sustained, significant increase in endothelial NF- k B
activation, as measured by the electrophoretic mobility
shift assay, occurred in HAECs exposed to prolonged
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steady low shear (LS, 2 dynes/cm2) as well as pulsatile LS
(pLS, 2 ± 2 dynes/cm2) for times exceeding 2 hours as
compared with HAECs exposed to high shear (HS, 16
dynes/cm2). Maximum activity in both LS and pLS condi-
tioned HAECs was observed at 16 hours as compared with
HAECs exposed to prolonged HS. In contrast, HS
exposed HAECs exhibited an early, transient increase in
NF-k B activity at 30 minutes relative to LS exposed cells
followed by a pronounced down regulation on continued
exposure to HS throughout the 24 hour flow experiments.
The observation that the response of endothelial NF- k B
activation response patterns to both low and physiological
high shear levels parallel the response of MCP-1 and
VCAM-1 gene expression suggested the possibility that
NF-kB might play an important regulatory role in mediat-
ing the response to these different flow environments.
To investigate the possible linkage between NF-k B acti-
vation and LS-induced gene expression and monocyte
adhesion, shear-induced NF-kB activation was blocked
using two strategies. First, on the basis of the reported abil-
ity of the antioxidant pyrrolidine dithiocarbamate (PDTC)
to block cytokine-induced NF-k B activation, HAEC were
preincubated with or without this agent before exposure to
low shear (2 dynes/cm2) for 6 hours. PDTC strongly inhib-
ited low shear-induced activation of NF- k B along with
expression of the VCAM-1 and MCP-1 genes and EC-Mn
adhesion. Paradoxically, NAC exerted a positive effect on
low shear-induced VCAM-1 expression and EC-Mn adhe-
sion, and only slightly downregulated NF-k B activation. To
further explore this involvement of NF-k B in the cellular
response to LS, HAEC were genetically altered to overex-
press I- k B, the natural inhibitor of NF- k B activation.
Similar to the results observed with chemical NF-k B inhibi-
tion, these transfected HAEC did not respond to LS with
an increase in NF-k B activity or enhanced gene expression.
In summary, an in vitro flow model is presented
demonstrating that endothelial cells exposed to chronic
low shear stress flow patterns exhibit an “activated” profile
characterized by increased monocyte recruitment preceded
by VCAM-1 and MCP-1 gene expression. Moreover, the
transcription factor, NF-k B, appears to be an important
element in the transduction of the shear stress signal into
this endothelial cell response. These results may give
important insights into possible cellular and molecular
mechanisms mediating the potential involvement of both
low shear stress flow patterns and monocyte recruitment in
atherogenesis and arterial restenosis.
Eugene A. Sprague, PhD
Sumathy Mohan
Robert M. Nerem
University of Texas Health Sciences Center
San Antonio, Tex
Georgia Institute of Technology
Atlanta, GA
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ALTERATIONS IN GENE EXPRESSION AT
GRAFT TO ARTERY ANASTOMOSES: A ROLE
FOR THE PROTEASOME IN VASCULAR
BIOLOGY
Anastomotic intimal hyperplasia that develops over the
course of months after placement of an arterial bypass con-
duit remains a major cause of prosthetic graft failure. The
resultant hyperplasia appears to be greatest at the down-
stream or distal anastomosis and is not dependent on the
type of graft material used.1 It has been established that
progression of the lesion involves migration and prolifera-
tion of smooth muscle cells (SMC) as well as the produc-
tion of increased extracellular matrix.2 This process
involves a complex set of interactions between SMC,
endothelial cells (EC), and a number of growth factors
and cytokines, resulting from a disruption in the balance
between inhibitory and stimulatory factors. In our model,
at approximately 3 months, a steady state is reached, with
matrix predominating in the initially smooth muscle
cell–rich lesion.
In order to evaluate this process further, we proposed
to identify specific genes that were either over or under
expressed in the development of intimal hyperplasia com-
pared with the relatively quiescent state of an unper-
turbed artery. By identifying genes with altered expres-
sion, additional evaluation of resultant proteins may give
insight into specific mechanisms. To this end, we have
employed two separate techniques: (1) mRNA differen-
tial display of unknown genes, and (2) Northern Blot
analysis of known genes.
mRNA differential display
We have used a canine model that produces a substan-
tial anastomotic intimal hyperplastic lesion. Expanded poly-
tetrafluoroethylene (ePTFE) grafts, which were 50 cm long
and had an 8-mm internal diameter, were placed in mongrel
dogs as described previously.3 The bypass originated in the
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left common carotid artery and ended at the distal abdom-
inal aorta as an end-to-side anastomosis. At harvest, a por-
tion of the distal anastomosis was taken for both histologic
and molecular analysis. Unaffected aorta was used as the
control. Molecular analysis was only performed on speci-
mens after histology confirmed that the tissue was represen-
tative of either intimal hyperplasia or normal aorta.4
To rapidly screen as many genes as possible, the tech-
nique of mRNA differential display was then performed
on the samples. Total RNA was isolated in the standard
fashion from both samples (intimal hyperplasia and normal
aorta). Potential DNA contamination was eradicated with
deoxyribonuclease. The total RNA samples were then
reverse transcribed with enzyme and either T12NG or
T12NC into more “workable” cDNA. Use of dTTP
(T12NG or NC) containing oligomers takes advantage of
the poly-adenylated (AAA) tail seen on most mRNA
species. At this point in the reaction, there is not enough
material to perform detailed analysis. To amplify, as well as
select out random genes, the polymerase chain reaction is
employed. Random genes are selected by the application
of numerous arbitrary primers consisting of varying 10
base pair arrangements.
The resultant reaction is run on a standard polyacry-
lamide gel. Each primer results in a differential display lane
containing 150 to 250 discrete bands, representing frag-
ments of individual genes. In our model, by employing
more than 20 different arbitrary primers, we estimate that
we have screened approximately 5000 genes. This repre-
sents anywhere from 25% to 50% of the estimated genes
expressed at any given time. On the gel, amplified cDNA
fragments from normal aorta are run next to cDNA ampli-
fied under the same conditions from intimal hyperplasia.
The majority of bands will be of similar intensity between
the two conditions, indicating that the individual gene
appears to be expressed at the same level in each condi-
tion. Those products with different intensities are cut
from the gel, purified, and reamplified.
Once these steps are completed, we have isolated
genes that may have altered expression. The next step is to
sequence the eluted “genes” to match them against
known genes in the DNA library, as well as to generate
radioactive probes. The radioactive probes are used in
confirmatory Northern Blot analysis. A known amount of
total RNA from each of the experimental conditions is
loaded on a gel. The intensity of the resultant signal from
the radioactive probe is then analyzed to allow quantita-
tive comparisons between the expression noted in normal
aorta versus that seen in intimal hyperplasia. It is at this
step that any alteration of expression is quantitatively con-
firmed. In general, in varying experimental conditions,
about 20% to 40% of the probes eluted from the differen-
tial display gel with possibly altered expression will in fact
prove to have altered expression on Northern Blot analy-
sis. A potential error lies in the fact that Northern Blot
analysis is not sensitive enough to detect differences in
genes that result in “low” expression. Thus, it is possible
to miss genes of low copy number that actually have
altered expression. The biologic significance of low level
expression is not known.
Thus far, we have identified 11 genes of interest from
differential display at this 90-day time point.4 Four of
them were subsequently confirmed to have altered expres-
sion. The most promising gene identified was interferon
gamma upregulated protein (IGUPI-5111), originally
identified and sequenced in human psoriatic keratinocytes.
Northern Blot analysis revealed over a three-fold decrease
in its expression in the area of intimal hyperplasia com-
pared with normal aorta. This was of interest because
IFN- g is known to inhibit the development of intimal
hyperplasia in experimental models. We speculated that
this gene may play a role in maintaining the nonprolifera-
tive state of the intima and media in normal artery. Thus,
decreased expression may result in a loss of inhibition and
the development of intimal hyperplasia.
Northern Blot analysis of known genes
As noted before, Northern Blot analysis of mRNA
expression allows for direct comparison between condi-
tions. It is known that with bypass grafting there are
unique cellular and biochemical events that take place at
specific intervals after surgery. In the first week after graft-
ing, there is migration and proliferation of SMC in the
neointima, and after 2 weeks, the events are more related
to elaboration of matrix. Thus, by choosing different
intervals, specific known genes can be examined by
Northern Blot for direct comparison of gene expression
under varying conditions.
Vascular endothelial growth factor is an exemplary
gene of interest because of its probable effect on preserv-
ing the endothelialized intima after vessel injury.5 To eval-
uate it in the context of arterial graftingm, we employed a
canine model in which cephalic veins (reversed) were used
to bypass a segment of ligated femoral artery. As described
previously, we then harvested vein/arterial anastomoses,
normal vein, and normal artery for mRNA analysis.
We chose an early (48 hours) and late (4 weeks) inter-
val for study. At 48 hours, VEGF mRNA expression was
significantly increased in both the vein graft itself as well as
the arterial portion of the anastomoses. By 4 weeks, VEGF
in the vein graft had returned to baseline but was still dra-
matically elevated in the arterial segment. We further con-
firmed these findings by using VEGF antibody and
immunohistochemical analysis to detect a similar increase
in the actual protein product. We speculated that VEGF
was induced at the point when ECs were damaged or lost
and started to repopulate the vein graft, thus playing a role
in the reendothelialization process. It is possible that
smooth muscle cells when exposed to stresses, such as
hypoxia, altered flow, shear stress, as well as to other
growth factors (PDGF, bFGF), are induced to express
VEGF as a protective mechanism.
Conclusion
The biology of intimal hyperplasia at the downstream
anastomoses of bypass grafts is complex. In order to clari-
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fy the events, evaluation of gene expression is a prelimi-
nary tool in evaluating the numerous events at an arterial
anastomosis. We have made use of two related techniques
to achieve this goal. The first method is mRNA differen-
tial display, allowing direct comparison of gene expression
between normal vessels and intimal hyperplasia. In this
manner, genes that were not previously expected to play a
role in the pathogenesis have been identified as well as the
finding of completely new genes in vascular biology.
Another method is Northern Blot analysis of RNA
obtained from varying experimental conditions. Genes
that have already been determined to play a role in vascu-
lar biology can be evaluated in the development of intimal
hyperplasia. Through this methodical evaluation of gene
expression, we can better understand the cellular and bio-
chemical events as well as the timing of anastomotic inti-
mal hyperplasia formation. Given these data, it is then pos-
sible to develop potential therapeutic strategies.
An example of the effectiveness of our strategy is the
identification of IGUP 5111 gene found to have
decreased expression in intimal hyperplasia. This gene was
not previously known to play any role in vascular pathobi-
ology. Recently IGUP 5111 has been shown to be identi-
cal to the gene for the proteasome regulator, PA28. The
proteasome (usually described as the 20S proteasome) is a
cytoplasmic protein with a cylindrical quaternary structure
that functions as a highly regulated multicatalytic pro-
teinase. A primary function is the degradation of
ubiquinated cellular proteins.6,7 In a complex process of
protein quality control, the ubiquitin proteins attach to
target proteins and cause them to unfold. The unfolded
protein enters the proteasome core and is degraded.
PA700 is another proteasome regulator that combines
with the 20S proteasome, forming the 26S proteasome,
and activates this process. Targets of the 26S proteasome
include the PDGF receptor and MAP kinase. Through
this mechanism, the proteasome has a strong regulatory
activity on multiple growth factors within the cytosol.
The gene we have identified as being down regulated in
anastomotic intimal hyperplasia, the PA28 proteasome reg-
ulator, activates the multipeptidase activity of the protea-
some, through which it is known to further degrade pro-
teins into peptides, and appears to play a role in the pro-
cessing of peptides that are ultimately transferred to the
MHC locus for antigen presentation. In recent work, we
have shown that the PA28 regulator is present in vascular
smooth muscle cells and is upregulated by g -interferon.8
These observations suggest the exciting possibility that the
proteasome system plays an important regulatory role in
vascular wall biology. Thus our strategy of using mRNA dif-
ferential display has allowed discovery of regulatory mecha-
nisms not previously associated with vascular wall biology.
Allen D. Hamdan, MD
William C Quist, MD, PhD
Darren Rohan, MD
Frank W. LoGerfo, MD
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EFFECTS OF HEMODYNAMIC FACTORS
ON THROMBOSIS AND REMODELING
FLUID STRESS AND MECHANICAL STRETCH
REGULATION OF PROTEASE ACTIVATED
RECEPTOR-1 EXPRESSION ON HUMAN
SMOOTH MUSCLE CELLS AND ENDOTHE-
LIAL CELLS
Exposure of endothelial cells to shear stress in vitro
produces marked alteration in cell morphology, consis-
tent with the proposed in vivo role of shear stress.
Moreover, shear stress–mediated regulation of endothe-
lial gene expression has been demonstrated for proteins
with key roles in maintaining homeostasis, cell migration,
and in cell proliferation. For a review, see Papadaki and
Eskin.2
It recently has been suggested that vascular smooth
muscle cells (VSMC) may also be responsive to shear stress.
In vivo studies of VSMC growth rates after balloon catheter
injury have demonstrated an inverse correlation between
growth rates and calculated shear stress forces. In vitro stud-
ies have confirmed the in vivo observations and demon-
strated that the synthesis of transforming growth factor-b
(TGF-b ), tissue plasminogen activator (tPA), heme oxyge-
nase-1, nitric oxide, and prostaglandins increased under
shear stress.1,3 Consistent with these observations, model-
ing studies supported the concept that VSCM in the normal
vasculature are exposed to significant shear stresses, in the
order of 1 to 10 dyne/cm2, due to interstitial fluid flow dri-
ven by transmural pressure gradients.
On the basis of these findings, the present study was
designed to determine whether shear stress mediates gene
expression in VSMC and endothelial cells, ultimately lead-
ing to the pathologic proliferation of VSMC at sites of dis-
turbed blood flow in the vasculature and perhaps control
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of vessel wall homeostasis under normal physiologic con-
ditions. The human protease activated receptor-1 (PAR-1)
gene was chosen because: (1) PAR-1 expression is known
to be increased dramatically after experimental injury in
animal models, after percutaneous transluminal coronary
angioplasty in patients, and in human atherosclerosis; and
(2) the known roles of thrombin on VSMC function and
proliferation state can be modulated by regulation of
PAR-1 expression.4
Research
The objective of this study was to investigate the effect
of mechanical hemodynamics, such as shear stress and
cyclic strain, on the expression of thrombin receptor: pro-
tease activated receptor-1 (PAR-1) in human aortic smooth
muscle cells (HASMC) and human endothelial cells.
Cultured HASMC were exposed to different levels of
shear stress using the parallel plate flow chamber system.
Northern Blot and flow cytometric analysis indicated that
PAR-1 mRNA and protein levels were reduced three-fold
by high wall shear stress (25 dyne/cm2), and low shear
stress (5 dyne/cm2) actually increased PAR-1 expression
at short times of exposure. mRNA half-life studies showed
that the decreased mRNA level was not due to changes in
the stability of PAR-1 mRNA. In order to see whether
shear stress would change cell responsiveness to thrombin,
Ca2+ mobilization and proliferation were measured in
presheared cells. Ca2+ rise after thrombin stimulation in
sheared cells was 50% less than in control cells using digi-
tal imaging microscopy of Fura-2 fluorescence on individ-
ual HASMC (n > 20 cells). Proliferation of HASMC after
thrombin treatment was also reduced in HASMC expo-
sure to shear stress (11931 ± 1473) versus control (15887
± 677 cpm) using 3H-thymidine incorporation.
In contrast to shear stress, PAR-1 mRNA level was
upregulated two-fold by high level of cyclic strain, 20%
strain at 60 cycles/min. Further studies will be developed
to explore the effect of cyclic strain on PAR-1 protein and
alterations in HASMC function and to explore the effects
of shear stress on regulation of other HASMC gene
expression important for vascular wall homeostasis.
Due to the importance of PAR-1 in the maintenance of
vascular integrity and a possible role in cell proliferation, we
investigated the effect of shear stress on PAR-1 expression
in human microvascular endothelial cells (HMECs) and
human umbilical vein endothelial cells (HUVECs).
HMECs and HUVECs were exposed to different levels of
shear stress: 5, 15, and 25 dyne/cm2 by parallel chamber
system. Using flow cytometry, it was shown that arterial
levels of wall shear stress (25 dyne/cm2 for 24 hours),
downregulated cell surface PAR-1 expression to approxi-
mately 60% and 45% of the stationary control levels in
HMECs and HUVECs, respectively. Northern Blot analy-
sis showed that PAR-1 mRNA levels in HMECs and
HUVECs also decreased in response to arterial shear stress
after 6 hours of exposure to flow (three-fold and two-fold
decrease compared with static controls, respectively). PAR-
1 mRNA levels in HMECs were also reduced significantly
by moderate shear stress (15 dyne/cm2) unlike HUVECs
where PAR-1 mRNA levels did not change. In addition,
low levels of shear stress (5 dyne/cm2) did not affect PAR-
1 mRNA levels in either HMECs or HUVECs. Further
studies are underway to evaluate whether changes in PAR-
1 expression by shear stress will lead to altered endohelial
cell function in response to thrombin, including changes in
nitric oxide production.
Conclusion
These results indicate that hemodynamic forces,
shear stress and cyclic strain, can significantly modulate
PAR-1 expression in HASMC and alter HASMC func-
tion, such as attenuation in Ca2+ rise and proliferation in
response to thrombin. They also support an important
role of hemodynamic forces on gene regulation of PAR-
1 in vascular diseases and a possible role in vascular
remodeling after changes in transmural flux, as would
occur with altered pressure distribution during space
flight.
Future work
A panel of human PAR-1 promoter-luciferase con-
structs will be transfected into endothelial cells to identify
the promoter elements involved in the shear-induced reg-
ulation of PAR-1 gene. These results will help to clarify
the molecular mechanisms of the shear-mediated signal
transduction and will be useful to develop novel method-
ologies in gene therapy. Furthermore, the role of the
cytoskeleton in transmitting the mechanical forces from
the membranes to the nucleus leading to gene regulation
Fig 1.
Fig 2.
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will be investigated using specific compounds that disrupt
the individual cytoskeletel elements of vascular cells.
Larry V. McIntire, PhD
Maria Papadaki, PhD
Kytai Truong Nguyen
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EXPRESSION OF TISSUE FACTOR AND TIS-
SUE FACTOR PATHWAY INHIBITOR BY VAS-
CULAR ENDOTHELIUM: EFFECTS OF SHEAR
STRESS AND ENDOTHELIAL CELL ORIGIN
Endothelial cells in vivo experience three significant
physical forces related to blood flow. Fluid shear stress
induced by blood flowing along the endothelial surface is
one of these and may be characterized in terms of its mean
level, spatial gradients, flow pulsatility, and any flow turbu-
lence. Another is transmural pressure, the force acting nor-
mal on the vessel wall and chiefly responsible for both radi-
al wall displacements and possible endothelial cell compres-
sion. The third is wall stretching and flexion due to pulsatile
blood flow and the viscoelastic nature of the blood vessel
wall itself. Effects of these physical forces on endothelial cell
function have been reviewed elsewhere.1 Of special interest
with respect to the problem of intravascular thrombosis are
the effects of shear stress on the expression of tissue factor
(TF) and tissue factor pathway inhibitor (TFPI) by activat-
ed and nonactivated endothelial cells.
TF is the membrane-bound glycoprotein that serves as
the nonenzymatic cofactor for factor VII/VIIa in the initi-
ation of blood coagulation, and TFPI, its principal inhibitor,
binds to both activated factor X and the ternary complex
formed by TF, factor VIIa and factor X. Both TF and TFPI
are made by endothelial cells, the former usually only after
cell activation. Available evidence suggests that TF activity is
frequently identifiable on the surface of activated, cultured
endothelial cell monolayers but is not normally found on
human endothelium in vivo. TF has not been found in nor-
mal vessels and tissues or in saphenous veins and internal
mammary arteries obtained during coronary bypass surgery,
although TF mRNA and protein are expressed in
macrophages, foam cells, monocytes adjacent to cholesterol
clefts, and smooth muscle cells.2 More recently, digoxi-
genin-labeled factors VIIa and X have been employed to
demonstrate the presence of TF not only in atherosclerotic
plaques but also in some endothelial cells overlying these
plaques.3 Cell culture studies, on the other hand, have long
shown the presence of functional TF on the surface of
endothelial cell monolayers.4,5 These contrasting in vivo
and in vitro findings may be explained in part by differences
in methodology, which have focused on functional mea-
surements in in vitro work but antigen and mRNA detec-
tion in most in vivo work. Indeed, the author’s impression
is that detection of TF antigen on endothelium is more dif-
ficult than measurement of the functional presence of TF.
In this work, we examine a second possibility: shear stress
down regulation of TF and TF mRNA in vivo and in vitro.
We therefore have studied the expression of TF under con-
ditions of stasis, venous shear stress, and arterial shear stress.
Methods
Endothelial cell monolayers and subendothelium
For studies of production of factor Xa (see below)
human umbilical vein endothelial cells (ECs) were har-
vested as described elsewhere6 and seeded on Permanox
chamber-slides (21 mm · 45 mm; Nalge Nunc, Inc,
Naperville, Ill) precoated with fibronectin (10 m g/mL).
Media consisted of M199, fetal calf serum, heparin,
endothelial cell growth supplement, L-glutamine, peni-
cillin/streptomycin, and supplemental sodium bicarbon-
ate. Monolayers were used when fully confluent.
Subendothelial matrices derived from these monolay-
ers were prepared by incubating monolayers with 0.1 N
NH4OH for 5 minutes to disrupt endothelial cells.7 In the
case of shear preconditioning (see below), cell removal
was performed in the flow chamber itself.
Tissue factor antigen
TF antigen was identified using an avidin-biotin com-
plex (Vector Laboratories, Burlingame, Calif). Primary TF
antibody was a polyclonal anti-human TF antibody raised
in rabbits to the extracellular domain of recombinant sol-
uble TF (courtesy of Dr Y. Nemerson, Mt Sinai Medical
Center, New York, NY).
Tissue factor mRNA
For mRNA studies, for which a larger surface area of
endothelial cells was desired per experiment, ECs were
cultured as previously but onto 38 mm · 75 mm glass
slides (Fisher Scientific Co, Pittsburgh, Pa) precoated with
fibronectin (10 m g/mL; Collaborative Biomedical
Products, Bedford, Mass). After exposure to stasis or shear
stress, cells were harvested for isolation of total RNA using
the guanidine isothiocyanate method. RT-PCR was per-
formed as described.8 Oligonucleotide primers for TF
were synthesized from published primer sequences.9
Shear preconditioning
Monolayers were mounted in specially designed parallel-
plate flow chambers, one of which10 accomodated the 21
mm · 45 mm Permanox slides, and the other11 accepted the
larger 38 mm · 75 mm glass slides. The first chamber was
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perfused with complete culture medium containing 50
U/mL IL-1-alpha (Genzyme, Inc, Cambridge, Mass) by
interposing the chamber between a sterile reservoir within an
incubator and a withdrawal pump (shear stress of 0.68
dyne/cm2) or by placing the chamber in a recirculating flow
device (within an incubator) driven by a gravity head in turn
maintained by a roller pump (shear stress of 13.2 dyne/cm2).
The second chamber was perfused only with the recirculating
device owing to the larger flow rates required for the same
shear stresses, given its larger cross-sectional area. Control
(static) monolayers were placed in an incubator in a tissue cul-
ture dish containing complete media and the same concen-
tration of IL-1-alpha. Duration of flow (or stasis) with simul-
taneous IL-1-alpha exposure was 4 hours.
Chromogenic assay for factor Xa
As a measure of functional TF, we determined levels of
activated clotting factor X (factor Xa) appearing in the
supernatant of intact endothelium or subendothelial
matrix using an amidolytic technique.12 Factor Xa pro-
duction was assayed for both intact endothelium and
subendothelial matrix in the same flow chamber (shear
preconditioned monolayers) under “quasi-static” condi-
tions at 0.054 dyne/cm2 or were mounted for assay pur-
poses in an identical chamber (control “static” monolay-
ers) at 0.054 dyne/cm2. The low shear stress during the
factor Xa assay was sufficient to allow chamber outflow
sampling (over a 40-minute period) but without disas-
sembly of the flow chamber.
Control experiments under “true” static conditions
were performed by adding the reaction complex directly to
washed chamber slides. These control experiments includ-
ed ones in which slides were incubated for 30 minutes with
a murine monoclonal antibody to human TF (Product
#4509, American Diagnostica, Greenwich, Conn). A con-
centration of 30 nmol/L was employed to inhibit virtually
all TF activity on intact endothelium,12 and preliminary
experiments showed that even 300 nmol/L inhibits only a
portion of the apparent activity in subendothelial matrix.
Results
Role of shear preconditioning
Preconditioning of the endothelial cells with shear stress
for 4 hours markedly reduced functional TF as assayed on
both intact endothelium and subendothelium. For static
controls, factor Xa production in fmol/min · cm2 (mean ±
SE [N]) was 8.0 ± 1.2 (9) for intact endothelium and 6.6 ±
1.1 (16) for subendothelium. The reduction for both intact
endothelium and subendothelium was more than two-fold
when shear stress was increased from zero (static controls)
to 0.68 dyne/cm2, and detectable factor Xa vanished alto-
gether at 13.2 dyne/cm2. Control experiments with an
antibody to TF, 30 nmol/L in the case of intact endotheli-
um and 300 nmol/L in the case of subendothelium,
demonstrated reductions of 59% and 47%, respectfully.
No change in endothelial cell monolayer morphology
was observed at 4 hours and over the range of shear stress
from zero to 13.2 dyne/cm2.
TF antigen on intact endothelium decreased in stain-
ing intensity with increasing shear stress. Staining on
matrix preparations showed occasional fragments of
endothelial cell membrane.
RT-PCR demonstrated a shear-stress associated diminu-
tion in TF mRNA compared with control GAPDH mRNA
(data not shown).
Conclusion
We report here that shear stress reduces the expression
of TF by both intact, activated endothelial cell monolayers
and subendothelial matrices derived from these monolayers.
In view of a parallel decrease in TF mRNA, the effect takes
place at least in part at the level of transciption or mRNA
stability. Other workers9 have reported a decrease with
repect to shear stress in both functional TF and TF mRNA
by TNF-alpha-activated endothelial cells, the magnitude of
the decrease being dependent on both shear intensity and
duration. In the “closed” cone-in-plate system used by
these investigators, it is possible that TFPI accumulated
over time and contributed to the observed effect for intact
endothelium. In contrast, the reduction in functional TF of
the present study was observed in a single-pass system,
which eliminates the possibility of TFPI accumulation, if
not a role for TFPI. This is not a trivial matter, as the pres-
ence of an antibody directed against Kunitz domain I of
human TFPI has been found by us to lead to a 2.4-fold to
3.7-fold increase in functional TF on intact endothelium,8
indicating a marked down regulation by TFPI of endothe-
lial cell functional TF under normal circumstances. No such
increase was observed with subendothelial matrices.
The inhibition of factor Xa production by anti-TF,
although substantial, is incomplete (of the order of 45% to
60%). For intact endothelium, this may be due to the fact
that the epitope recognized on TF for this particular anti-
body is somewhat removed from the functional domains
of TF. For subendothelium, matrix proteins may in addi-
tion offer steric hindrance to the antibody, effectively
sequestering a portion of the TF.
These findings suggest that flow has a direct effect in
diminishing the potential for activated endothelial cells
to generate functional TF. Conversely, one may speculate
that stasis in vivo may promote coagulation by permit-
ting the reverse to occur: the relative upregulation of TF
and TF mRNA compared with that which exists under
normal venous or arterial flow conditions. Such a process
may be operative in deep venous thrombosis or in coro-
nary artery thrombosis as a compounding event after
acute near-closure due to platelet thrombi or vessel
spasm. Although the precise mechanism for this flow
effect remains unknown, it is clear that down regulation
of both TF mRNA and factor Xa production under shear
conditions occurs at the level of transcription. The pre-
cise role of TFPI under flow conditions is an object of
the current study.
Eric F. Grabowski, MD, ScD
Massachusetts General Hospital
Boston, Mass
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FLOW AND TGF-b SIGNALING IN VASCULAR
ENDOTHELIUM
Vascular endothelium is an important transducer and
integrator of both humoral and biomechanical stimuli
within the cardiovascular system. This single cell–thick tis-
sue plays a central role in the maintenance of vascular
homeostasis in health, and its modulation to a maladaptive
or dysfunctional phenotype is thought to be a critical step
in the initiation of vascular disease (eg, atherosclerosis).
The identification and characterization of the endothelial
genes involved in these processes is an important area of
investigation.
The TGF-b superfamily of growth factors constitutes a
large and diverse family of protein growth factors (eg, TGF-
b s, BMPs, activins) that play important roles in processes
ranging from differentiation and development to the regu-
lation of cell growth and extracellular matrix biology.
Through the work of many investigators, there is increasing
evidence for an important role of the TGF- b family of
growth factors in vascular disease pathogenesis. However,
despite the compelling evidence for the role(s) of this fami-
ly of growth factors in vascular diseases, little is known
about the mechanisms at the cellular and molecular level by
which these factors elicit their effects in vascular cells.
MAD-related proteins (now known as Smad proteins)
are a newly identified family of intracellular proteins that
are thought to be essential intracellular components in the
signaling pathways of the serine/threonine kinase recep-
tors of the TGF- b superfamily.1,2 There are currently at
least eight known human Smad proteins. Sequence analy-
sis of this class of proteins reveals a family of closely relat-
ed species of approximately 400 amino acids that do not
contain any obvious homologies to other classes of pro-
teins. Some Smad proteins are thought to function as reg-
ulated transcriptional effectors.
We have demonstrated that in endothelial cells the
human Smad2 protein can function as a TGF-b —regulat-
ed transcriptional activator.3 Upon TGF- b stimulation,
Smad2 present within the cytoplasm of the cell interacts
directly with the intracellular portion of the activated type
1 TGF-b receptor present at the cell surface and is phos-
phorylated by the kinase domain of the receptor on a spe-
cific set of C-terminal serine residues. Phosphorylated
Smad2 is then released from the receptor and interacts
with a distinct Smad, Smad4, also present in the cytoplasm
of the cell. This heteromeric complex subsequently
translocates to the nucleus of the endothelial cell where
these proteins can modulate gene expression. This process
requires specific domains of the Smad2 and Smad4 pro-
teins that contain transcriptional activation activity and
involves a functional interaction with the conserved tran-
scriptional coactivators CBP/P300 in endothelial cells.3,4
Utilizing a differential display strategy to identify flow
regulated genes in endothelial cells,5 we recently identified
two additional members of the Smad family expressed in
human endothelial cells now known as Smad6 and
Smad76. The Smad6 and Smad7 proteins are encoded by
two unique genes that were found to be selectively
inducible in cultured human vascular endothelial cells by
steady laminar shear stress, a physiologic fluid mechanical
stimulus.6 Smad6 and Smad7 possess unique structural fea-
tures (compared with previously described Smads, such as
Smad2 and Smad4, discussed previously) suggesting that
they subserve unique functions. Indeed, transient overex-
pression of Smad6 or Smad7 in vascular endothelial cells
potently inhibits the activation of a transfected TGF- b
responsive reporter gene.
We have gone on to demonstrate that Smad7 can
inhibit TGF-b signaling by interacting in a stable way with
the activated TGF-b type 1 receptor at the cell surface thus
blocking the ability of Smad2 to interact with this recep-
tor.7 Smad6 appears to inhibit TGF- b signaling via a dis-
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tinct mechanism in endothelial cells involving the disrup-
tion of required Smad2-Smad4 protein-protein interac-
tions. Thus, Smad6 and Smad7 constitute a novel class of
Smad proteins, termed vascular Smads, that are inducible
species, capable of negatively modulating TGF- b signaling.
Interestingly, both of these proteins appear to manifest an
endothelial-selective pattern of expression within the nor-
mal arterial vasculature, suggesting that the flow respon-
siveness of these genes observed in vitro is relevant to their
expression in vivo. Furthermore, the observation that flow
stimuli, such as shear stresses, can modulate the expression
of these novel Smad proteins in endothelial cells suggests
that there are important interactions between the TGF- b
and flow signaling pathways in these cells. Current efforts
are directed at trying to understand the role(s) of Smad
proteins in the transduction of biomechanical stimuli (in
addition to humoral stimuli) in vascular cells.
In summary, Smad protein signaling in endothelial
cells is a complex, regulated process involving multiple
functionally distinct classes of Smad proteins. Smad pro-
tein-mediated signaling may represent a potentially impor-
tant mechanism by which endothelial cells integrate and
transduce both biomechanical (eg, shear stress or flow)
and biochemical (eg, TGF-b superfamily) stimuli. As such,
these proteins may be important targets for future diag-
nostic and therapeutic initiatives in vascular disease.
James N. Topper, MD, PhD
Falk Cardiovascular Research Center
Stanford University School of Medicine
Stanford, Calif
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POSTER SESSION
MONOCYTE ADHESION TO INJURED VES-
SELS: SPECIFIC INHIBITION OF FIBRINO-
GEN/MAC-1 INTERACTION BY 1-DOMAIN
PEPTIDE
We previously showed that mAb 7E3, which was
raised against platelet integrin a IIIbb 3 and cross reacts with
the monocyte integrin a Mb 2 (Mac-l), inhibits binding of
monocytes to both fibrinogen (Fg) in vitro and balloon-
injured arteries ex vivo. Epitope mapping localized the
7E3 recognition site to a portion of the I-domain of the
a M subunit. We used synthetic I-domain peptides to study
the specific role of Fg/Mac-l interactions in mediating
monocyte adhesion to sites of vascular injury.
Peptides R1.1 (GCPQEDSDIAFLIDGSGSIIPHDF)
and R1.2 (control) had been derived from adjacent 7E3-
binding and nonbinding regions of a M, respectively.
Balloon injury of the iliofemoral arteries was performed in
NZW rabbits (n = 12). In three animals, a unilateral injury
was performed with a contralateral sham; all others were
injured bilaterally. Vessels were harvested 30 minutes–7
days after injury for ex vivo monocyte adhesion. Vessel
segments were pretreated with peptide (500 m g/mL, 30
minutes, at 22°C), incubated with 51Cr-labelled THP-1
cells for 1 hour, rinsed, and bound radioactivity deter-
mined. An in vitro assay was also done using Fg-coated
wells, THP-1 cells, and peptide. In vitro, R1.1 decreased
monocyte adhesion to Fg by 74% compared with R1.2
(1433 ± 419 cells/well vs 5603 ± 1204 cells/well).
Balloon injury induced a more than five-fold increase in
THP-1 adhesion compared with sham injury. Balloon-
injured, R1.1-treated arteries demonstrated significantly
less monocyte adhesion (12,036 ± 4938 cells/cm2 vs
22,080 ± 6408 cells/cm2) compared with R1.2. These
data support a critical role for Fg/Mac-l interactions on
injured vascular surfaces and may provide an avenue for
early modification of postinjury inflammatory and throm-
botic cascades.
Sidhu P. Gangadharan, MD
Janet Plescia, BS
Mohanned Eslami, MD
Dario C. Altieri, MD
Michael S. Conte, MD
Brigham & Women’s Hospital
Boston, Mass
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ENDOTHELIAL NITRIC OXIDE SYNTHASE
(eNOS) IS NOT REQUIRED FOR BASIC
FIBROBLAST GROWTH FACTOR (bFGF)
INDUCED ANGIOGENESIS IN VIVO
Nitric oxide has been implicated as a crucial signaling
molecule and regulator in angiogenesis, a process that
requires endothelial cell proliferation, migration, and dif-
ferentiation. bFGF is a potent angiogenic factor that has
been shown to induce the cellular responses associated
with angiogenesis, including endothelial cell division and
migration. In vitro, bFGF increases NO production by
stimulation of eNOS expression. However, the absolute
requirement of eNOS for bFGF-induced angiogenesis has
not been established. We approach this question by carry-
ing out experiments using eNOS–/– gene deficient mice.
We injected 0.5 mL of growth factor reduced Matrigel
mixed with and without bFGF (40 ng/mL) subcuta-
neously into the abdomen of wild-type and eNOS–/–
mice. Matrigel, an artificial basement membrane matrix,
was the substrate on which endothelial cells from sur-
rounding vessels migrate, proliferate, and form capillaries.
At 10 days, the Matrigel plugs were recovered, fixed, and
processed for H&E staining. Angiogenesis was measured
by the number of vessels penetrating the Matrigel plug.
The finding that angiogenesis is significantly attenuat-
ed in eNOS–/– mice clearly established the essential role of
eNOS in angiogenesis. However, the upregulation of
angiogenesis in the eNOS–/– mice by bFGF to a degree
comparable with that of the wild-type mice suggests the
existence of alternative compensatory signaling pathway
other than eNOS and NO that mediates the effects of
bFGF. Elucidating and manipulating these intracellular
signals in the future might have a therapeutic role in mod-
ulating angiogenesis, with important implications in
tumor biology, wound healing, and formation of collater-
al vessels in response to ischemia.
Paul C. Lee, MD
Timothy R. Billiar, MD
Simon C. Watkins, MD
Bartley P. Griffith, MD
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ARTERIAL REMODELING IN THE RABBIT:
STRUCTURAL CHANGES IN RESPONSE TO
CHRONIC HINDLIMB ISCHEMIA
Background: The structure of arteries changes in
response to changes in flow. Most studies of flow-induced
arterial remodeling either focus on the microcirculation,
employ nonphysiologic flow models (AV fistula), or use acute
measurements of flow. We used a chronic, conscious rabbit
model of remodeling of the internal iliac artery (IIA) after
external iliac (EIA) ligation to study the interaction of flow
and structural changes in a large conduit artery collateral.
Methods: Thirty-four adult male NZW rabbits under-
went distal right EIA ligation or sham operation. Animals
had aortography at 0, 1, 2, 4, or 8 weeks, were killed, and
perfusion fixed, and the IIAs were excised. Luminal diam-
eter (LD) and medial thickness (MT) and medial smooth
muscle nuclear number (NN) were measured in the IIA by
computer digital image analysis. Transit time flow probes
were placed on the common iliac artery (CIA) of 28 addi-
tional rabbits 1 week before EIA ligation. Flow data were
measured daily. Data (mean ± SEM) were analyzed by
ANOVA (*P < .05).
Results: Right IIA LD increased more than 20% at 2
weeks and more than 40% at 8 weeks. Right IIA MT
increased in a bimodal fashion at 1 and 4 to 8 weeks. Right
IIA wall area increased progressively from 20% at 1 week
to 80% at 8 weeks (P < .05). NN did not increase until 8
weeks (875 + 71 vs 558 + 32; P < .001). Shear rate
increased early but normalized by 2 weeks and was less
than baseline at 8 weeks.
Conclusion: This model of modestly increased collater-
al flow demonstrates arterial remodeling with increased
arterial diameter, luminal area, wall thickness, and nuclear
number. These structural changes are first seen at 1 to 2
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weeks and are complete at 8 weeks. Because the early
increase in medial thickness is not associated with an
increase in cell nuclei, early remodeling may involve changes
in extracellular matrix. Late remodeling may involve
smooth muscle proliferation. The temporal discordance
between structural change and shear normalization suggests
that factors other than shear normalization may either initi-
ate or perpetuate the arterial remodeling in this model.
Brian G. Halloran, MD
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VASCULAR ENDOTHELIAL GROWTH FAC-
TOR INHIBITS APOPTOSIS IN VASCULAR
SMOOTH MUSCLE CELLS EXPOSED TO
ULTRAVIOLET B IRRADIATION
Deregulated apoptosis among vascular smooth muscle
cells (VSMC) can undermine the integrity of an athero-
sclerotic plaque and contribute to the rupture of its
fibrous cap. Vascular endothelial growth factor (VEGF) is
produced by VSMC and is present in atherosclerotic
lesions. Although VEGF has well characterized interac-
tions with endothelial cells, its effect on VSMC apoptosis
has not been examined. We demonstrate that VEGF atten-
uates apoptosis in VSMC that have been exposed to UVB
irradiation.
Methods: Cultured human VSMC were subjected to
40 J of UVB irradiation and then replenished with fresh
media containing 10 ng/mL of VEGF. Control cells were
shielded with opaque covers during UV exposure.
Eighteen hours after exposure, the cells were collected and
analyzed using an enzyme linked immunoabsorbent assay
for histone-associated DNA fragments. The degree of
apoptosis was measured as light absorbance at 405 nm.
Results: UVB irradiation consistently induced apopto-
sis: the average absorbance of exposed cells was 1.43 ver-
sus 0.54 for control cells (n = 8). Adding 10 ng/mL of
VEGF after UV exposure significantly reduced the level of
apoptosis by an average of 42% (n = 4). VEGF did not
have any effect on non-exposed cells.
Discussion: UVB irradiation is a reliable and valid model
that induces apoptosis via the same molecular pathways that
can be demonstrated in atherosclerotic lesions. Although
VSMC reportedly do not express VEGF receptors, we have
shown that VEGF significantly attenuates apoptosis in
VSMC. In an ongoing project, immunohistochemistry will
be used to determine whether apoptotic stimuli induce
VEGF receptor expression in VSMC, and cellular proteins
will be analyzed to study the mechanism whereby VEGF
inhibits VSMC apoptosis. Our preliminary data implicate
VEGF as an important regulator of VSMC apoptosis.
Michael J. Costanza, MD
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MITOGENICITY OF VEGF ± HEPARIN IN 
FIBRIN GLUE (FG)
FG has been used for local cytokine delivery on both
vascular grafts and angioplasty sites. We measured the dif-
fusive release of VEGF165 and of heparin from FG and the
mitogenic activity of VEGF165 ± heparin in FG on canine
endothelial cells (EC) and smooth muscle cells (SMC).
125I-VEGF and 3H-heparin release from FG into the
overlying media was serially measured over 96 hours, and
the data are reported as the mean % released ± standard
deviation. SMC or media only (no cells) were plated on FG
containing radioactive VEGF or heparin in an immediate
or 24 hour delayed fashion for 72 hours to determine the
% release of VEGF and heparin into the media with the two
different methods of plating. For proliferation assays,
media were placed on the FG for 24 hours and removed
before plating cells to minimize the effect of the soluble
VEGF and heparin. Proliferation assays were performed for
EC and SMC plated on FG containing various concentra-
tions of VEGF and heparin with media containing 10%
serum. Data are shown as mean % of negative control (FG
with no additives) ± standard deviation.
At 24 hours, 54 ± 1% and 58 ± 1% of the radioactive
VEGF and heparin were released, respectively, with mini-
mal rebase thereafter (58 ± 1% and 66 ± 1% at 96 hours).
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The presence or absence of cells did not effect VEGF or
heparin release, but there was 3 · more VEGF and 4· more
heparin in the media for the immediate versus delayed plat-
ing (P < .001 for both VEGF and heparin), which validates
the use of delayed plating. With no heparin, VEGF of 100
ng/ml or more was needed to induce EC proliferation.
Heparin at 5 U/mL enhanced EC proliferation at the
VEGF 100 ng/mL dose as compared with no heparin (P <
.001) but not at the VEGF 1000 ng/mL dose, which like-
ly represents a maximal response. With heparin at 500
U/mL, the EC died. In contrast, VEGF ± heparin did not
affect SMC proliferation.
For in vivo use, VEGF at 1000 ng/mL should leave
mitogenic concentrations of VEGF intact after the initial,
diffusive loss and the addition of heparin 5 U/mL may
enhance VEGF mitogenic activity. We conclude that FG
with VEGF 1000 ng/mL and heparin 5 U/mL is the
optimal concentration because this will encourage EC, but
not SMC, proliferation.
Paula K. Shireman, MD
Howard P. Greisler, MD
Loyola University Medical Center
Maywood, Ill
HYALURONAN IS INDUCED BY ARTERIAL
INJURY AND PROMOTES COLLAGEN GEL
CONTRACTION BY SMOOTH MUSCLE CELLS
(SMC) AND ADVENTITIAL FIBROBLASTS:
POTENTIAL ROLE IN POST-ANGIOPLASTY
REMODELING AND RESTENOSIS
Restenosis after arterial reconstruction remains an
enormous clinical problem caused in large part by changes
in artery wall geometry (remodeling). Hyaluronic acid
(HA) has been shown to play an important role in tissue
reorganization after injury. We hypothesized that HA
alters the interaction of SMCs and myofibroblasts with
other matrix components, such as collagen, modulating
tissue contraction at sites of arterial injury. To test this
hypothesis, the pattern of HA staining was characterized
in the artery wall of atherosclerotic monkeys after angio-
plasty. The effect of HA on collagen gel contraction by
SMCs and adventitial fibroblasts was also determined. HA
staining increased in the artery wall at 4 days after angio-
plasty and at 14 days in the early neointima. HA staining
was diffuse within the neointima at 28 days, and quantita-
tive analysis showed significant increases in the intima and
media (P < .001; n = 36) but not the adventitia. Staining
persisted in the neointima at 4 months. Contraction of
collagen gels was similar at 18 hours (~60%) for monkey
aortic SMCs and adventitial fibroblasts. HA increased gel
contraction in a dose-dependent manner (P < .05 for 25%
and 50% HA). The affect may be physical, or steric,
because HA failed to increase gel contraction if the cell-to-
collagen ratio was held contant and contraction increased
in the absence of HA when cell-to-collagen ratio was
increased. In summary, HA is a prominent component of
the extracellular matrix at sites of arterial injury and pro-
motes collagen gel contraction in culture, possibly by
improving cell-collagen interaction. Strategies to alter HA
elaboration at sites of arterial injury may improve artery
wall remodeling and thus inhibit restenosis.
Michael G. Hughes, BA
James M. Wong, MD
Lisa Gotow, MS
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PHYSIOLOGIC EFFECTS OF STRESS ON VAS-
CULAR SMOOTH MUSCLE
Background: It has been proposed that the small heat
shock protein, HSP27, regulates contractile responses of
vascular smooth muscle (VSM). Cellular stressors (arsen-
ite) lead to increases in the phosphorylation of HSP27. We
hypothesized that stress would lead to alterations in the
contraction or relaxation of VSM.
Methods: Bovine VSM strips were equilibrated in
buffer, and physiologic responses were determined in a
muscle bath. The strips were treated with buffer alone
(control, C), arsenite (0.5 mmol/L, 30”, AS), in the pres-
ence or absence of SB203580, which inhibits HSP27
phosphorylation. The VSM was equilibrated for 2 hours
and then treated with the contractile agonist serotonin (5
HT, 1 m mmol/L, 10”) followed by the adenylate cyclase
activator, forskolin (Fsk 10–5 mol/L). The contractile
results are the % of contraction to an initial high KCI con-
traction (110 mmol/L) and relaxation as % relaxation (±
SEM, *P < .05, ANOVA, n = 8).
EC SMC
VEGF (ng/mL) 0 10 100 1000 100
No heparin 100 ± 6 100 ± 4 115 ± 4* 159 ± 7* 106 ± 3
Heparin 5 97 ± 5 100 ± 3 136 ± 6*† 156 ± 10* 111 ± 5
Heparin 50 91 ± 7 92 ± 6 116 ± 10* 121 ± 10* 103 ± 6
Heparin 500 8 ± 3 5 ± 3 5 ± 2 2 ± 1 103 ± 6
*P < .01 versus same heparin, no VEGF.
†P < .001 versus VEGF, no heparin.
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Results: Stress alone (AS) did not inhibit contractile
responses (Fig l) but decreased the relaxation response (Fig
2). The effects of arsenite were inhibited by SB203580.
Conclusion: Stress does not effect contraction respons-
es but impairs cyclic nucleotide-dependent relaxation.
These effects were inhibited by SB203580, suggesting the
effects of stress are mediated by HSP27 phosphorylation.
Louis F. Knoepp, MD
Colleen M. Brophy, MD
Arthur Beall, PhD
Medical College of Georgia
Augusta, Ga
FUNCTIONAL ROLE OF CONNECTIVE TIS-
SUE REPAIR IN EXPERIMENTAL AORTIC
ANEURYSMS
Purpose: To determine the temporal changes in aortic
wall connective tissue proteins, the relative expression of
connective tissue genes, and the role of connective tissue
repair during the development of elastase-induced abdom-
inal aortic aneurysms (AAA).
Methods: Twenty-four male Wistar rats underwent
transient aortic perfusion with porcine pancreatic elastase.
Aortic diameters (AD) were measured with microcalipers,
and AAA were defined as an increase in AD of at least
100%. Aortic wall desmosine (Des) and hydroxyproline
(OHP) concentrations were measured before elastase per-
fusion (day 0) and at 2-day, 7-day, and 14-day intervals
later, and aortic wall expression of a 1(I) procollagen (PC),
tropoelastin (TE), and lysyl oxidase (LOx) was measured
by RT-PCR and Southern Blot analysis. The relative den-
sity of each mRNA species was normalized to that
obtained for GAPDH in the same sample. A separate
group of 16 animals was treated with BAPN, a LOx
inhibitor, after elastase perfusion.
Results: All animals developed AAA between days 7
and 14, with a mean increase in AD of 375.5%. Aortic wall
Des concentration decreased to 2.5% of normal by day 14,
but the decrease in OHP was less dramatic (67.8% of nor-
mal). Whereas the relative expression of both TE and PC
increased up to day 7, TE expression decreased by day 14
and PC continued to rise. In contrast, LOx expression
decreased substantially by day 14. In 13 of 16 BAPN-
treated rats (81%), acute aortic dissection developed
between days 3 and 6, coincident with aortic wall infiltra-
tion by inflammatory cells, with a 50% mortality from
either thrombosis or rupture.
Conclusion: Significant alterations in rat aortic wall
expression of connective tissue genes occur during the
development of elastase-induced AAA, along with a pro-
nounced decrease in elastin concentration and a stabiliza-
tion of aortic wall collagen. Rats treated with BAPN expe-
rience early deaths from aortic dissection at the same time
that proteinase-secreting inflammatory cells begin to infil-
trate the elastase-perfused aorta, suggesting that connec-
tive tissue repair is required to stabilize the aorta during
aneurysm development.
Mark D. Huffman, BS
John A. Curci, MD
Gail Moore, BS
Brent T. Kerns, MD
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Washington University School of Medicine
St Louis, Mo
AD mean Des pmol OHP nmol TE/GAPDH PC/GAPDH LOx/GAPDH
Day 0 1.63 mm 376.9 ± 21.6 121 ± 10 undetectable undetectable 3.09 ± 1.49
Day 2 2.25 mm 209.0 ± 18.1 70 ± 10 0.05 ± 0.03 0.19 ± 0.19 1.74 ± 0.68
Day 7 3.15 mm 175.0 ± 61.4 99 ± 15 0.18 ± 0.17 0.78 ± 0.78 1.42 ± 0.59
Day 14 7.75 mm 9.3 ± 1.4 82 ± 14 0.05 ± 0.04 0.87 ± 0.36 0.13 ± 0.05
